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Abstract 
 
 Fast photochemical oxidation of proteins (FPOP) has shown great promise in the 
elucidation of the regions of a protein’s structure that are changed upon interaction with 
other macromolecules, ligands, or by folding.  The advantage of this protein footprinting 
method is that it utilizes the reactivity of hydroxyl radicals to stably modify solvent 
accessible residues non-specifically in a microsecond.  The extent of •OH labeling at sites 
assays their solvent accessibility.  We have corroborated the predicted profoundly short 
timescale of labeling empirically, by FPOP-labeling three oxidation-sensitive proteins 
and examining their global FPOP product outcomes.  The novel test developed to validate 
conformational invariance during labeling can be applied generally to any footprinting 
methodology where perturbation to protein structure by the footprint labeling is 
suspected.  The stable modifications can be detected and quantified by the same 
proteolysis, chromatography, and mass spectrometry techniques employed in proteomics 
studies; however, proteomics software does not automatically report the residue-resolved 
full-sequence-coverage footprint information found in proteomics-like FPOP data.  Here 
we report the development of software tools to facilitate a comprehensive and efficient 
analysis of FPOP data, and demonstrate their use in a study of barstar in its unfolded and 
native states.  We next show that SO4-• can serve as an alternative non-specific labeling 
agent that can be generated by the FPOP apparatus on the same fast timescale as •OH.  
This demonstrates the tunable nature of FPOP.  We have used FPOP to characterize the 
oligomeric structures of three human apolipoprotein E (ApoE) isoforms and a monomeric 
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mutant in their lipid-free states.  Only one isoform of ApoE is strongly associated with 
Alzheimer’s disease; unfortunately, the structural reason for this association is not 
known, in part because no high resolution structure exists of any isoform.  We find that 
the three common isoforms of ApoE are very similar in their solvent accessible footprint, 
that their oligomeric interactions involve several regions in the C-terminal domain, and 
that the N-terminal domain of each resembles the monomeric mutant’s N-terminal 
domain, the truncated form of which has been characterized as a four-helix bundle.  
Finally, we find by FPOP that ApoE interacts with β-amyloid peptide 1-42 at a specific 
site in its N-terminal domain. 
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1 Mass Spectrometry-Based Protein Footprinting 
 
1.1 Protein Structure Determination 
1.1.1 High resolution determination. 
 The determination of tertiary and quaternary protein structure is the central issue 
in discovering the mechanisms of protein function.  X-ray crystallography is the 
preeminent methodology capable of providing high resolution three-dimensional 
macromolecular structure.  By this method, an electron density map is generated from the 
diffraction pattern created by X-rays diffracted by a protein crystal.  The primary 
sequence of the protein is modeled to fit this electron density map, resulting in a structure 
with atomic-coordinate detail for most of its atom.  At lower resolution the 
macromolecular shape can be determined.  Of the 72,717 structures entered in the protein 
data bank (www.pdb.org)1 as of April 2011, 63,322 were determined by X-ray 
crystallography.   
 The limitation of X-ray crystollography is primarily the limitation of protein 
crystallization.  Some proteins cannot crystallize because their native structure is only 
stabilized by interaction with other biomolecules, which cannot be sequestered in an 
ordered crystal.  Many transmembrane proteins fall in this category, though much 
progress has been made in their structural elucidation by crystallography2.  Other proteins 
may not crystallize owing to the highly variable conformations parts of their sequence 
visit.   The excision of such regions can give truncated protein variants that readily 
crystallize3.  This strategy is one of several employed in crystallography that may perturb 
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the structure of the protein from its native conformation.  Protein crystals are highly 
protein-concentrated.  Due to this property, the determination of the monomer structure 
of proteins that have a propensity to oligomerize can be difficult or impossible. 
 The remaining fraction of high resolution structures in the protein data bank have 
been determined by NMR spectroscopy.  This method utilizes the magnetic-spin 
properties of nuclei to determine distance constraints between the probed atoms of a 
macromolecule.  These constraints and the primary sequence of the protein are used to 
construct a high resolution model.  The NMR experiment is usually done on proteins in 
solution.  This has enabled the study of proteins in a dynamic context, including protein 
folding4, folding pathways5, and enzyme dynamics6.  The structural progression through 
such pathways can studied by NMR relaxation dispersion experiments that resolve short-
lived intermediate states and conformations of low abundance relative to the dominant 
equilibrium conformation7-8. 
 There are two primary limitations to NMR structural determination.  The first is 
that, just as for X-ray crystallography, certain proteins are not well suited to study 
because their native conformation is not stable under the conditions of the experiment.  
NMR typically requires 100s of µg of material and operates on high protein-concentrated 
solutions.  As well, very flexible proteins may present an ensemble of native 
conformations that thereby confounds resolved analysis.  The second limitation is that 
proteins <40 kDa are not well assayed by NMR unless they are highly symmetric, such as 
seen with the 900 kDa GroES-GroEL complex9.  Carbon-13, nitrogen-15, and fluorine-19 
labeling of proteins permits NMR experiments that focus on these nuclei.  For proteins 
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larger than 10 kDa, uniform 13C and 15N labeling is often employed to simplify the 
analysis without sacrificing structural resolution10.  In conjunction with 13C and 15N 
labeling, solid state magic angle spinning NMR (MAS NMR)11 can reveal the structure of 
proteins without the requiring their macroscopic alignment12; by this method the high 
resolution structures of membrane proteins have been determined13-14.  In proteins that 
are intractable to high resolution elucidation by NMR, 19F can be used to provide lower 
resolution information about domain and oligomeric properties15.   
1.1.2 Low resolution determination. 
 Other methodologies utilize the physical, nuclear, and electronic structure 
properties of the analyte protein to provide structural information about the protein by 
itself or in the context of an interaction.  By themselves, such particle scattering, 
spectroscopic and physical methods cannot provide the detail afforded X-ray and NMR 
techniques.  Cryo-electron microscopy (cryo-EM) is one method which, while it cannot 
determine individual protein structures at atomic resolution, is better suited for 
determining the gross structure of large biomolecular assemblies than either X-ray 
crystollography or NMR spectroscopy16-17.  A common theme for low resolution 
techniques like cryo-EM is that the interpretation of the technique’s data will coincide 
with the incorporation of X-ray or NMR high resolution structures, as components of the 
studied system or as a putative model of the system or part of the system18. 
 Circular dichroism (CD) spectroscopy has a long history of use as a technique to 
characterize the secondary structure content of proteins in solution19-20, wherein the 
allowed rotations between neighboring amide groups along the protein backbone are 
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probed.  This spectroscopic method sees the average of all positions in a protein in its 
average conformation.  For some protein systems, the ensemble of protein conformations 
may be broad.  This may obscure important macromolecular interactions present in a 
subset of proteins in the ensemble if inherently averaged spectroscopic methods are used.  
 Fluorescence spectroscopy and Förster (fluorescence) resonant energy transfer 
(FRET) have been used to rescue such interactions by allowing for exquisite—even 
single molecule21-22—detection of proteins.  FRET can provide quantitative distance 
information relating to the natural fluorophores tryptophan and tyrosine in their structural 
context, as well as strongly absorbing fluorophores like flouroscein and rhodamine when 
they are conjugated to the macromolecules or ligands.   In fluorescence correlation 
spectroscopy (FCS), the size and shape of macromolecules can be inferred from the FCS-
observed diffusion of a small number of such molecules in a very small volume.  From 
this geometric model the stoichiometry and subunit orientations of protein complexes or 
oligomers can be determined23. 
 Sedimentation and native gel electrophoresis techniques can distinguish protein 
complexes and oligomers from monomeric species.  Though clearly of low resolution, 
such information is critical to the understanding of quaternary structure, which more 
resolved methods may not be able to probe.  In addition, sedimentation experiments can 
be used to assay the shape of the macromolecule or complex24.  
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1.2 Mass Spectrometry-Based Footprinting 
1.2.1 General principles. 
An intermediate level of structural information can be realized by mass 
spectrometry (MS)-based protein footprinting.  Protein footprinting is an assay that 
monitors protein conformation by selectively labeling or cleaving residues.  This 
selectivity is in part a function of the target solvent accessibility, thus an implicit picture 
of protein structure is afforded by footprinting.  The ways of modifying residues are 
diverse and have been in practice for over forty years25.  More recently, the advent of 
macro-biomolecular mass spectrometry using ESI and MALDI ionization sources has 
enabled the study of proteins in physiologic quantities—though the ionization by these 
methods cannot be said to be “physiologic” in most applications26-27.  Certain 
modification strategies are well suited to mass spectrometric analysis as they can be 
employed under such physiologic conditions: aqueous neutral-buffered saline solution 
with dilute homogenous or mixed protein.  As a result mass spectrometry is an important 
contributor to the elucidation of protein structure, and to the understanding of protein 
intermolecular interaction: identifying partner binding sites, stoichiometry, affinity, and 
dynamics28.  
The standard approach in protein footprinting is to determine which sites or 
regions on a protein exhibit a change in solvent accessibility between two or more states 
of the protein.  This has been applied in thousands of studies that have variously 
examined protein folding29, complexation30, membrane orientation31, and other contexts 
effecting change in protein structure.  As long as the protein system is not perturbed by 
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the labeling, the extent of labeling will be attenuated in regions that have limited or no 
solvent accessibility.  For example, to map the binding site of a protein with its ligand, 
one applies labeling conditions identically to both apo and holo states, digests the protein 
by proteolysis, and examines the extent of labeling visited on each peptide by mass 
spectrometry.  Peptides or residues that have undergone more labeling in the apo state 
may comprise the ligand binding site, though they may instead be distal to it and are 
protected in the holo state by virtue of an allosteric response to binding.  As with other 
methodologies, this strategy is empowered by a priori knowledge of the apo structure; 
mapping the protected regions onto the high resolution structure can help distinguish 
binding sites from other regions sensitive to allostery32. 
1.2.2 Global experiments. 
 When comparing states of a protein system, the overall level of labeling of each 
state’s constituents is often informative of the presence of structural change, much like 
CD spectroscopy, and may provide important thermodynamic information.  Hydrogen 
deuterium exchange (HDX) is a footprinting technique that probes the solvent accessible 
and hydrogen bonding environment of amide backbone hydrogens33.  Commonly HDX 
experiments use pepsin proteolysis at low pH immediately after exchange labeling; the 
peptide products are then scanned by MS for peptide-resolved analysis.  Alternatively, by 
skipping the proteolysis step the total protein deuterium uptake can be monitored.  Such 
global analysis can detect whether protein rearrangement or binding is has occurred by 
comparison to a control state, for as few as 10 involved residues or fewer still, depending 
on experiment precision.  This is an important tool sensitive to secondary, tertiary, and 
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quaternary structural change, whereas CD spectroscopy only assays changes in secondary 
structure.  For example, by ligand titration the intermediate equilibria between apo and 
holo endpoint states scan be examined by HDX to elucidate the binding constant of the 
protein-ligand interaction34.  
1.2.3 Local experiments. 
 Ultimately mass spectrometry-based protein footprinting is used to examine 
changes in solvent accessibility at a peptide or residue-resolved level.  As mentioned, 
HDX is a prominent choice for peptide-resolved footprinting.  The advantage to this 
method is that it is non-residue specific in its amide labeling, except for proline.  
Moreover, the nature of HDX ensures that solvent-exposed amide hydrogens not 
involved in hydrogen bonding will be labeled with 100% efficiency for seconds-to-
minutes exposures.  A useful consequence of this is that determining the labeling yield 
for a peptide is done by measuring the change in mass of the peptide compared to its non-
labeled theoretical mass.  The more solvent-exposed residues a peptide possesses during 
the HDX exposure, the more its uptake mass will be increased.  This makes HDX and 
MS natural partners, because the potential ionization biases affecting mass spectral 
intensity35 are not shared by the m/z measurement.   
 Until recently, the goal for residue-resolved HDX footprinting could only be 
realized for those residues serendipitously overlapped by more than one pepsin 
proteolytic peptide36.  The collision induced dissociation (CID) fragmentation 
experiment, conducted in ion trap mass spectrometers, is used to generate the 
characteristic fragment ion spectra of peptides to uniquely identify their sequences.   This 
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experiment cannot be used to locate residue sites of HDX because of 1H-2H scrambling 
induced by the multiple collisions of CID37.  A new method of fragmentation called 
electron-transfer dissociation (ETD)38 has been demonstrated to solve this problem in the 
MS analysis of HDX-labeled peptides39.  In ETD, scrambling is less probable due to the 
near vertical electronic transition a peptide undergoes with the addition an electron, from 
which state fragmentation directly proceeds. 
 If the labeling is stable, identification of the modification sites can be done using 
a proteomics-based “bottom-up” mass spectrometry methodology40.  In this 
methodology, proteolytic peptides are chromatographically resolved and detected in a 
hybrid mass spectrometer capable of monitoring their accurate mass-to-charge ratios at 
high resolving power (ideally).  The instrument’s other spectrometer acquires the 
characteristic product ion spectra of peptide ions subjected to CID in an elution-
dependent manner.  The high-resolution LC-MS intensities provide a quantitative 
measure of each peptide, and their product ion spectra, acquired in this tandem MS/MS 
mode (MS2), can indicate their identity and modification site(s).  The yield of labeling at 
a residue or peptide is determined directly from levels of modified and unmodified 
peptides.  An important aspect of stable (irreversible) covalent labeling is that, unlike 
HDX, protein conformation may be very sensitive to the labeling.  If it is sensitive and its 
response occurs on the timescale of the labeling, the footprinting results will be biased by 
the sampling of these non-native structures.  Sufficient care must be taken in the 
experiment and its analysis to avoid such bias. 
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1.3 Hydroxyl Radical Footprinting 
1.3.1 Utility and chemistry 
 Hydroxyl radical labeling is a class of stable modification footprinting methods, 
each differentiated by the means of •OH generation.  Hydroxyl radicals well probe 
solvent accessibility by virtue of their comparable size to water and high reactivity to 
several amino acid sidechains.  The fundamental advantages to this strategy are twofold.  
(1) While modified protein is subjected to hours or days of handling and proteolysis 
before LC-MS/MS acquisition, the primary sequence of modified residues is preserved 
by virtue of the stability of the covalent modification.  (2) The hydroxyl radical is a 
general reactant, affording a higher resolution footprint than covalent approaches which 
target single chemical groups, such as the acetylation of primary amines.  Xu and Chance 
have shown in X-ray and γ-ray water radiolysis-initiated oxidation studies41-43 that 14 of 
the 20 amino acid sidechains and the disulfide bond can be reliably modified when 
solvent exposed. 
 While there are many pathways for •OH-mediated labeling on residue sidechains, 
the most common net mass shift is the +15.9949 Da incorporation of oxygen in air-
equilibrated solutions40-41, 43-44.  The initial •OH reaction is different for aromatic and 
sulfur-containing residues than for aliphatic residues, but the involvement of molecular 
oxygen, the involvement of secondary radical reactions, and the similarity of the end 
products gives credence to examining one pathway; shown is reaction of •OH with 
leucine (Scheme 1.1).  First, hydrogen is abstracted preferentially at the β- and γ- carbon 
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sites of the sidechain45, followed quickly by reaction with O2 to give a peroxy radical.  
The reaction with O2 is diffusion controlled in oxygenated solutions40, 46. 
 
Scheme 1.1: The partial mechanism of leucine oxidation by hydroxyl radical to form a 
hydroxylated product. 
 
There are several pathways by which the peroxy radical ultimately gives way to a 
hydroxyl modification; the other slightly less common product is a carbonyl 
modification40.  In these pathways, reaction with radical species is required to return the 
protein to an even-electron molecule.  The peroxy radical is capable of forming a dimer 
with other peroxy species such as HOO• and  O2•-, which through a cyclic transition state 
can give rise to carbonyl products47.  Table 1.1 lists the common modifications we have 
observed in our •OH-mediated protein footprinting experiments32, 48-51; these are 
consistent with the contemporary and preceding work of others in the field40. 
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Table 1.1: Initial •OH-amino acid sidechain reaction rates and common mass 
spectrometry-observed products of •OH-mediated protein footprinting 
amino acid 
k
•OH              
(M-1 sec-1)52 common modifications (Da)
40
 
Cys 3.5 x1010 –15.9772 +31.9898 +47.9847   
Trp 1.3 x1010 +3.9949 +15.9949 +31.9898 +47.9847  
Tyr 1.3 x1010 +15.9949 +31.9898 +47.9847   
Met 8.5 x109 –32.0085 +15.9949 +31.9898   
Phe 6.9 x109 +15.9949 +31.9898 +47.9847   
His 4.8 x109 –23.0160 –22.0320 –10.0320 +4.9789 +15.9949 
Arg 3.5 x109 –43.0534 +13.9793 +15.9949   
Ile 1.8 x109 +13.9793 +15.9949    
Leu 1.7 x109 +13.9793 +15.9949    
Val 8.5 x108 +13.9793 +15.9949    
Pro 6.5 x108 +13.9793 +15.9949    
Gln 5.4 x108 +13.9793 +15.9949    
Thr 5.1 x108 –2.0157 +15.9949    
Lys 3.5 x108 +13.9793 +15.9949    
Ser 3.2 x108 –2.0157 +15.9949    
Glu 2.3 x108 –30.0106 +13.9793 +15.9949   
Ala 7.7 x107 +15.9949     
Asp 7.5 x107 –30.0106 +15.9949    
Asn 4.9 x107 +15.9949     
Gly 1.7 x107 n.d.     
 
 While hydroxyl radicals are non-specific reactants, they do not label sidechains 
with equal efficiency.  The reaction rate of •OH with amino acid sidechains is 2000-fold 
higher for cysteine, the most reactive amino acid, than glycine, the least (Table 1.1).  The 
second order rates in Table 1.1. pertain to amino acids free in solution, not residues in a 
protein.  Even so, these rates reflect the inherent reactivity of residues in their fully 
exposed protein structural context: the MS-determined residue reactivity with •OH in 
unstructured peptides mirrors Table 1.1, with the exception that Met is second in the 
order42. 
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 Clearly another potential advantage to •OH-mediated footprinting is that it is so 
fast: the residue sidechain reactivity approaches the diffusion limit for Met, Trp, Tyr, and 
Cys residues.  Recently Chen and colleagues53 and Stocks and Konermann29 were able to 
probe sub-millisecond protein folding using a methodology, described below, which 
takes advantage of inherent reactivity of •OH to make microsecond “snapshot” footprints 
of the proteins. 
1.3.2 Methods of •OH-labeling 
 There are several hydroxyl radical footprinting approaches currently in use; a 
detailed review has been recently published40.  Among the first DNA-protein and protein-
ligand binding site footprinting studies have used hydroxyl radicals generated from 
catalytic Fenton chemistry54 consuming hydrogen peroxide55-56.  The Fe(II)-
EDTA/H2O2/ascorbate Fenton system is currently a standard means for studying DNA 
and RNA interactions57 because it allows for the stoichiometric generation of •OH from 
Fe(II) and H2O2 at neutral pH without risking Fe(III) precipitation as Fe2O3.  The 
ascorbate is used to make the iron catalytic as it reduces Fe(III) back to Fe(II). 
 The synchrotron X-ray and 137Cs γ-ray radiolysis methods generate hydroxyl 
radicals as the major reactive products from water radiolysis by high energy photons.  
The first step in •OH formation is the ejection of an electron from water.  This high 
energy electron ionizes other water molecules, which ultimately generates hydroxyl 
radicals and other less reactive oxidants58-59.  These methods have been successfully 
applied to footprinting DNA/protein interactions, RNA folding, and large proteins60-62.   
The synchrotron X-ray source produces a high intensity beam such that millisecond 
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exposures are sufficient to oxidize proteins63; longer times are typically needed for γ-ray 
radiolysis as the 137Cs source is not as intense64.  The benefit to the radiolysis method is 
that no additives are needed: water provides the source of •OH. 
 Ultraviolet light can homolytically cleave H2O2 to give •OH65.  Sharp and 
colleagues first demonstrated this method of footprinting by their oxidative-labeling of 
myoglobin, with •OH generated from 5 M H2O2 irradiated by 254 nm light66.  The 
quantum yield of  UV H2O2 decomposition was first measured at 0.567, but a more recent 
measurement has Φ = 0.80 ± 0.168. 
1.3.3 Fast Photochemical Oxidation of Proteins (FPOP) 
 Hambly and Gross50-51, and independently Aye and coworkers, have developed 
the method of fast photochemical oxidation of proteins (FPOP), which generates the 
radical from photolysis of hydrogen peroxide with pulsed 248 nm light69. At 248 nm the 
extinction coefficient is 24 cm-1M-1  68.  The KrF excimer laser UV source provides a high 
flux of light, minimizing the exposure of protein to peroxide—the standard protocol uses 
20 mM peroxide.  Glutamine is included as a radical scavenger to limit the timescale of 
oxidation.  The synchronization of the flow rate through the fused silica reaction cell with 
the excimer laser pulse frequency ensures all sample protein is irradiated once, but for a 
measurable exclusion fraction. 
 The primary advantage to FPOP is that the near mM •OH exposure of proteins is 
confined to a microsecond window, defined by the 17 ns laser pulse at its start and by the 
radical scavenging of glutamine.  By one microsecond the free [•OH] is 50,000-fold less 
concentrated than at the outset under typical FPOP conditions, according to the pseudo-
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first order analysis of its consumption51.  This timescale of labeling predicts that the 
labeling-perturbed conformations of proteins aren’t sampled by the labeling in cases 
where proteins are structurally sensitive to oxidation.  Studies by Chung and coworkers70-
71
 using 2D IR spectroscopy, dispersed vibrational echo spectroscopy, and MD 
simulation, showed that the fast-folding response of ubiquitin proceeds within 3 µs of an 
abrupt T-jump.  Although such perturbation is wholly different than chemical 
modification, the timescale of ubiquitin response is suggestive of the earliest global 
changes we may expect for proteins conformationally sensitive to oxidative modification.  
In some cases, still faster ns motions in regions of flexibility give rise to larger-scale 
slower motions in the protein’s exploration of conformation space72.  It is possible that 
initial modifications to such regions of high flexibility may alter the attendant structural 
progression of larger regions.  This should be kept in mind with all stable-modification 
footprinting methods, and is why FPOP, with its radical scavenger-tunable timescale, is 
an attractive footprinting method.  
1.4 Dissertation Topics 
1.4.1 Chapter 2  Validation of the FPOP timescale. 
 Like other chemical footprinting techniques, FPOP must ensure only the native 
conformation is labeled.  Although oxidation via hydroxyl radical induces unfolding in 
proteins on a millisecond timescale, FPOP is designed to limit •OH exposure to 1 µs or 
less by employing a pulsed laser for initiation to produce the radicals and including a 
radical-scavenger to limit their lifetimes.  We applied FPOP to three oxidation-sensitive 
proteins and found that the distribution of modification (oxidation) states is Poisson when 
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a scavenger is present, consistent with a single conformation protein modification model.  
This model breaks down when a scavenger is not used and/or hydrogen peroxide is not 
removed following photolysis.  The outcome verifies that FPOP occurs on a time scale 
faster than global conformational changes in these proteins.  This study has been 
published in Analytical Chemistry73. 
1.4.2 Chapter 3  Development of efficient and comprehensive footprinting analysis 
software. 
 Mass spectrometry-based protein footprinting is a powerful method for unveiling 
many kinds of protein interactions that cannot be studied by X-ray crystallography or 
NMR spectroscopy.  To realize the maximum information a protein footprinting study 
can offer, residue-resolution of the footprinting label is needed for every residue sensitive 
to the labeling chemistry.  Hydroxyl radical-mediated labeling has proven to be a very 
informative protein footprinting method, because of the number of solvent accessible 
residues that may be labeled by •OH.  The paradox of such a method is that finding all 
•OH-labeling fates in the proteolyzed sample’s LC-MS/MS acquisition data is daunting 
without the help of automated software.  While the proteomics field has enjoyed the 
concomitant development and refinement of bioinformatics software, these software are 
not well suited to the task of assigning most LC-MS features from related sets of LC-
MS/MS acquisitions to the modified and unmodified proteolytic peptides of one or a few 
proteins that have suffered a broad distribution of modifications.  We present Excel-based 
tools developed to facilitate this task, providing a means for achieving a comprehensive 
residue-resolved analysis of footprinting data in an efficient manner.  To demonstrate the 
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software and the utility of •OH-mediated labeling, we show that FPOP easily 
distinguishes the buried and exposed residues of barstar in its folded and unfolded states. 
1.4.3 Chapter 4  Extension of the FPOP method to new reagents. 
 The focus of this work is to expand the original design of FPOP and introduce 
SO4-•, generated by 248 nm homolysis of low mM levels of persulfate, as a radical 
reactant in protein footprinting.  A feature of FPOP is that its design accommodates other 
reagents, increasing its versatility.  The new persulfate FPOP system is a potent, non-
specific, and tunable footprinting method: 3-5 times less persulfate is needed to give the 
same global levels of modification seen with FPOP photolysis of hydrogen peroxide.  
Although solvent-exposed His and Tyr residues are more reactive with SO4-• than with 
•OH, a thorough LC/MS/MS and structural analysis of apomyoglobin and calmodulin 
labeled products, shows that •OH can probe smaller accessible areas than SO4-•, with the 
possible exception of when histidine is modified.  This is consistent with the larger size 
of the SO4-• compared to •OH.  We find that His64, an axial ligand in the heme-binding 
pocket of apomyoglobin, is substantially up-labeled by SO4-• relative to •OH.  Finally, 
because the kinds of modification and residue selectivity for both FPOP methods are 
strikingly similar, we believe the choice for either method should be made considering 
first the physical properties of persulfate and hydrogen peroxide, especially their 
membrane permeability. This study has been published in Analytical Chemistry48. 
1.4.4 Chapter 5  Application of FPOP: apolipoprotein E oligomerization. 
 The three common isoforms of apolipoprotein E (ApoE) differ at two sites in their 
299 amino-acid sequence but these differences modulate the structure of ApoE to affect 
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profoundly the isoform associations with disease.  The ApoE ε4 allele in particular is 
strongly associated with Alzheimer’s disease.  The study of the structural effects of these 
mutation sites in aqueous media is hampered by the aggregation proclivity of each ApoE 
isoform. Hence, understanding the differences between isoforms must rely on lower 
resolution biophysical measurements, mutagenesis, homology studies, and the use of 
truncated ApoE variants.  In this study, we report two comparative studies of the ApoE 
family by using the mass spectrometry-based protein footprinting methods of FPOP and 
glycine ethyl ester (GEE) labeling.  The first experiment examines the three full-length 
WT isoforms in their tetrameric state and finds that the overall structures are similar with 
the exception of M108 in ApoE4, which is more solvent-accessible in this isoform than in 
ApoE2 and ApoE3.  The second experiment provides clear evidence, from a comparison 
of the footprinting results of the wild-type proteins and a monomeric mutant, that several 
residues 183-205 and 232-251 are involved self-association.   
1.4.5 Chapter 6  Application of FPOP: apolipoprotein E monomeric mutant 
structure prediction. 
We validate the presumed four-helix bundle structure of the N-terminal domain of 
the full length Apolipoprotein E (ApoE) by means of protein footprinting using the 
method of FPOP in a new way.  The validation of this structure is made by comparison of 
the extent of oxidative modifications at the amino-acid  level with the calculated 
sidechain solvent-accessible surface area, taken from the most recent high resolution N-
terminal domain structure of truncated Apolipoprotein E.  We subjected a monomeric 
mutant of the Apolipoprotein E3 variant to FPOP footprinting to warrant conclusions 
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based on the monomeric structure of ApoE.  This study highlights the applicability FPOP 
footprinting for structural hypothesis testing when high-resolution studies are not 
possible, and it points to immediate application towards unraveling the structural 
differences between the wild type variants of Apolipoprotein E in lipid-free and –bound 
states.  
1.4.6 Chapter 7  Application of FPOP: apolipoprotein E-Αβ42 interaction. 
 The β-amyloid peptide 1-42 may be the most important biomolecule implicated in 
Alzheimer’s disease pathogenesis.  Cerebral plaques comprised of the insoluble fibrillar 
form of this peptide are found in all patients diagnosed with Alzheimer’s disease.  The 
soluble oligomers of β-amyloid 1-42 are neurotoxic.  The amyloid hypothesis suggests 
that the clearance of this peptide in the brain is central to affecting the likelihood of 
Alzheimer’s disease onset.  One protein known to interact with this peptide in its fibrillar 
and soluble forms is apolipoprotein E.  Strikingly, the apolipoprotein E4 isoform of this 
protein confers a 12-fold greater risk for Alzheimer’s disease for people with two copies 
of this allele than for people with no copies.  The molecular characterization of β-
amyloid interaction with apolipoprotein E isoforms has thus been an important goal of 
many studies; owing to the oligomeric properties of both biomolecules, no high 
resolution structure of the complex or of ApoE exists.  We have used the FPOP method 
of mass spectrometry-based protein footprinting to provide an intermediate-resolution 
picture of this interaction for lipid-free ApoE3 and ApoE4.  We find that both proteins 
exhibit Aβ42 binding in their N-terminus domains, involving residues W34 and Y36.  
Arginine 167 also shows significant protection in the Aβ42-present state.  It is not 
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contiguous in the N-terminus domain structures of ApoE, and we argue that this site is 
protected by a similar allosteric response by both proteins upon Aβ42 binding.  Proline 
293 is also involved in a C-terminal domain interaction in ApoE3, but the overall 
footprinting signals in the C-terminal domain suggest that this interaction is not as strong 
as the N-terminal domain.  These results are consistent with several studies that have 
examined the domain interactions with Aβ independently. 
1.5 References 
1. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, 
I. N.; Bourne, P. E., The Protein Data Bank. Nucleic Acids Research 2000, 28 (1), 235-242. 
2. White, S. H., Biophysical dissection of membrane proteins. Nature 2009, 459 (7245), 
344-346. 
3. Pantazatos, D.; Kim, J. S.; Klock, H. E.; Stevens, R. C.; Wilson, I. A.; Lesley, S. A.; Woods, V. 
L., Rapid refinement of crystallographic protein construct definition employing enhanced 
hydrogen/deuterium exchange MS. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (3), 751-756. 
4. Jane Dyson, H.; Ewright, P., Insights into the structure and dynamics of unfolded 
proteins from nuclear magnetic resonance. In Advances in Protein Chemistry, George, D. R., Ed. 
Academic Press: 2002; Vol. Volume 62, pp 311-340. 
5. Dyson, H. J.; Wright, P. E., Unfolded Proteins and Protein Folding Studied by NMR. 
Chemical Reviews 2004, 104 (8), 3607-3622. 
6. Schnell, J. R.; Dyson, H. J.; Wright, P. E., Structure, Dynamics, and Catalytic Function of 
Dihydrofolate Reductase. Annual Review of Biophysics and Biomolecular Structure 2004, 33 (1), 
119-140. 
7. Bouvignies, G.; Vallurupalli, P.; Cordes, M.; Hansen, D.; Kay, L., Measuring 
1
H
N
 
temperature coefficients in invisible protein states by relaxation dispersion NMR spectroscopy. 
Journal of Biomolecular NMR 2011, 50 (1), 13-18. 
8. Neudecker, P.; Lundström, P.; Kay, L. E., Relaxation Dispersion NMR Spectroscopy as a 
Tool for Detailed Studies of Protein Folding. Biophysical journal 2009, 96 (6), 2045-2054. 
9. Griswold, I. J.; Dahlquist, F. W., Bigger is better: megadalton protein NMR in solution. 
Nat. Struct. Mol. Biol. 2002, 9 (8), 567-568. 
10. Venters, R. A.; Calderone, T. L.; Spicer, L. D.; Fierke, C. A., Uniform carbon-13 isotope 
labeling of proteins with sodium acetate for NMR studies: application to human carbonic 
anhydrase II. Biochemistry 1991, 30 (18), 4491-4494. 
11. Andrew, E. R.; Bradbury, A.; Eades, R. G., Nuclear Magnetic Resonance Spectra from a 
Crystal rotated at High Speed. Nature 1958, 182 (4650), 1659-1659. 
12. Castellani, F.; van Rossum, B.; Diehl, A.; Schubert, M.; Rehbein, K.; Oschkinat, H., 
Structure of a protein determined by solid-state magic-angle-spinning NMR spectroscopy. 
Nature 2002, 420 (6911), 98-102. 
20 
 
13. Li, Y.; Berthold, D. A.; Gennis, R. B.; Rienstra, C. M., Chemical shift assignment of the 
transmembrane helices of DsbB, a 20-kDa integral membrane enzyme, by 3D magic-angle 
spinning NMR spectroscopy. Protein Sci. 2008, 17 (2), 199-204. 
14. Andronesi, O. C.; Becker, S.; Seidel, K.; Heise, H.; Young, H. S.; Baldus, M., Determination 
of Membrane Protein Structure and Dynamics by Magic-Angle-Spinning Solid-State NMR 
Spectroscopy†. J. Am. Chem. Soc. 2005, 127 (37), 12965-12974. 
15. Garai, K.; Mustafi, S. M.; Baban, B.; Frieden, C., Structural differences between 
apolipoprotein E3 and E4 as measured by 19F NMR. Protein Sci. 2009, 19 (1), 66-74. 
16. Jomaa, A.; Stewart, G.; Martín-Benito, J.; Zielke, R.; Campbell, T. L.; Maddock, J. R.; 
Brown, E. D.; Ortega, J., Understanding ribosome assembly: the structure of in vivo assembled 
immature 30S subunits revealed by cryo-electron microscopy. RNA 2011, 17 (4), 697-709. 
17. Wulff, R. P.; Lundqvist, J.; Rutsdottir, G.; Hansson, A.; Stenbaek, A.; Elmlund, D.; Elmlund, 
H.; Jensen, P. E.; Hansson, M., The Activity of Barley NADPH-Dependent Thioredoxin Reductase 
C Is Independent of the Oligomeric State of the Protein: Tetrameric Structure Determined by 
Cryo-Electron Microscopy. Biochemistry 2011, null-null. 
18. Zheng, W., Accurate Flexible Fitting of High-Resolution Protein Structures into Cryo-
Electron Microscopy Maps Using Coarse-Grained Pseudo-Energy Minimization. Biophysical 
journal 2011, 100 (2), 478-488. 
19. D'Anna, J. A.; Isenberg, I., Histone cross-complexing pattern. Biochemistry 1974, 13 (24), 
4992-4997. 
20. Fasman, G. D., Circular Dichroism and the Conformational Analysis of Biomolecules. 
Plenum Press: New York, 1996. 
21. Schuler, B.; Eaton, W. A., Protein folding studied by single-molecule FRET. Current 
Opinion in Structural Biology 2008, 18 (1), 16-26. 
22. Hofmann, H.; Hillger, F.; Pfeil, S. H.; Hoffmann, A.; Streich, D.; Haenni, D.; Nettels, D.; 
Lipman, E. A.; Schuler, B., Single-molecule spectroscopy of protein folding in a chaperonin cage. 
Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (26), 11793-11798. 
23. Hess, S. T.; Huang, S.; Heikal, A. A.; Webb, W. W., Biological and Chemical Applications of 
Fluorescence Correlation Spectroscopy:  A Review†. Biochemistry 2001, 41 (3), 697-705. 
24. Lebowitz, J.; Lewis, M. S.; Schuck, P., Modern analytical ultracentrifugation in protein 
science: A tutorial review. Protein Sci. 2002, 11 (9), 2067-2079. 
25. Hirs, C. H. W.; Di Sabato, G.; Ottesen, M.; Gold, A. M.; Gurd, F. R. N.; Horton, H. R.; 
Koshland, D. E.; Kimmel, J. R.; Klotz, I. M.; Ludwig, M. L.; Hunter, M. J.; Neumann, N. P.; Ray, W. 
J.; Riordan, J. F.; Vallee, B. L.; Sela, M.; Arnon, R.; Spande, T. F.; Witkop, B.; Stark, G. R.; Wilcox, P. 
E.; Wold, F., In Methods in Enzymology, Academic Press: 1967; Vol. 11, pp 485-748. 
26. Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M., Electrospray 
ionization for mass spectrometry of large biomolecules. Science 1989, 246 (4926), 64-71. 
27. Karas, M.; Bachmann, D.; Hillenkamp, F., Influence of the wavelength in high-irradiance 
ultraviolet laser desorption mass spectrometry of organic molecules. Anal. Chem. 1985, 57 (14), 
2935-2939. 
28. Konermann, L.; Tong, X.; Pan, Y., Protein structure and dynamics studied by mass 
spectrometry: H/D exchange, hydroxyl radical labeling, and related approaches. J. Mass 
Spectrom. 2008, 43 (8), 1021-1036. 
21 
 
29. Stocks, B. B.; Konermann, L., Time-Dependent Changes in Side-Chain Solvent 
Accessibility during Cytochrome c Folding Probed by Pulsed Oxidative Labeling and Mass 
Spectrometry. Journal of Molecular Biology 2010, 398 (2), 362-373. 
30. Takamoto, K.; Chance, M. R., Radiolytic Protein Footprinting with Mass Spectrometry to 
Probe the Structure of Macromolecular Complexes. Annual Review of Biophysics and 
Biomolecular Structure 2006, 35 (1), 251-276. 
31. Wen, J.; Zhang, H.; Gross, M. L.; Blankenship, R. E., Membrane orientation of the FMO 
antenna protein from Chlorobaculum tepidum as determined by mass spectrometry-based 
footprinting. Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (15), 6134-6139. 
32. Zhang, H.; Gau, B. C.; Jones, L. M.; Vidavsky, I.; Gross, M. L., Fast Photochemical 
Oxidation of Proteins for Comparing Structures of Protein-Ligand Complexes: The Calmodulin-
Peptide Model System. Anal. Chem. 2010, 83 (1), 311-318. 
33. Chen, S.; Engen, J. R., Isotope Exchange and Covalent Modification Strategies for 
Studying Protein Structure and Function. Cur. Anal. Chem. 2009, 5, 205-212. 
34. Zhu, M. M.; Rempel, D. L.; Du, Z.; Gross, M. L., Quantification of Protein-Ligand 
Interactions by Mass Spectrometry, Titration, and H/D Exchange: PLIMSTEX. J. Am. Chem. Soc. 
2003, 125 (18), 5252-5253. 
35. Fenn, J. B., Ion formation from charged droplets: roles of geometry, energy, and time. J. 
Am. Soc. Mass Spectrom. 1993, 4 (7), 524-535. 
36. Althaus, E.; Canzar, S.; Ehrler, C.; Emmett, M.; Karrenbauer, A.; Marshall, A.; Meyer-
Bäse, A.; Tipton, J.; Zhang, H.-M., Computing H/D-Exchange rates of single residues from data of 
proteolytic fragments. BMC Bioinformatics 2010, 11 (1), 424. 
37. Hoerner, J. K.; Xiao, H.; Dobo, A.; Kaltashov, I. A., Is There Hydrogen Scrambling in the 
Gas Phase? Energetic and Structural Determinants of Proton Mobility within Protein Ions. J. Am. 
Chem. Soc. 2004, 126 (24), 7709-7717. 
38. Syka, J. E. P.; Coon, J. J.; Schroeder, M. J.; Shabanowitz, J.; Hunt, D. F., Peptide and 
protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. 
Sci. U.S.A. 2004, 101 (26), 9528-9533. 
39. Rand, K. D.; Zehl, M.; Jensen, O. N.; Jørgensen, T. J. D., Protein Hydrogen Exchange 
Measured at Single-Residue Resolution by Electron Transfer Dissociation Mass Spectrometry. 
Anal. Chem. 2009, 81 (14), 5577-5584. 
40. Xu, G.; Chance, M. R., Hydroxyl Radical-Mediated Modification of Proteins as Probes for 
Structural Proteomics. Chem. Rev. 2007, 107 (8), 3514-3543. 
41. Xu, G.; Chance, M. R., Radiolytic Modification of Acidic Amino Acid Residues in Peptides: 
Probes for Examining Protein-Protein Interactions. Anal. Chem. 2004, 76 (5), 1213-1221. 
42. Xu, G.; Chance, M. R., Radiolytic Modification and Reactivity of Amino Acid Residues 
Serving as Structural Probes for Protein Footprinting. Anal. Chem. 2005, 77 (14), 4549-4555. 
43. Xu, G.; Chance, M. R., Radiolytic Modification of Sulfur-Containing Amino Acid Residues 
in Model Peptides: Fundamental Studies for Protein Footprinting. Anal. Chem. 2005, 77 (8), 
2437-2449. 
44. Xu, G.; Takamoto, K.; Chance, M. R., Radiolytic Modification of Basic Amino Acid 
Residues in Peptides: Probes for Examining Protein−Protein Interactions. Anal. Chem. 2003, 75 
(24), 6995-7007. 
22 
 
45. L. Hawkins, C.; J. Davies, M., EPR studies on the selectivity of hydroxyl radical attack on 
amino acids and peptides. Journal of the Chemical Society, Perkin Transactions 2 1998,  (12), 
2617-2622. 
46. Garrison, W. M., Reaction mechanisms in the radiolysis of peptides, polypeptides, and 
proteins. Chem. Rev. 1987, 87 (2), 381-398. 
47. Russell, G. A., Deuterium-isotope Effects in the Autoxidation of Aralkyl Hydrocarbons. 
Mechanism of the Interaction of PEroxy Radicals. J. Am. Chem. Soc. 1957, 79 (14), 3871-3877. 
48. Gau, B. C.; Chen, H.; Zhang, Y.; Gross, M. L., Sulfate Radical Anion as a New Reagent for 
Fast Photochemical Oxidation of Proteins. Anal. Chem. 2010, 82 (18), 7821-7827. 
49. Gau, B. C.; Sharp, J. S.; Rempel, D. L.; Gross, M. L., FPOP Labels Proteins Faster than They 
Unfold. In Proceedings of the 56th ASMS Conference on Mass Spectrometry and Allied Topics, 
Denver, Colorado, 2008. 
50. Hambly, D.; Gross, M., Laser flash photochemical oxidation to locate heme binding and 
conformational changes in myoglobin. Int. J. Mass Spectrom. 2007, 259 (1-3), 124-129. 
51. Hambly, D. M.; Gross, M. L., Laser Flash Photolysis of Hydrogen Peroxide to Oxidize 
Protein Solvent-Accessible Residues on the Microsecond Timescale. J. Am. Soc. Mass Spectrom. 
2005, 16 (12), 2057-2063. 
52. Buxton, G. V.; Greenstock, C. L.; Helman, W. P.; Ross, A. B., Critical Review of Rate 
Constants for Reactions of Hydrated Electrons, Hydrogen Atoms and Hydroxyl Radicals (*OH/*O-
) in Aqueous Solution. J. Phys. Chem. Ref. Data 1988, 17 (2), 513-886. 
53. Chen, J.; Rempel, D. L.; Gross, M. L., Temperature Jump and Fast Photochemical 
Oxidation Probe Submillisecond Protein Folding. J. Am. Chem. Soc. 2010, 132 (44), 15502-15504. 
54. Fenton, H. J. H., The oxidation of tartaric acid in presence of iron. J. Chem. Soc. Proc. 
1894, 10, 157-158. 
55. Tullius, T. D.; Dombroski, B. A., Hydroxyl radical "footprinting": high-resolution 
information about DNA-protein contacts and application to lambda repressor and Cro protein. 
Proc. Natl. Acad. Sci. U.S.A. 1986, 83 (15), 5469-5473. 
56. Shanblatt, S. H.; Revzin, A., Interactions of the catabolite activator protein (CAP) at the 
galactose and lactose promoters of Escherichia coli probed by hydroxyl radical footprinting. The 
second CAP molecule which binds at gal and the one CAP at lac may act to stimulate 
transcription in the same way. J. Biol. Chem. 1987, 262 (24), 11422-11427. 
57. Tullius, T. D.; Greenbaum, J. A., Mapping nucleic acid structure by hydroxyl radical 
cleavage. Current Opinion in Chemical Biology 2005, 9 (2), 127-134. 
58. Hawkins, C. L.; Davies, M. J., Generation and propagation of radical reactions on 
proteins. Biochim. Biophys. Acta Bioenergetics 2001, 1504 (2-3), 196-219. 
59. Davies, M. J.; Dean, R. T., Radical-Mediated Protein Oxidation: From Chemistry to 
Medicine. Oxford University Press: 1997. 
60. Maleknia, S. D.; Ralston, C. Y.; Brenowitz, M. D.; Downard, K. M.; Chance, M. R., 
Determination of Macromolecular Folding and Structure by Synchrotron X-Ray Radiolysis 
Techniques. Anal. Biochem. 2001, 289 (2), 103-115. 
61. Kiselar, J. G.; Maleknia, S. D.; Sullivan, M.; Downard, K. M.; Chance, M. R., Hydroxyl 
radical probe of protein surfaces using synchrotron X-ray radiolysis and mass spectrometry. Int. 
J. Radiat. Biol. 2002, 78 (2), 101 - 114. 
62. Guan, J. Q.; Takamoto, K.; Almo, S. C.; Reisler, E.; Chance, M. R., Structure and Dynamics 
of the Actin Filament. Biochemistry 2005, 44 (9), 3166-3175. 
23 
 
63. Maleknia, S. D.; Brenowitz, M.; Chance, M. R., Millisecond Radiolytic Modification of 
Peptides by Synchrotron X-rays Identified by Mass Spectrometry. Anal. Chem. 1999, 71 (18), 
3965-3973. 
64. Sharp, J. S.; Tomer, K. B., Analysis of the Oxidative Damage-Induced Conformational 
Changes of Apo- and Holocalmodulin by Dose-Dependent Protein Oxidative Surface Mapping. 
Biophys. J. 2007, 92 (5), 1682-1692. 
65. Schrank, S. G.; José, H. J.; Moreira, R. F. P. M.; Schröder, H. F., Applicability of Fenton 
and H2O2/UV reactions in the treatment of tannery wastewaters. Chemosphere 2005, 60 (5), 
644-655. 
66. Sharp, J. S.; Becker, J. M.; Hettich, R. L., Analysis of Protein Solvent Accessible Surfaces 
by Photochemical Oxidation and Mass Spectrometry. Anal. Chem. 2003, 76 (3), 672-683. 
67. Weeks, J. L.; Matheson, M. S., The Primary Quantum Yield of Hydrogen Peroxide 
Decomposition. J. Am. Chem. Soc. 1956, 78 (7), 1273-1278. 
68. Schiffman, A.; Nelson, J. D. D.; Nesbitt, D. J., Quantum yields for OH production from 193 
and 248 nm photolysis of HNO[sub 3] and H[sub 2]O[sub 2]. The Journal of Chemical Physics 
1993, 98 (9), 6935-6946. 
69. Aye, T. T.; Low, T. Y.; Sze, S. K., Nanosecond Laser-Induced Photochemical Oxidation 
Method for Protein Surface Mapping with Mass Spectrometry. Anal. Chem. 2005, 77 (18), 5814-
5822. 
70. Chung, H. S.; Ganim, Z.; Jones, K. C.; Tokmakoff, A., Transient 2D IR spectroscopy of 
ubiquitin unfolding dynamics. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (36), 14237-14242. 
71. Chung, H. S.; Khalil, M.; Smith, A. W.; Ganim, Z.; Tokmakoff, A., Conformational changes 
during the nanosecond-to-millisecond unfolding of ubiquitin. Proc. Natl. Acad. Sci. U.S.A. 2005, 
102 (3), 612-617. 
72. Henzler-Wildman, K. A.; Lei, M.; Thai, V.; Kerns, S. J.; Karplus, M.; Kern, D., A hierarchy of 
timescales in protein dynamics is linked to enzyme catalysis. Nature 2007, 450 (7171), 913-916. 
73. Gau, B. C.; Sharp, J. S.; Rempel, D. L.; Gross, M. L., Fast Photochemical Oxidation of 
Protein Footprints Faster than Protein Unfolding. Anal. Chem. 2009, 81 (16), 6563-6571. 
 
 
24 
 
2  Fast Photochemical Oxidation of Protein Footprints 
Faster than Protein Unfolding 
2.1 Introduction 
Protein footprinting is an assay that monitors protein conformation by selectively 
labeling or cleaving residues.  This selectivity is, in part, a function of the target protein’s 
solvent accessibility; thus, an implicit picture of protein structure is afforded by 
footprinting.  Although the ways of modifying residues are diverse, and many have been 
in practice for over forty years,1  the advent of biomolecular mass spectrometry, 
associated with ESI and MALDI ionization and interfaced to liquid chromatography, now 
makes possible highly specific, sensitive, and rapid analysis of modified peptides and 
proteins.2-3  Thus, we are attempting to establish a marriage of mass spectrometry and 
chemical footprinting to afford a tool for the elucidation of protein structure and 
dynamics, and for the identification of partner binding sites, stoichiometry, and affinity.4  
Protein oxidation by hydroxyl radicals is one class of footprinting methods; the 
various subclasses are differentiated by the means used to generate the •OH.  Hydroxyl 
radicals probe solvent accessibility because they have comparable size to solvent water 
molecules and high reactivity with a significant fraction of amino acid side chains.  The 
advantages of hydroxyl radical footprinting are twofold.  First, the primary sequence of 
modified residues is preserved by virtue of the stability of the covalent modification even 
though a protein may be subjected to several hours and even days of handling and 
proteolysis following the chemical footprinting step.  Second, the hydroxyl radical is a 
reactive reagent, modifying many amino acid residues and affording a higher coverage 
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footprint than those covalent approaches that target specific residues (e.g., the acetylation 
of primary amines).  Xu and Chance5-7 showed that in X-ray and γ-ray water radiolysis, 
up to 14 of the 20 sidechains and cys-cys disulfide bonds can be usefully modified for 
footprinting experiments.  
As implied above, there are several hydroxyl radical footprinting approaches 
currently in use; a detailed review was recently published.8  Among the first DNA:protein 
and protein:ligand binding site footprinting studies have used hydroxyl radicals generated 
from catalytic Fenton chemistry9 consuming hydrogen peroxide.10-11  The synchrotron X-
ray and 137Cs γ-ray methods generate hydroxyl radicals as the major reactive products 
from water radiolysis by high-energy photons.  These methods were originally developed 
by Chance12-14 and coworkers to footprint DNA/protein interactions, RNA folding, and 
large proteins.  Recently Hambly and Gross, and independently Aye et al.,15-17 reported a 
method of fast photochemical oxidation of proteins (FPOP) that generates •OH by 
photolysis of mM hydrogen peroxide with a pulsed laser (either 248-nm KrF excimer 
laser or 266-nm frequency quadrupled Nd YAG).  The laser provides a spatially small, 
high flux of light, maximizing the exposure of a small volume of protein solution to 
radicals and ensuring all but a small exclusion fraction of the protein is irradiated only 
once (Figure 2.1).  In the design by Hambly and Gross, a constituent radical scavenger 
limits the timescale of oxidation.  During a short timescale of oxidation (~ µs), 
footprinting occurs at high yield. 
   
Figure 2.1:  Schematic of the FPOP fused silica reaction regio
pulse frequency, and laser spot size settings.
 
Here we report the first experimental evaluation of FPOP to test the claim by 
Hambly and Gross that it labels a protein faster than its unfolding.  Fast laser 
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Venkatesh and coworkers21 proposed a method of ascertaining whether hydroxyl 
radical reactions sample the native protein conformation or upset the structural 
equilibrium during the timescale of exposure.  Their approach is appropriate for 
continuous-dose methods because they provide a near steady state hydroxyl radical 
concentration, allowing for a pseudo-first order kinetic model to be used.22-23  The FPOP 
method, however, cannot be so evaluated because it is pulsed.  A single laser pulse 
provides a well defined start, and chemical quenching provides the “shutter” for the 
reaction.   The 17-nsec laser pulse generates an [•OH ] of approximately 1 mM.  We 
estimate that the presence of glutamine radical scavenger at 20 mM effectively quenches 
radical exposure by ~ 1 µs; thus, the [•OH ] is not at steady state.16  . 
The desired test is one for change in conformation induced by FPOP, but only for 
change occurring on the labeling timescale.  One means of monitoring protein 
conformational changes is to track their charge-state distribution.24-29  This approach, 
however, has difficulty distinguishing fast and slow FPOP-induced conformation 
changes.  One might follow Maleknia and coworkers30-32, who developed a method of 
protein footprinting by generating reactive oxygen species in an ESI source, 
accommodating rapid mass spectrometry analysis, but this approach suffers from the 
uncertainty that protein conformation in a charge dense droplet in a high electric field is 
relevant to solution biology. The special experimental features of FPOP require an 
indirect evaluation method. 
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2.1.1 Test of Hypothesis that FPOP Oxidizes Protein Faster than its Unfolding.   
 If an effective radical exposure at 1 µs is shorter than a significant structural 
response to oxidative modification, and if the probability of modification at a site is a 
function of its solvent accessibility, it follows that the modification probability at each 
site is independent of other incurred modifications for such an exposure.  It is also a 
function of the site’s inherent chemical reactivity.6, 33  The modification probabilities of 
the most sensitive sites can be approximated by an average probability.  A binomial 
distribution models the outcomes of this approximation.  The probability a protein will be 
modified k times is: 
	
; ,   
1      (1) 
for  potential modification sites, each with  probability of modification.  As  
increases, this probability diminishes for any one site, yet the product  is invariant.  
For example, two proteins, one large and one small, undergoing controlled oxidative 
labeling will exhibit the same product distribution only if they are exposed at equal mass 
concentration other things being equal (i.e., the solvent accessibility/size ratio and 
average reactivity of each site).  The limiting case of the binomial distribution as   ∞ 
is the Poisson distribution, with a probability mass function: 
	
;    !"!       (2) 
Significantly, this is parameterized by only one factor, , which is the expected number 
of events $% and their variance $%  $% .   In practice for  > 50 and  < 0.02, an 
optimal  gives a Poisson distribution matching the binomial, per outcome, to within the 
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determination error (inclusive of experimental error and modeling uncertainty) of any 
•OH modification state of a protein. 
The dominant product pathway for most residue sidechains reacting with •OH is 
the net addition of oxygen (+16 Da) as a hydroxyl group (as substitution of H for OH).8, 
34
  Consequently, the distribution of modified products can be simplified as a 0, +16, +32. 
. . addition state distribution, wherein proteins are binned only by the number of 
increments in 16 Da they have gained.  For a properly controlled FPOP experiment, we 
hypothesize that the distribution of 0, +16, +32… products should be very nearly Poisson 
if the footprinting reactions occur more rapidly than any significant protein unfolding.  
This hypothesis is the basis for our evaluation of the three aforementioned proteins 
subjected to varying oxidation conditions. 
2.2 Experimental section 
2.2.1 Reagents.   
Bovine β-Lactoglobulin A, lysozyme from chicken egg white, 30% hydrogen 
peroxide, L-glutamine, L-methionine, catalase, urea, ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), acetonitrile, formic acid, and  
phosphate buffered saline (PBS) were purchased from the Sigma Aldrich Chemical 
Company (St. Louis, MO). Bovine CaM was purchased from Oceanbiologics (Corvallis, 
OR).  The proteins were used without further purification.  tris-(2-Carboxyethyl) 
phosphine hydrochloride (TCEP-HCl) was purchased from Pierce Biotechnology, Inc 
(Rockford, IL).  Purified water (18 MΩ) was obtained from an in-house Milli-Q 
Synthesis system (Millipore, Billerica, MA). 
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2.2.2 Oxidative-modification labeling.   
Each 50 µL sample was prepared in PBS (10 mM phosphate buffer, 138 mM 
NaCl, 2.7 mM KCl, pH 7.4 at 25 °C) with a final protein concentration of 10 M.  Apo-
CaM samples included 100 µM EGTA for the chelation of adventitious calcium.  
Glutamine was added to a final concentration of 20 mM in normal FPOP samples.  
Hydrogen peroxide was added to a final concentration of 15 mM just before FPOP 
infusion.  The flowing sample solution was collected in a 0.6 mL microcentrifuge tube 
containing an additional 20 µL of 100 nM catalase and 70 mM methionine in PBS, as per 
the normal FPOP procedure.  The breakdown of peroxide by catalase was conducted by 
treating the sample for 10 min at room temperature before freezing the samples at -80°C. 
FPOP was conducted as described previously, but with150 µm ID fused silica 
(Polymicro Technologies, Phoenix, AZ).16  The 2.54 mm beam width was measured from 
a 30-shot burn pattern on label tape affixed to a temporary beam stop placed in the plane 
of the flow cell.  Samples with an approximate 15% exclusion volume fraction (EVF) 
were infused at a rate of 19.00 ± 0.04 µL/min, and the excimer pulse frequency was set to 
6.00 ± 0.02 Hz.  30% and 60% EVF samples were infused at the same rate but with 4.94 
± 0.02 and 2.82 ± 0.02 Hz pulse frequencies, respectively. 
2.2.3 Mass spectrometry.   
Each sample was thawed and ZiptipC4-desalted (Millipore, Billerica, MA) before 
ESI MS acquisition on a Waters Ultima Global quadrupole time-of-flight (Milford, MA), 
operating in V mode at 12,000 FWHM resolving power at 838.8 m/z ((CF3COONa)6Na+ 
calibrant ion).  Some samples were subjected to a 1 h, 37 °C incubation in 8 M urea, 5 
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mM TCEP prior to de-salting.  The 10 µL 50% acetonitrile 1% formic acid elution 
solution was diluted 3-fold with 50% acetonitrile prior to direct infusion.  The capacity of 
the 0.6 µL bed ZiptipC4 is approximately 3.3 µg, so that 180-230 pmol of protein was 
infused at a flow rate adjusted to insure accuracy in the time-to-digital conversion of the 
multi-channel plate detector, requiring 80-180 ion counts/scan base peak.  Scans 
spanning the entire chromatogram were summed to improve the signal to noise, typically 
60-150 scans depending on the flow rate. 
2.2.4 Data analysis.   
A 20-40 m/z spectrum window about the 15th charge state of β-lg and apo-CaM 
and 10th charge state of LysC was fit with a model FPOP product distribution (described 
below), for each protein replicate.  The window range encompassed all detected product 
peaks and a 10 m/z region lower than the unmodified peak average m/z for baseline 
estimation. 
2.3 Mathematical Modeling 
The FPOP charge state spectrum model is the weighted sum of the set of Nox non-
zero oxygen-addition states [M + O + z·H]z+, [M + 2·O + z·H]z+, …, [M + Nox ·O + 
z·H]z+, together with the unmodified state  [M + z·H]z+.  The ith state Ai is represented as 
an unresolved isotopic distribution centered on the [M + i·O + z·H]z+ average m/z; its 
contribution is weighted by the coefficient ai.  The sum has the form: 
&'()*+, ./0'1, 2⁄ ; 45, 46, … , 489  ∑ 4;89;<5 =;
, 2⁄  > ?  (1) 
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The baseline constant E is the average spectrum noise taken 5-7 m/z lower than the 
unmodified protein peak in the zth charge state.  There is no uncertainty in the form of the 
isotopic distribution as we know the elemental composition of each oxygen-addition 
product.  A Mathcad 14 Minimize algorithm was used to fit the model to the spectrum to 
determine the coefficient values; these values convey the oxygen-addition state 
distribution and were tested for goodness-of-fit to a Poisson distribution.  The solution 
convergence tolerance was 10-12.   
 We further expand the spectrum model two ways.  One motivation is to deal with 
the charge state spectrum that is complicated by low abundance starting material and 
electrospray adducts, and other FPOP oxidation products that do not correspond to +16, 
+32…  We assume that these latter adducts are equally likely to be observed for each 
+16, +32… state, including the unmodified protein, with an important exception 
discussed below.  ESI MS of control samples, wherein the protein is subjected to 
identical sample handling and peroxide exposure but not pulsed laser irradiation, provides 
spectra for determining the presence of adducts of the starting protein and other 
impurities, ESI-induced losses of ammonia and water, direct hydrogen peroxide 
oxidation, and salt complexation.  A peak detection algorithm was employed to detect 
and pass the mass shifts and relative intensities of these peaks to the modeling algorithm.   
The low abundance FPOP products that do not correspond to the substitution of H 
for OH or the simple addition of an oxygen atom (+16) fall into two categories: resolved 
and unresolved.  Resolved peaks corresponding to losses of ammonia, water, and the -30 
Da major product of acidic residue oxidation from the zero oxygen-addition state were 
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observable as they are shifted to lower m/z than the major oxygen-addition product 
series.  Especially for apo-CaM (see Figure 2.4), these peaks were more conspicuous than 
in the control and must result from species produced in the FPOP treatment.  Additional 
control experiments in which hydrogen peroxide was not added showed that the excimer 
laser did not contribute to these modifications (data not shown).  Other FPOP products 
include but are not limited to +14 Da carbonyl incorporation at aliphatic residues, -23, -
22, -10 and +5 Da shifted histidine oxidation products, and -43 Da deguanidination at 
arginine.8  Their low abundance is obscured by the dominant 0, +16, +32… distribution 
and so are unresolved.  The distribution of proteins undergoing such reactions and having 
i+16 Da additions, was modeled as a normal distribution, whose amplitude, variance, and 
centroid displacement from the ith oxygen-addition state were set by the algorithm.  All of 
the parameters that model the complexity of each population of proteins having 0, +16, 
+32… mass increments were determined by preliminary empirical modeling, in the case 
of resolved and control adducts, or for the unresolved adducts, by the same Minimize 
algorithm that determines the state coefficients.  It is important to note that these 
parameters are state-invariant, unlike the state coefficients. 
The second spectrum model expansion is crucial for determining the distribution 
of 0, +16, +32, . . . for its Poisson goodness-of-fit evaluation.  Owing to the EVF, only a 
fraction of the full contribution of the 0th state (i.e., the signal for the unoxidized protein) 
should be included in the FPOP product distribution analysis.  This fraction represents the 
proteins in the irradiated volume that undergo no additions of 16, 32…  Furthermore this 
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fraction contributes FPOP adducts other than those in the series corresponding to +16, 
+32…, whereas the EVF does not.  The model is rewritten as: 
&'()*+, ./0'1  
1  @45=′5 > @45=5 > ∑ 4;89;<6 =; > ?   (2) 
Here the 0th state is split between the exclusion volume portion 
1  @45=′5, which has 
the form of a simple isotopic distribution convolved with those adduct peaks seen in the 
control experiments, and the irradiated volume portion, @45=5, which has a form 
identical to all other oxygen-addition states and so contains all complicating terms.  The 
parameter f is not the irradiation fraction of the 0th state; rather, the adjusted coefficient 
fa0, is proportional to the 0th state peak area attributed to this fraction by definition (eq 2).  
The other ai coefficients are likewise proportional to their +16, +32… state peak areas.  
The parameter f is fixed in the modeling algorithm by its relation to the independently 
measured EVF: 
@
?AB  1  CDE·∑ GHI89HJKGK′ LCDE·GKGK′      (3) 
The underscored state variables denote integration over the entire m/z spectrum 
encompassing the charge-state product distribution. 
A Mathcad 14 Minimize algorithm was also used to fit a Poisson distribution to 
the set of 0, +16, +32…  state peak areas M@=5, =;| O  1, … , PQ.  The Poisson 
characteristic parameter  determined by this minimization gives the Poisson +16, +32… 
addition state expectation value.  A second modeling approach was also examined, in 
which f was varied to optimize a Poisson fit, thereby determining the EVF.  This tests the 
corollary of our hypothesis: that an FPOP protein-product distribution well modeled by a 
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Poisson should provide an EVF corroborating its independent measure—although a 
match doesn’t prove the converse.  The reader is referred to Supporting Information for a 
more detailed discussion of the modeling and Poisson-fitting algorithms. 
2.4 Results and Discussion 
2.4.2 Argument for Poisson.  
Taking that a single conformation protein invariant to FPOP has a large number 
of independent sites of low modification probability, the distribution of species for which 
the molecular weight has increased by 0, +16, +32… should be well modeled by a 
Poisson distribution.  The low specificity of hydroxyl radical footprinting means up to 85 
residue sidechains in a 100-residue protein may be modified, depending on •OH 
exposure.  The frequency of a residue’s modification can be further split among the 
atomic sites of the residue (e.g., phenylalanine can be modified at o, m, p sites).  It 
follows that there are more than 100 oxidative-modification sites, even for a small 100-
residue protein.  The probability of reaction is site-specific, and is determined by the 
site’s inherent reactivity and solvent accessibility.  Xu and Chance6 showed in γ-ray 
radiolysis dose experiments that among 10 of the 12 most reactive amino acids, oxidation 
by hydroxyl radicals spans a 30-fold range of first-order product formation rates..  
While the reactivity at any site is unique, it is well approximated as having an 
average modification probability .  We designed the FPOP experiment so that the 
OH radicals have a short lifetime in a properly quenched experiment.  Shortening the 
radical exposure time reduces the set of reactive sites, thereby improving the 
representation of each site as the average—though if too short the semi-residue resolution 
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of the footprint experiment is lost.  Replacing 20 mM Gln with 20 mM Phe depletes 
[•OH] at a 10-fold faster rate16; we observed that >90% of oxidative-modification 
products for several proteins are abolished with this change (data not shown).   
In the event that the protein partially contorts from its native conformation on the 
timescale of radical exposure, the distribution of products from oxygen addition will 
change if one or more oxidation targets has a substantially different solvent accessibility.  
In this case, the resultant distribution cannot be Poisson for two reasons.  First, the site 
probabilities are no longer independent.  Second, the native state  cannot describe 
the average modification probability for newly exposed sites because their exposure time 
is shorter.  For the simplest example, consider the oxidative modification of a mixture of 
two protein conformations, each insensitive to oxidation-induced perturbation and each 
with its own .  The oxygen-addition state distribution for each population is ideally 
Poisson, but the overall protein population is not; that is, the distribution from the sum of 
two Poisson distributions having different means is not itself Poisson. 
 Although we have not tested that a protein with an invariant conformation 
exhibits a Poisson-like oxygen-addition distribution following FPOP, this is a reasonable 
assumption.  Rather, if we find the distribution of products is Poisson or nearly so, we 
may conclude the conformation was unaffected during labeling.  Thus, the test for 
induced FPOP-timescale conformation change requires (1) determining the distribution 
of products corresponding to substitution of H by OH or by addition of an oxygen atom, 
(2) determining its best-fitting Poisson distribution, and (3) evaluating the goodness-of-
fit.   
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We also tested whether changes to the FPOP procedure and to post-labeling 
conditions and sample handling affect the product distribution.  When the Gln radical 
scavenger normally constituent with the sample is removed, the radical lifetime is 
determined principally by its self-reaction rate and is 100-times longer.16, 33  
Consequently, we expect that oxidation-sensitive proteins will adopt significantly 
different product distributions from a best fitting Poisson because there will likely be a 
structural response on this timescale.  Furthermore, given that covalent modification 
footprinting can involve days of sample handling, millimolar levels of hydrogen peroxide 
may slowly oxidize proteins especially at exposed Met and Cys.35  Intentionally or 
otherwise, buried residues often experience solvent exposure with such handling, so that 
all peroxide-reactive residues are vulnerable.  By omitting catalase and allowing 
hydrogen peroxide to persist following FPOP treatment, we can test the sensitivity of 
FPOP-treated protein to further peroxide oxidation and long-time (minute-hour) 
conformational change. 
2.4.2 Data Acquisition and Analysis.   
 We chose not to model a deconvoluted or de-charged mass spectrum of each 
sample, owing to uncertainties in fitting to the output of the Waters MaxEnt1 maximum 
entropy algorithm supplied with the mass spectrometer data system.  We selected single 
charge states instead: the 15th charge state of β-lg and 10th charge state of LysC.  These 
choices are justified by their match to the charge state-invariant product distribution of 
the FPOP-treated protein, determined in an experiment wherein the protein was denatured 
by urea prior to ESI-MS (data not shown).   
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This integrity of a distribution determined for a charge state is of concern because 
ESI affords different responses (different charge-state distributions) to different 
conformers of a protein.  A partially unfolded protein can accommodate more protons 
and will have a charge state distribution shifted to higher charge.  In fact, two proteins (β-
lg and LysC) exhibited product distributions that were charge-state dependent; that is, at 
higher charge states, the unmodified peak is significantly diminished, and the higher +16, 
+32… states are relatively more populated than at lower charge states.  Denaturing and 
reducing (β-lg has 2 and LysC 4 disulfide linkages) a portion of each protein following 
FPOP treatment just prior to desalting and direct infusion, we could minimize any 
dependence of the relative product distribution on charge state.  This charge-state 
dependence indicates that the protein ultimately infused for ESI analysis existed as a 
mixture of conformers in the un-denatured treatment (an acidic 50% acetonitrile solution 
does not fully denature β-lg and LysC although this may be a function of their intact 
disulfide bonds).  Venkatesh, Sharp and coworkers21-22 showed that the proteins selected 
for this study are susceptible to partial unfolding upon oxidation.  Our finding that 
proteins undergoing multiple +16, +32…additions dominate the higher charge states 
corroborates their finding.  Although the 8 M urea denaturing solution was freshly 
prepared, significant carbamylation (+43 Da) of primary amines was observed in the 
unoxidized control sample for both proteins.  On this basis, we chose to analyze single 
charge states to obtain the distribution of 0, +16, +32… states and eschewed the analysis 
of post-FPOP urea-denatured samples.   
39 
 
On the other hand, apo-CaM, a 16.8 kDa dumbbell-shaped protein with no 
disulfide bonds, showed a relative distribution of FPOP products that were invariant of 
charge state.  Its 15th charge state was analyzed because its peaks were the most intense in 
the mass spectrum. 
2.4.3 Agreement with a Poisson Distribution.   
 The optimum model fit to the 15th charge state of β-lg sample oxidized under 
normal FPOP conditions (Figure 2.2) typifies the fit observed for all three proteins under 
the same conditions.  The spectrum/model relative residuals (normalized to the spectrum 
intensity) at each data point are generally in good agreement.  The model fit, however, is 
poorer at higher m/z: the average |relative residual| doubles from 0.042 at to 0.082 at m/z 
> 1235 (Figure 2.2a).  The higher +16, +32… addition states are more resolved in the 
calculated (model) spectrum than in the experimental spectrum.  This may be a 
consequence of an underestimation of the background contribution in this region.  Given 
this uncertainty, the states analyzed for Poisson likeness were restricted to the first states, 
accounting for at least 95% of the signal. 
  
  
Figure 2.2:  Mass spectrum and model of prote
ESI-QTOF mass spectrum of the 15th charge state of FPOP
its composite model.  Graph (b) is of the background
oxygen-addition state components (hashed fil
contribution from the exclusion volume fraction (not shown) and a 47% contribution 
from the irradiated portion of the sample.
 
Each 0, +16, +32…
isotopic distribution peak with a centroid at [M
distribution with an intensity 1.0 ± 0.3% that of the major peak; this was seen for all 
proteins and FPOP treatments.  The portion of the 
additions in the irradiated volume is fixed in the spectrum modeling by the measured 
EVF (eq 3). 
40 
 
in FPOP products.  Graph (a) is of the 
-treated β-lactoglobulin and 
-subtracted model and its first five 
l). The 0th state (gray) has a 53% 
 
state contribution in 2b has two dominant features: a major 
r + O + 15H]15+, and a broad normal 
0th state owing to zero oxygen 
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The distribution is affected by changes in EVF, radical scavenger, and post-FPOP 
oxidation protection: Figure 2.3 shows spectra of β-lg treated with these variations and 
again typifies the CaM and LysC spectra (Figure 2.4).  Intensity is plotted relative to each 
spectrum’s maximum.  Exposure for 5 min to 15 mM H2O2 does not oxidize the proteins 
(Figures 2.3a, 2.4a, 2.4d).  In the “normal” FPOP treatment, radical exposure is 
controlled with constituent Gln scavenger.  Post-FPOP oxidation is minimized by 
removing any left over H2O2 with catalase and adding millimolar levels of Met.36  
Methionine, a competitive oxidation reagent, was used because the samples were not 
analyzed immediately after their treatment.  Tuning the EVF from 60 to 15% by 
increasing the laser frequency for samples submitted to a properly controlled FPOP 
procedure (Figure 2.3b-d) increases the levels of oxidation.  Without radical control (no 
Gln scavenger) and/or removal of peroxide post-FPOP (Figure 2.3e-f), the product 
distributions skew significantly to higher oxidation levels.  The S/N is also worse, as an 
equivalent amount of protein is spread over more states, relative to the other spectra. 
 The Poisson fitting to the modeled distribution of β-lg samples is shown in Figure 
2.5.  The state coefficients R@45, 4;| O  1, … , PS determined by the spectrum modeling 
are proportional to the ion counts comprising the peak area of each state; these values are 
normalized to give probability values in the figure.  In all cases, the @ factor was fixed by 
the measured EVF, except for the FPOP experiments without the glutamine scavenger.  
The standard error bars are in general small except for the 0th state.  This stems from the 
sensitivity of the 0th state to the @ factor calculation—small changes in the set of 
 coefficients 
worsening the spectrum model fit.  
 
Figure 2.3:  ESI-QTOF mass spectra of the 15th charge state of six 
samples subjected to varying FPOP conditions. Spectrum (a) is of the 
laser irradiation; (b) is of a normal FPOP treatment with an EVF 60%; (c) is of a normal 
treatment with an EVF 30%; (d
treatment (all controls); (e) is of a treatment absent 20 m
without use of scavenger (Gln), removal of peroxide (by catalase) and control of post 
FPOP oxidation (addition of Met).
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 can compensate a larger change in  without unduly 
 
β-lactoglobulin 
control, absent only 
-f) are of samples with an EVF of 15%; (d) is of a normal 
M Gln; and (f) is of a treatment 
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Figure 2.4: ESI-QTOF mass spectra (a-c) are of the 15th charge state apo-calmodulin; 
spectra (e-g) are of the 10th charge state of lysozyme.  Spectra (a) and (d) are of the 
controls, absent only laser irradiation; (b) and (e) are of samples after normal FPOP 
treatment (i.e., with scavenger and removal of peroxide post FPOP); (c) and (f) are of 
samples after FPOP treatment absent the scavenger (20 mM Gln).  
 
Qualitatively, the Poisson distribution fitting to the sample distributions obtained 
by appropriately controlled FPOP at all experimental EVF levels is much better than for 
samples submitted to FPOP but without scavenger (Gln) or post-FPOP removal of 
peroxide by catalase. This is also realized for the other two proteins, apo-CaM and LysC.  
Table 1 summarizes the Student’s-t goodness-of-fit evaluation for each 0,+16, 
+32,…oxidation state.  The chi-Squared goodness-of-fit test was not employed because 
of the modeling uncertainty in binning large ion counts among oxidation states, and it 
does not convey per state residual statistics. 
 Figure 2.5:  The irradiatio
spectrum of each bovine β
that the calculated EVF matched the independently measured EVF.  Per condition, shown 
with standard error bars along a solid line, are the averages of the normalized ion counts 
of 4 replicates (a-c) and 2 replicates (d
non-linear regression best fit Poisson distribution to the average oxygen
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n volume oxygen-addition state ion counts are modeled for the 
-lactoglobulin sample.  The modeling was constrained such 
-e). The diamonds along a dotted line show the 
-addition state 
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distribution. The number of states per sample distribution fit to a Poisson was chosen to 
account for at least 95% of protein signal.  Plot (a) is for sample submitted to FPOP but 
without the glutamine radical scavenger.  When all zero oxygen-addition protein is 
assigned to the EVF, its value is 9%, short of the measured 15%. Plot (b) is for sample 
submitted to FPOP but without removal of peroxide post-FPOP, with a 15% EVF.  Plot 
(c) is for sample FPOP-treated with a 15% EVF. Plot (d) is for sample FPOP-treated with 
a 30% EVF. Plot (e) is for sample FPOP-treated with a 60% EVF. 
 
 
Table 2.1: Student’s t Goodness-of-Fit Statistics of the Poisson Fit to the FPOP 16 Da-
Increment State Distribution
a 
 
Protein 
 
β-Lactoglobulin 
 
Apo-Calmodulin
 
Lysozyme
 
FPOP 
Condition 
 
Normal  Absent Gln  
Absent 
Catalase  Normal
d 
 Normal
d
  
Normal  Absent Gln  Normal
d
  
Absent 
Gln
d
  
EVF 
 
15% 15% 15% 30% 60% 15% 15% 15% 15% 
Poisson Mean
 
1.6 2.9 1.3 1.4 1.1 1.6 2.7 2.5 3 
No. of States 
Fit
b 
 
7 10 7 6 5 6 10 7 10 
No. of States, 
p-value > 0.05
c
 
6
 
2
 
2
 
6
 
5
 
5
 
0
 
5
 
4
 
Student’s t p(state)-values 
 
p(0)
 
0.9
 
e
 
0.1
 
0.9
 
1.0
 
0.04
 
e
 
0.7
 
e
 
p(1)
 
0.6
 
0.007
 
0.00001
 
0.2
 
0.3
 
1.0
 
0.01
 
0.02
 
0.3
 
p(2)
 
0.003
 
0.1
 
0.001
 
0.8
 
0.5
 
0.01
 
0.006
 
0.5
 
0.01
 
p(3)
 
0.9
 
0.0001
 
0.1
 
0.4
 
0.2
 
0.8
 
0.0002
 
0.5
 
0.01
 
p(4)
 
0.1
 
0.002
 
0.001
 
0.6
 
0.4
 
0.03
 
0.003
 
0.5
 
0.1
 
p(5)
 
0.9
 
0.4
 
0.0004
 
0.2
 
 
0.2
 
0.03
 
0.2
 
0.1
 
p(6)
 
0.3
 
0.00005
 
0.0001
   
0.3
 
0.002
 
0.005
 
0.0009
 
p(7)
 
 
0.00002
 
   
0.2
 
0.001
 
 
0.0003
 
p(8)
 
 
0.0002
 
    
0.002
 
 
0.1
 
p(9)
 
 
0.0004
 
    
0.004
 
 
0.01
 
a
Each Poisson distribution was fit to the exclusion volume fraction constrained model of a single charge 
state Q-TOF spectrum of the FPOP-treated sample spectrum.   
b
The number of states is inclusive of ≥ 95% of protein signal  
c
The null hypothesis for each state is that its observed normalized frequency = Poisson distribution 
probability for that outcome. 
d
These treatments were analyzed in duplicate; all others in quadruplicate. 
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For the FPOP experiment in which the EVF was 15% and no scavenger (Gln) was 
present, the EVF could not be correctly calculated (Figure 2.5a).  Setting the @ factor to 
zero (i.e., the protein in the exclusion volume accounts for all of the zero-addition state) 
forces the model to give an EVF of 9%.  The fraction of unoxidized protein is 
significantly less than the measured EVF.  A reasonable interpretation of the result in 
Figure 2.3e is that there is some zero oxygen-addition state contribution from the 
irradiated volume; this further depresses the calculated EVF from the expected value. In 
fact, uncoupling the calculated EVF from its measured value by using the Poisson-
dependent modeling approach shows that for the FPOP-treated sample without 
scavenger, the EVF is less than half 15% (Table 2).  This is illustrated for β-lg in Figure 
2.6.  Each normalized distribution is for sample submitted to FPOP with a 15% EVF; 
plots a and b clearly show poorer fitting than the plot obtained when the sample is 
submitted to FPOP with the correct controls in place (plot c). 
 
Table 2.2:  Exclusion Volume Fraction (EVF) Determination From the Poisson-
Parameterized Modeling of Spectra 
Protein 
 
β-Lactoglobulin 
 
Apo-Calmodulin
 
Lysozyme
 
FPOP 
Condition 
 
Normal Absent Gln  
Absent 
Cat  
Absent 
All  Normal Normal Normal 
Absent 
Gln  
Absent 
Cat  Normal 
Absent 
Gln  
EVF 
 
15%  15%  15%  15%  30%  60%  15%  15%  15%  15%  15%  
Modeled 
EVF 
 
0.17 
±0.02 
0.070 
±0.004 
0.211 
±0.003 0.066 
0.30 
±0.03 
0.54 
±0.01 
0.11 
±0.01 
0.060 
±0.005 
0.031 
±0.006 
0.11 
±0.01 
0.048 
±0.001 
 
 Figure 2.6:  The irradiation volume oxygen
spectrum of each β-lactoglobulin sample.  A non
distribution was simultaneously determined; the EVF was varied to opt
condition, shown with standard error bars along a solid line, are the averages of the 
normalized ion counts of 4 replicates (b and c); case (a) is singlicate.  The number of 
states per sample distribution plotted account for at least 95
diamonds along a dotted line show the Poisson distribution.  Plot (a) is for sample FPOP
treated without glutamine radical scavenger, post
methionine.  The best fit exclusion volume was calculated at 6.
FPOP-treated without glutamine, with a calculated EVF of 7.0 ± 0.4%.  Plot (c) is for 
sample FPOP-treated with a calculated EVF of 17 ± 2%.  In all cases the measured EVF 
was 15%. 
 
Thus, contrary to the controlled FPOP treatment,
is oxidized when the radical scavenger is absent.  This may occur for three reasons: (1) 
the radical and protein diffuse from the irradiated volume, (2) oxidation is initiated by 
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-addition state ion counts are modeled for the 
-linear regression best fit Poisson 
imize the fit.  Per 
% of protein signal.  The 
-FPOP catalase, or post-
6%. Plot (b) is for sample 
 some of the protein in the EVF 
-
FPOP 
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diffuse 248 nm light outside the considered reaction volume, and/or (3) one protein is 
oxidized by another following laser irradiation. The first mechanism is unlikely.  Even 
without considering the hydroxyl radical recombination rate of 5.5x10-9 M-1s-1, the 
concentration of hydroxyl radical 5 microns into the exclusion volume after 100 µsec is 
only 0.15% the 1 mM theoretical maximum instantaneous [•OH ] in the irradiated 
volume16, 33   The •OH diffusion coefficient was estimated by molecular dynamics 
simulation to be 7.1x10−9 m2 s−1.37-38  Without any scavenger, protein oxidation in the 
excluded volume may be due to lingering radicals created at low levels from H2O2 
photolysis.  Although highly collimated, the incident laser beam edges may extend >10 
microns beyond the observed irradiation width.  Finally, the oxidation by hydroxyl 
radicals is not a one-step process.  In some protein-hydroxyl radical reactions, superoxide 
is created.  Superoxide has a longer half-life than hydroxyl radical; sulfur-containing 
residues are sensitive to this ROS, although their reaction with O2-• is much slower than 
with •OH.7, 36  Additionally, some protein-hydroperoxide intermediates may react 
intermolecularly instead of following the usual pathways to modification.39  These 
peroxides are formed predominantly at aliphatic residues where a carbon-centered radical 
from hydrogen abstraction by an hydroxyl radical is stabilized by aqueous molecular 
oxygen.34   
The last mechanism of intermolecular oxidation is potentially a problem for all 
oxidative-modification footprinting strategies.   Yet evidence thus far from proteolysis 
and MS/MS analysis of constituent peptides shows that the sites of oxidation are 
consistent with the residue sidechain solvent accessibilities calculated from x-ray 
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crystallography and NMR structures of several proteins.13, 15-16, 22  States higher than +8 
oxygens are of very low abundance when FPOP is correctly controlled, but they are 
significantly more populated when a radical scavenger is not included.  Latent protein-
peroxide oxidation of newly accessible residues may be a millisecond-minute pathway 
capable of enriching these higher states without the presence of large excesses of Gln.   
2.5 Conclusion 
FPOP conducted properly by including control on radical lifetime and minimizing 
exposure to peroxide post FPOP provides a means of footprinting proteins without 
perturbing unduly their conformation during labeling.  Although some proteins 
undergoing several oxidations do unfold at longer times (by the time of ESI-MS), this 
unfolding occurs post-FPOP, as established by finding a good fit of the +0, +16, +32…  
state product distribution to a Poisson distribution under proper conditions.  The 
underlying assumption is that the Poisson model is applicable to footprinting a protein 
population sharing an invariant conformation and having many non-cooperative 
oxidation sites.  In cases where radical and peroxide controls are not sufficient, the 
product distribution is shifted to higher states of modification, as expected, and is not 
well described by a Poisson distribution.  The implication that partial unfolding occurs 
during the timescale of modification is consistent with the Poisson model.  This test is not 
ad-hoc as it holds for three proteins.  Moreover, we suggest that the approach is an 
appropriate validation of any oxidative-modification footprinting.  The global 
modification distribution of •OH-treated proteins larger than 20 kDa can also be 
examined for concordance with a Poisson distribution—in fact the Poisson approximation 
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of the binomial distribution is improved with more labeling sites.  Accurate modeling 
requires approximately half-height resolution of distinct +16 Da states; FTMS resolution 
is needed for proteins as large as BSA (66 kDa).  The modification distribution should be 
only a function of the native conformation state of a protein.  If the native state is an 
equilibrium mixture of conformations, the distribution will not necessarily be Poisson.  If 
this non-Poisson distribution is the product of properly controlled FPOP, then it serves as 
the model distribution for testing conformation change with additional perturbations 
(such as denaturant) to the native equilibrium. 
2.6 Supplemental Section: Mathematical Modeling  
 A model of the control spectrum was first determined, providing a set of model 
peaks which were overlaid with each 0, +16, +32…  peak of the oxidized protein sample 
spectrum.  This reasonably assumes that the adduct peaks owing to inherent protein 
modification, ESI losses of ammonia and water, hydrogen peroxide oxidation, and salt 
complexation were equally likely for any major 0, +16, +32… protein state.  These peaks 
never comprised more than 5% of the unmodified protein signal in the control spectrum 
(see Figures 3a, 4a).  Peak detection made use of a filter matched to the natural isotopic 
profile component orthogonal to the class of linear functions, first, to identify the 
spectrum points that had a filter response that was a fraction of the difference between the 
local maximum and minimum as noise, second, to mark the peaks at the local maxima of 
the filter response that were above the filter response to the noise points, and third, to 
provide the basis for finding the peak edges via mass shifted versions of the filter 
followed by peak centroid and area calculation.  The parameters passed for subsequent 
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modeling are a set of mass shifts T∆VWXYZ[\| ]  1 … WXYZ[^, each with an according 
fraction _` , relative to _[  1 for the base 1th peak at ∆VWXYZ[a  0. 
The FPOP charge state spectrum model is the weighted sum of the set of P 0, 
+16, +32… states M=5YYc[
V, =6
V, …  =89
VQ; the set of 4; contribution coefficients 
are determined by a non-linear regression fitting to the spectrum (eq 3).   
&
V; @  45=5YYc[
V; @ > ∑ 4;89;<6 =;
V > ?   (3) 
The independent variable V is the spectrum m/z; the model is parameterized by 0 d @ d
1.  The baseline constant ? is the average noise 5-7  m/z lower than the unmodified 
protein peak of the spectrum about the charge state (e.  The contribution of proteins 
suffering zero +16 Da additions to the spectrum can be split between the fraction 
excluded from the reaction volume and the fraction in the irradiated volume escaping +16 
Da chemistry (eq 4). 
=5YYc[
V; @  
1  @=5PW[
V > @=5
V    (4) 
The exclusion volume component absent the factor 
1  @ is the sum over control 
spectrum peaks, of which the base peak at .Z/(e is dominant.  
=5PW[
V  ∑ _`g8hij8a`<6 k(e · V ;  Vl5`      (5) 
k
m; ml is the isotopic distribution interpolation function with its centroid at ml Da; the 
argument m is supplied as a de-charged mass in Da.  The isotopic distribution for a 
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protein of known composition is approximated by binning in one Da increments its 
isotopes, considering the natural isotope abundances of carbon, hydrogen, nitrogen, 
oxygen, and sulfur.  The mass difference m  ml determines the interpolation from .Z; the 
normalized values of the closest bin nearer .Z and closest bin further .Z define a straight 
line whose intersection with m  ml provides the function value.  The centroid (eq 6) is a 
de-charged mass centered about the Oth +16 Da state, shifted by the ]th control mass shift. 
Vl;`  .Z > (e · ∆VWXYZ[\ > O · 16       (6) 
 
 The Oth +16 Da state (eq 7) has an additional compound component o;`
V (eq 8) 
which accounts for low abundance resolved and unresolved FPOP products.   
=;
V  ∑ _`g8hij8a`<6 pk(e · V ;  Vl;` > o;`
Vq    (7)  
 
o;`
V  r exp vpV  Vl;` > wq

2y z
> { ( |k(e · V ;  Vl;` > (e · ∆Vc}P"  
~9
<6
> r exp vpV  Vl;` > w > (e · ∆Vc}P"q2y z 
(8) 
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Losses of ammonia, water, and the -30 Da acidic residue FPOP product from the 
0 state are resolved from the major 0, +16, +32…  states by virtue of a negative m/z shift.  
A preliminary peak detection algorithm is employed to detect and pass the mass shifts 
∆Vc}P"and relative intensities ( of c}P  d 2 “auxiliary” resolved peaks to the iterative 
modeling algorithm.  We model proteins suffering unresolved non +16 Da chemistry and 
having O +16 Da additions as a normal distribution with an amplitude r, standard 
deviation y, and with a centroid shifted from the Oth +16 Da state by w. 
As there are many atomics sites for dominant 0, +16, +32… chemistry, so there 
are many for the low yield pathways.  We presume the likelihood of dominant chemistry 
at any site is independent of the fates at other sites, as long as the protein conformation is 
in stasis; it follows that the low abundance non +16 Da chemistry is also independent of 
additional FPOP modification.  Consequently the distribution of proteins suffering any 
such resolved or unresolved non +16 Da pathway and having O +16 Da additions, but for 
the centroid shift Vl;` and amplitude 4; of the state, is otherwise the same.  We further 
suppose that any resolved modification has its own set of additional unresolved 
“daughter” products with the same normal distribution (we do not imply a lineage of 
products). 
Substituting equations 5 and 7 into 4 gives equation 9. 
=5YYc[
V; @  ∑ _`g8hij8a`<6 k(e · V ;  Vl5` > @ · ∑ _`g8hij8a`<6 o5`
V   (9) 
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The parameter @ isn’t determined at a priori but rather is constrained by the independent 
measure of the EVF (eq 10).  
?AB
@  
6GK9ga
6GK9gaLGKL∑ GHI89HJ      (10) 
The integrated 0, +16, +32… spectrum contributions absent @ coefficients are given 
equations 11 and 12.  The numerical integration range ,/26  ,/25 spans the entire 
charge state and its return to baseline noise. 
=;   4;=;
V0V//K      (11) 
=5PW[   45=5PW[
V0V//K       (12) 
The EVF is independently determined from the ID of the fused silica tubing and the 
measured flow rate of the infusion, pulse frequency of the excimer laser, and irradiation 
cross-section width of the beam (see Figure 1).  Equation 10 can be rearranged to give the 
explicit constraint on @ (eq 13). 
@
?AB  1  CDE·∑ GHI89HJKGK9gaLCDE·GKGK9ga    (13) 
 The model is fit to the real spectrum in Mathcad 14 by the “Minimize” algorithm, 
which uses a quasi-Newton nonlinear regression process to determine the set == of 
parameters Rr, w, y, 4; | O  0,1, … , PS minimizing the RMSD function (eq 14). 
.&o
==  ∑ 
P;
P9 9       (14) 
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The sum is over all P data/model pairs; tolerance for RMSD convergence was 10-12 in 
all cases.  The minimization algorithm is invoked iteratively; each iteration is 
parameterized by @, determined in the previous step by eq 13 or by an estimate at the 
outset.  The modeling is completed when @ converges to within ± 0.0005 of the previous 
value. 
 The same Mathcad 14 Minimize algorithm can be used to fit a Poisson 
distribution to the set of 0, +16, +32… state abundances M@=5, =;| O  1, … , PQ.  The 
Poisson characteristic parameter  can be determined by this minimization of the root 
squared deviation function (eq 15). 
&o
  p@=5  @=5 > ∑ =89<6 '!q > ∑ =;  @=5 > ∑ =89<6   !H;! 
89;<6  
 (15) 
As long as the centroid for each peak in each +16 Da state is well within the domain of 
integration, the integrated states absent their contribution coefficients is constant (eq 16).  
This simplifies the RSD to the form used for our fitting (eq 17). 
 =;
V0V //K ,        O  0, … , P;     , 2⁄ 5  Vl;`  , 2⁄ 6  (16) 
&o   · p@45   @45  > ∑ 489<6 '!q > ∑ 4;  @45  > ∑ 489<6   !H;! 
89;<6  
 (17) 
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Thus the Poisson fitting determines the set of state coefficients R@45, 4;| O  1, … , PS; it 
is useful to consider the value each takes on as a scaled ion count.  The fit is to the first 
P states which comprise ≥ 95% of protein signal.  
 In the second modeling approach &
V; @ is constructed as described above.  At 
each iteration, the model is fit to the spectrum, parameterized by the preceding step @ 
value.  The next @ is determined by the Minimize algorithm on the Poisson fitting 
function &o
, @ (eq 15).  Unlike the first modeling procedure, here a Poisson fitting is 
accomplished in tandem with each model fitting until convergence in @ is met, as defined 
above. 
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3 Characterization of the Mass Spectrometry-Observed 
Hydroxyl Radical Footprint of Barstar in its Native and Cold-
Denatured States, Using a Novel Excel-based Data Analysis 
Platform, Commercial LC-MS Peak Detection Software, and 
Error-Tolerant Database Search. 
 
3.1 Introduction 
 The promise of mass spectrometry-based (MS-based) protein footprinting is that 
residue-resolved structural information may be realized for proteins in states inaccessible 
to study by NMR spectroscopy and X-ray crystallography1-2.  Hydroxyl radical-mediated 
footprinting3 is one such method that has come to prominence in the last decade for 
several reasons.  First, all residue sidechains except glycine are reactive with •OH4, 
though at differing rates5.  Secondly, most of the •OH-mediated products are stable 
modifications detectable by MS6-8.  Finally, the size of •OH is comparable to water.  Thus 
with proper radical control, the extent of labeling of protein sidechains by •OH is a 
function of their solvent accessibilities.  The protein footprinting goal is usually to 
determine which sites exhibit changes in their solvent accessible surface areas (SASAs) 
upon the protein’s interaction with a ligand, another protein, or folding induction.  Where 
there is direct interaction, so must the labeling be attenuated9.  Thus, the accurate 
determination of the labeling yield at each residue is the central analytic challenge of 
•OH-mediated protein footprinting. 
 The MS-based detection of footprinting modifications is often done in a “bottom-
up” approach, where the protein(s) of interest are isolated and proteolyzed prior to 
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chromatographic (LC) separation and MS detection.  This methodology is also employed 
in proteomics10.  Owing to its non-specificity and reactivity, •OH-mediated footprinting 
in particular complicates the LC-MS pattern of a single proteolyzed protein, so as to 
resemble the information content from a more complex biological sample in a proteomics 
study (Figure 3.1).  In such studies, the inference of proteins in the sample is based on the 
detection of their proteolytic peptides.  One means of detecting these peptides is to couple 
the LC to a hybrid mass spectrometer, capable of determining with ppm resolution 
peptide “precursor” masses eluting in time, while in tandem performing fragmentation, or 
MS2, experiments on a subset of these peptides to generate their characteristic 
fragmentation spectra.  These MS2 spectra, together with their precise precursor masses, 
can be identified with a high degree of confidence using such algorithms such as 
Mascot11 and the appropriate protein database.  Automated matching can also determine 
the location of modifications, if the appropriate variable modifications are considered in 
the search algorithm. 
  
  
Figure 3.1:  The LC vs. high resolution MS plots for the LC
complex samples.  Plot A shows a 130 min acquisition for a proteomics sample from a 
biological source (unpublished data)
footprinting sample, of FPOP
 
 The quantitative analyses of LC
studies are similar.  In either case the
shared by the samples are used in the fold change metric, unless an MS
method is employed.  This usually requires high resolution LC
two or more species with the s
their elution.  Typically the peak area from an extracted ion chromatogram (EIC) with a 
stated m/z +/-5 ppm can be attributed to a single ion, though MS
needed for its confirmation or identification.  In quantitative proteomics, a comparison is 
made between two or more samples, either by a method of stable
side-by-side label-free quantitation with normalization
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 intensities of the same or related precursor ions 
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 spectral counting 
-MS monitoring, so that 
ame nominal mass and charge state can be distinguished in 
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 experimentation is 
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.  If the stable-isotope
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sample is labeled perfectly—that is, at a precisely known frequency—and if the labeled 
sample is mixed with the basis sample perfectly, then the only bias remaining between 
samples is biological.  The peptides that exhibit a significant difference in abundance 
between samples are attributed to the up or down regulation of their associated protein.  
More care must be taken in the normalization of label-free proteomics samples, to correct 
for biases in overall protein expression, loss, and column loading.  One large potential 
source of bias is chromatographic variation—EIC peak alignment is crucial to ensure that 
the same peptide abundances are compared between samples.  
 While mass spectrometry-based protein footprinting uses the same analytical tools 
and protocols as proteome studies, there are several important distinctions that ultimately 
have motivated the work presented in this study.  The first is that the analyte protein(s) is 
known, is often highly purified, and often is not in a biologically complex milieu.  In our 
footprinting studies, the quantities needed for LC-MS/MS analysis has not exceeded a 
picomole9, 14-16, allowing study of protein at sub-micromolar levels if an absence of 
interaction is required.  This is still very much more than some proteins detected in 
complex biological mixtures.  The second distinction is that, whereas the detection of 
only two unique peptides belonging to a protein are required to declare its presence in a 
typical proteomics experiment10,  the goal of footprinting analysis is to detect all 
proteolytic peptides of the analyte protein at levels that enable the detection of their 
footprinting-modified sibling peptides.   
 The final distinction between proteomics and footprinting LC-MS/MS: the 
comparison is not of the abundances of a single peptide shared by two samples.  Rather 
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the comparison is inherently normalized, in that per-residue labeling yields are compared.  
Biases in proteolysis and column loading are unimportant because these should not affect 
yield—what happens to the unmodified peptide happens equally to modified peptide.  
Biases in ionization efficiency may not be shared equally between modified and 
unmodified peptides, but they should be shared equally among different samples, as long 
as the same column and MS source conditions are used within a contiguous time frame.  
Biases in labeling are obviated by doing same-day labeling.  
 These distinctions have several consequences.  Full “analytic” coverage is a more 
stringent criterion than full sequence coverage, because regions of the protein that have 
too few or many intervening sites of proteolysis may give rise to peptides that are 
detected only at low abundance.  Detecting the modified sibling of such peptides can be 
problematic.  Compensating this drawback is the a priori knowledge of protein sequence 
and possible modification fates.  This can be used to program the spectrometer on which 
peptides to perform MS2 experiments.  Low abundant eluting peaks having the right 
precursor mass may thus be selected when they would have otherwise been ignored by 
the normal decision algorithm.  More importantly, knowing all probable outcomes of a 
labeling experiment should empower the data analysis to greatly enhance analytic 
coverage.  
 The software packages now available to analyze quantitative proteomic data is 
extensive13.  These software are tasked, as a first step, with identifying and measuring 
peptide levels in a biological samples from the LC-MS/MS raw data.  Such programs 
could be used to analyze the same kind of data from a protein-footprinting study.  
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Generating a concise and single-protein-centric output, amenable to addressing the 
questions of structural change, is not easily accomplished by these large packages yet.  
The goal of analytic coverage, and the providence of a priori knowledge of sample 
composition, demands that the highest level of scrutiny be used in indentifying modified 
and unmodified peptides.  Ultimately this requires the scientist’s inspection of spectra.  
This also falls out of the normal purview of proteomics studies.   We have written 
Excel-based protein-footprinting software with these considerations in mind.  Automated 
LC-MS peak detection and alignment must still be performed by external software, and 
MS2 database searching also done by Mascot (forthcoming versions will allow for 
Sequest17 and OMSSA18 searching).  Our software accomplishes four things.  (1) All LC-
MS species within a certain mass tolerance of putative modified or unmodified peptides 
of the analyte protein or proteins are found, and when possible, annotated with their 
associated MS2 Mascot call, in a protein-centric output.  (2) Chromatographically 
unresolved peptide isomers and discrepant calls are identified and ranked for validation 
decisions.  (3) Validation can be done systematically and efficiently with the MS2 testing 
tools, and by virtue of the organized protein-centric output.  (4) The final per-residue 
output necessary for hypothesis testing is generated. 
 As a demonstration of the software and the value of •OH-mediated protein 
footprinting, we present the footprinting results of barstar in its folded and unfolded 
states.  Barstar is a 10.2 kDa protein, whose function is to inhibit the ribonuclease activity 
of barnase in Bacillus amyloliquefaciens19-20.  We have chosen this protein due to its 
peculiar thermal stability: it adopts its native structure at room temperature but is 
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unfolded at 0 °C 21-22.  The footprinting method we employed is fast photochemical 
oxidation of proteins (FPOP) 16, 23, which creates •OH at sub mM levels with the 
homolytic cleavage of H2O2 by a 17 ns pulse of 248 nm from a KrF excimer laser source.  
The protein exposure to •OH is kinetically limited to a microsecond by the inclusion of a 
radical scavenger, such that only the equilibrium state of the protein is sampled24. 
3.2 Experimental Procedures 
3.2.1 Reagents.   
 E. coli-expressed and purified barstar C82A variant was kindly provided by Drs. 
C. Frieden and G. DeKoster.  HPLC-grade water, 30% H2O2, L-glutamine, L-methionine, 
catalase, guanidinium chloride (GdnCl), and phosphate buffered saline (PBS) were 
purchased from the Sigma Aldrich Chemical Company (St. Louis, MO). 
3.2.2 Equilibration and FPOP labeling.   
 Each sample was composed of 10 µM barstar, 1.5 M GdnCl, and 15 mM 
glutamine in PBS buffer.  The “cold” equilibration solution was incubated at 0 °C and the 
“warm” solution at 22 °C room temperature two hours prior to labeling.  Cold and warm 
sample replicates were drawn from these solutions; to each replicate H2O2 was added by 
10-fold dilution to a 20 mM final concentration, two min prior to its infusion through the 
FPOP apparatus.  The FPOP apparatus was used as previously described 16 but with 150 
µm i.d. fused silica (Polymicro Technologies, Phoenix, AZ).  In addition, for cold 
samples, a thermally insulated box with two chambers abutted the FPOP apparatus.  The 
1st chamber contained an ice batch and copper tubing connected to a compressed air 
supply.  The 2nd adjacent chamber, into which the copper tubing emptied, was 
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constructed to enclose the syringe pump, optics stand, and intervening fused silica, with a 
2 cm2 window for laser transmission.  The 2nd chamber temperature was kept to less than 
3°C by adjusting the compressed air flow through the ice bath. 
 The KrF excimer laser power (GAM Laser Inc., Orlando, FL) was adjusted to 45 
mJ/pulse, and its pulse frequency was set to 5 Hz.  The flow rate was adjusted to ensure a 
25% exclusion volume to avoid repeat •OH exposure24.  Excess H2O2 was removed 
immediately following FPOP labeling by collecting samples in microcentrifuge tubes 
containing 10 µL of 200 fM catalase.  This catalase solution also contained methionine to 
give a final concentration of 20 mM following collection.  O2(g) was removed from the 
samples by centrifugation, and samples were subsequently frozen in N2(l) and stored at -
80°C prior to proteolysis.  A control sample was drawn from the same equilibration 
solutions and handled identically except that the laser was not used. 
3.2.3 Proteolysis.  
 All samples were proteolyzed with 10:1 protein:trypsin (by weight) at 37 °C for 3 
h, then de-salted by ZiptipC18 (Millipore, Billerica, MA) with elution into 10 uL of 50% 
acetonitrile 1% formic acid solution.  A portion of this was diluted 25-fold with water and 
0.1% formic acid for autosampler loading.  
3.2.3 LC-MS/MS acquisition. 
 Five microliters of each replicate was loaded by autosampler onto a 20 cm 
column with a PicoFrit tip (New Objective, Inc, Woburn, MA), bomb-packed with C18 
reverse phase material (Magic, 0.075 mm × 200 mm, 5 µm, 300 Å, Michrom, Auburn, 
CA).  Peptides were eluted by a 70 min, 260 nL/min gradient coupled to the nanospray 
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source of an LTQ-Orbitrap mass spectrometer (Thermo Fisher, Waltham, MA).  Mass 
spectra were obtained at high mass resolving power (100,000 for ions of m/z 400) on the 
Orbitrap component, and the six most abundant ions eluting per scan were each subjected 
to CID MS2 experiment in the LTQ component, using a collision energy 35% of the 
maximum, a 2 Da isolation width, and wideband activation.  Precursor ions were added 
to a dynamic exclusion list for 8 s to ensure good sampling of the apex of their elution 
peaks.  Blanks were run between every sample acquisition. 
3.3 Data Analysis 
3.3.1 Overview.   
 The general approach for data analysis is diagramed in Figure 3.2.  Sample 
replicates are drawn from a stock solution of the equilibrium conditions.  Analytic 
replicates can also created at the time of LC-MS/MS acquisition as typically more than 
five-fold of material is present in the de-salted peptide eluent than is needed.  We note 
that creating analytic replicates may treble again the instrument time, already long 
because of the replicate no-laser controls needed for FPOP.  The inclusion of replicates 
serves more than the purpose of providing statistics.  Just as replicate LC-MS/MS 
analyses expands the number of identified proteins in a proteomics experiment25-26, so 
with replicates does the probability of selection for MS2 and subsequent identification 
improve for low-abundance modified peptides.   
 Figure 3.2:  The workflow for protein footprinting, LC
Gray boxes signify external software used in this study; blue boxes signify software 
developed for protein footprinting.
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-MS/MS acquisition, and analysis.  
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Good peak sampling is important in both the MS and MS2 domains.  The abundance of 
an ion is determined from its integrated EIC peak area in the high resolution MS domain 
(Figure 3.3).  Automatic gain control, maximum trap fill times, lock-mass selection, m/z 
resolution, and number of MS2 experiments are all parameters that affect the frequency of 
the Orbitrap scans; we have striven for a 0.3 Hz frequency to well represent 10-20 sec 
peak widths.  For data-dependent MS2 selection, precursor ions were added to a dynamic 
exclusion list on their first occurrence for 8 s to ensure good MS2 sampling of the apex of 
their elution peaks. 
  
  
Figure 3.3:  Four high MS resolution extraction ion chromatograms of FPOP
and unmodified tryptic peptides of Apolipoprotein E3 (unpublished data).  Plot A shows 
in red the EIC at 422.737
correspond respectively to the unmodified and oxygen
WELALGR peptide.  Plot B shows in red the EIC at 865.9258 +/
black 873.9232 +/- 0.0043 m/z.  
oxygen-modified doubly-
relative intensity is determined relative to the unmodified peptides’ maximum intensities; 
the modified peptides are shown on 
LTQ-Orbitrap cannot continuously monitor each m/z; rather are shown the discrete 
scans’ intensities at each m/z.  The MS2 spectra associated with each peak have been 
matched by Mascot database searching and 
residue-resolved +15.9949 Da modifications are indicated for each black EIC where 
possible.  The blue underlines convey the LC
Elucidator feature detection and alignment system.
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4 +/- 0.0021 m/z, and in black 430.7349 +/- 0.0021 m/z.  These 
-modified doubly-protonated 
- 0.0043 m/z, and in 
These correspond respectively to the unmodified and 
protonated SELEEQLTPVAEETR peptide.  In both plots the 
a magnified scale.  The LC-MS acquisition in the 
been validated by manual inspection; the 
-MS peaks tabulated by the Rosetta 
 
 
 
-modified 
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3.3.2 Feature detection and alignment.   
 Accurate LC-MS peak software must be used to automate the accounting of 1000s 
of EIC peaks.  A feature is tabulated as the sum of all EIC peaks of ions with the same 
elution time and same (+/- 5 ppm) de-charged monoisotopic mass.  Abundant tryptic 
peptide features are often the sums of ten or more ion isotopomer intensities split among 
two or more charge states.  The features must be listed with their de-charged 
monoisotopic mass centroids.  The fidelity of peak alignment software is extremely 
important in footprinting analysis, as it is in label-free proteomics.  If the 
chromatographic reproducibility is poor, we recommend individually processing each 
data set; this significantly increases the analysis time because the validation step must be 
repeated for each occurrence.  We have used Rosetta Elucidator (Microsoft, Bellevue, 
WA) in our work, though several other free and commercial packages are available13, 27. 
 Usually oxidative modifications make a peptide more hydrophobic than its 
unmodified root, such that it will elute earlier in reverse phase chromatography.  A 
solvent-exposed region of a protein may undergo modifications at several neighboring 
sites in the protein population.  Often the resulting set of peptide isomers perfectly 
resolve, as is seen in Figure 3.3A for a peptide of FPOP-treated apolipoprotein E3 
(unpublished data).  Modified residues that exhibit more than one EIC peak are the result 
of the non-specificity of •OH in hydrogen abstraction or direct addition4.  Sometimes 
these modifications are not well chromatographically resolved (Figure 3.3B), and some 
peak detection programs such as Elucidator may tabulate these as a single broad peak.  
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The methodology and software presented here helps the user to make consistent, 
systematic decisions about such data. 
3.3.3 Mascot database searching.   
 The searching must be done on the .dta files created by the feature detection and 
alignment software, which has been parameterized to associate one .dta file per MS2 
spectrum.  The IDs assigned by the LC-MS peak software connect the MS2 spectra to 
their parent MS features; each unique feature ID is linked to the exact .dta filenames 
created by the same LC-MS peak software for the feature’s MS2 spectra.  Other programs 
which also extract MS2 spectra from .raw files as .dta files, should not be used because 
they will not follow the precise naming convention of the LC-MS peak software 
alignment software.   
 Currently the software supports the comma separated values (.csv) output of 
Mascot11.  For •OH-mediated footprinting, all commonly observed modifications for 
residues should be input into the Mascot variable modification database; redundant 
entries do not confuse the algorithm.  A recent review lists these and their likely 
mechanisms of formation3.  The set of .dtas created by the LC-MS peak software must be 
merged into a Mascot generic file (.mgf) prior to search submission.  If .mgf file is 
smaller than 50 Mb, a single search against a restricted database and specifying the most 
likely •OH modifications, such as the single and double net oxygen additions to Met, Trp, 
Tyr, Phe, and His, and single net oxygen additions to Leu, Ile, Val, Gln, Glu, Lys, and 
Arg, may be attempted. 
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 An approach less prone to crashing and more comprehensive in its output, is to do 
an “error-tolerant” search28 of the analyte protein after a preliminary search is done 
without specifying variable modifications.  In this approach the error-tolerant .csv output 
is used as it contains a large set of modified peptide identifications, many of which will 
indicate •OH-mediated product chemistry.  The error-tolerant search will also contain 
incorrect assignments in part because the MS2-matched putative peptide is no longer 
required to have a precursor mass within the specified instrument tolerance of the 
observed ion.  We recommend also using the .csv output of the preliminary search in the 
feature-matching program, as some spectra erroneously matched by the error tolerant 
search will have their true match in the preliminary search.  The benefit to doing error 
tolerant searching is that many more MS2 spectra are discovered, which may be 
associated with modified and unmodified peptides of the analyte protein.  Then more 
features of LC-MS low intensity may be considered.  The tradeoff is that more manual 
validation is required to accept these calls in the quest for accurate and full analytic 
coverage.  If two or more proteins are labeled in the experiment, error tolerant searching 
should be done for each independently.  Any number of .csv reports can be used by our 
software. 
3.3.4 Protein-specific theoretical modified peptide list.   
 To augment the MS2-Mascot-matched list of LC-MS features associated the 
analyte protein, a list of proteolytic peptides of the protein together with any combination 
of anticipated residue modifications is needed for accurate LC-MS mass matching.  The 
Excel spreadsheet tool “Unmodified and modified peptide masses from proteolysis of 
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protein” generates such a list.  This tool uses the input sequence of the analyte protein, 
and may also use optional inputs: user-defined variable and fixed modifications per 
amino acid type or per specific residue, sites of known sequence breaks, and proteolytic 
sites masked from cleavage.  Execution of the “Get_Peptides” macro will guide the user 
through choices in proteolytic enzyme, number of modifications to allow, and which 
•OH-mediated products to consider, if desired.  The output provides the list of putative 
peptides for accurate mass matching and a list of protonated ion m/z values for manual 
EIC lookup or inclusion list building.  For two or more proteins in a single study, specify 
an abbreviation to append to each peptide corresponding to its protein source.  
3.3.5 Feature annotation.   
 The Excel spreadsheet “Match LCMS features with acc mass and Mascot calls” 
marries the MS2-Mascot-matched calls with their LC-MS peak software-derived feature 
list, and augments these with accurate mass matches from the “Unmodified and modified 
peptide masses from proteolysis of protein”-generated theoretical modified peptide list.  
There are four input worksheets that must be completed before the 
“Match_peaks_to_peptides” macro can be run.  The “input LCMS features” worksheet of 
the spreadsheet requires as input, a list of the feature IDs determined by the LC-MS peak 
software.  Their mass and time centroids can also be included, as well as the feature 
intensities for each sample by column; this option allows for other kinds of LC-MS peak 
software outputs.  In the “input dta list” worksheet the list of all .dta filenames and their 
associated feature IDs and .raw file sources should be provided.  The LC-MS peak 
software should create .dta filenames for the MS2 spectra by including in them the name 
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of the .raw file from which each MS2 spectrum originated.  The spreadsheet uses this 
information to group spectra with their original acquisition names, thereby allowing 
acquisition-specific spectral counting per feature.  Into the “input exact mass list” 
worksheet the theoretical modified peptide list is put.   
 The “input proteins” worksheet, the fourth and final input worksheet of the 
spreadsheet, specifies the precedent order of proteins by the position of their sequence 
entry.  These sequences are used as the organizing directory for outputting annotated 
features.  They should be the same sequences used to generate the exact mass list, if a list 
is to be used, and they must be the same sequences used by Mascot to generate the .CSV 
report(s).  The protein list is prioritized: a feature having a Mascot annotation exactly 
matching a sequence from the first protein will be described as a peptide originating from 
the first protein, even if a homologous protein lower on the list shares the same sequence.  
This is intended.  Same sequence peptides from two protein sources share the same LC-
MS properties, so their intensities should be compared in a single output line having one 
annotation.  The output columns differentiate the peptides’ sources by passing along their 
acquisition names. 
 Execution of the “Match_peaks_to_peptides” macro initiates the dialog for 
looking up aligned data files specific to each LC-MS acquisition, if this sample intensity 
information was not provided in the 1st worksheet.  A second dialog will ask for the .csv 
report(s); these should be placed in the same folder.   A threshold can optionally be 
employed to filter low intensity data, though this is not recommended for beginning 
experiments.  We do recommend using a Mascot score threshold of 30 or better, as 
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validating matches deemed poor by Mascot is likely to be challenging or impossible.  
Finally, the macro will ask for an accurate mass match tolerance; for Fourier transform 
spectrometers we have used 8-10 ppm.   
 After execution the two outputs are provided.  The “condensed Mascot output” 
worksheet is a report of the Mascot-matched spectra exceeding the threshold and matched 
to the proteins on the list.  The first eight columns are the same fields found in the Mascot 
.csv report(s), where each row pertains to a unique Mascot call.  Rather than repeat the 
same entry lower on the list for other matching MS2 spectra, all spectra that match this 
entry are listed to the right of the annotation columns, and the best scoring peptide of 
these is listed in column 19.  Instead of relying on Mascot for the proper protein 
annotation, the matched peptide sequence is tested against the protein list provided in the 
“input proteins” worksheet.  In this way redundant entries in the search database do not 
confuse the output annotation.  The protein-centric peptide annotation and associated LC-
MS feature ID are provided in columns 9-18.  These fields are shared in the second 
output described next. 
 The “annotate LCMS output” worksheet lists the LC-MS features matched by 
Mascot searching or accurate mass matching first by protein, then N-terminus to C-
terminus peptide order, then by elution time.  The first 15 columns in the output 
worksheet annotate the LC-MS feature; the subsequent columns provide the intensities, 
relative intensities, and spectral counts per feature for each sample acquisition.  A 
feature's relative intensity per sample acquisition is its absolute intensity divided by the 
average of all absolute intensities, at least 0.1% as large as the acquisition’s maximum 
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intensity, in the subset of LC-MS peak software features putatively matched to the 
analyte protein(s) in the “input proteins” worksheet.  Table 3.1 shows the annotation 
columns for one tryptic peptide of barstar.  The theoretical mass is based on the Mascot-
matched call or accurate mass match, and the ppm error is based on the observed mass 
difference with the putative theoretical peptide.  The “net modified mass change” is 
determined as the difference between the observed mass centroid and the theoretical 
unmodified peptide.  Features with the “# supporting MS2 spectra” field blank are 
present owing to an accurate mass match with the theoretical modified peptide list.  The 
“potential modification(s)” field reflects one potential combination of modifications 
giving rise to the net-modified-mass change for these entries. 
3.3.6 Ranked calls.  
 Sometimes when more than one spectra are associated with a single LC-MS 
feature, Mascot-matching will determine that some of the spectra are indicative of one 
peptide, while the other spectra are indicative something else.  These discrepancies arise 
for two reasons.  The first is the occasional nearly-coincident elution of modified peptide 
isomers.  In Figure 3.3B, a single LC-MS feature between 33.3 and 34.3 min is clearly a 
mixture of three modified peptide isomers that are not resolved to half height.  The 
second reason is mistakes are sometimes made by error-tolerant Mascot-matching, 
particularly when an MS2 spectrum is sparse, the modification is in a peptide region 
insensitive to CID fragmentation, or multiple modifications are present on the peptide.  It 
has been beyond our scope to construct an algorithm that could resolve these 
78 
 
discrepancies with high fidelity.  Rather a ranking is made of all discrepant calls to allow 
for systematic decisions as to which calls deserve validation or correction, and which are 
Table 3.1: Annotation output for barstar tryptic peptide 3-11, from the “Match LCMS 
features with acc mass and Mascot calls” spreadsheet. 
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3-11_bs AVINGEQIR 1014.54580 1014.5444 -1.4 15.994 
 
I10 1 2 10 0.67 51.2 27.60 44682884_1 
3-11_bs AVINGEQIR 1014.54580 1014.5444 -1.4 15.994 
 
I5 2 2 5 0.33 43.4 27.60 44682884_2 
3-11_bs AVINGEQIR 1012.53016 1012.5289 -1.2 13.979 _14 
 
1 1 
   
27.68 44682976_1 
3-11_bs AVINGEQIR 1014.54580 1014.5437 -2.1 15.993 
 
I10 1 1 5 1.00 56.8 28.59 44682694_1 
3-11_bs AVINGEQIR 1028.56140 1028.5590 -2.3 30.008 
 
N6 1 2 6 0.75 49.1 28.78 44682198_1 
3-11_bs AVINGEQIR 1028.56140 1028.5590 -2.3 30.008 
 
G7 2 2 2 0.25 39.9 28.78 44682198_2 
3-11_bs AVINGEQIR 1012.53016 1012.5284 -1.7 13.979 _14 
 
1 1 
   
28.83 44683820_1 
3-11_bs AVINGEQIR 1014.54580 1014.5442 -1.6 15.993 
 
I5 1 2 5 0.63 52.1 29.90 44683417_1 
3-11_bs AVINGEQIR 1014.54580 1014.5442 -1.6 15.993 
 
V4 2 2 3 0.38 41.6 29.90 44683417_2 
3-11_bs AVINGEQIR 1012.53016 1012.5287 -1.4 13.979 _14 
 
1 1 
   
31.23 44684712_1 
3-11_bs AVINGEQIR 1028.56140 1028.5593 -2.0 30.008 
 
G7 1 1 1 1.00 45.7 31.26 44683899_1 
3-11_bs AVINGEQIR 970.54470 970.5429 -1.9 -28.008 
 
R11 1 1 14 1.00 65.6 31.44 44681013_1 
3-11_bs AVINGEQIR 998.55089 998.5508 -0.1 0.000 
  
1 1 
   
31.81 44682389_1 
3-11_bs AVINGEQIR 998.55090 998.5482 -2.7 -0.003 
  
1 1 46 1.00 62.2 31.82 44681205_1 
3-11_bs AVINGEQIR 1001.56290 1002.5631 997 4.012 
 
N6 1 1 10 1.00 44.2 31.83 44681370_1 
3-11_bs AVINGEQIR 998.58730 998.5865 -0.8 0.036 
 
Q9 1 1 33 1.00 62.2 31.86 44681624_1 
3-11_bs AVINGEQIR 999.53490 999.5318 -3.1 0.981 
 
N6 1 2 50 0.96 70.7 32.24 44681006_1 
3-11_bs AVINGEQIR 999.53490 999.5318 -3.1 0.981 
 
Q9 2 2 2 0.04 37.4 32.24 44681006_2 
3-11_bs AVINGEQIR 999.53490 999.5319 -3.0 0.981 
 
N6 1 2 50 0.88 70.7 33.18 44681251_1 
3-11_bs AVINGEQIR 999.53490 999.5319 -3.0 0.981 
 
Q9 2 2 7 0.12 43.0 33.18 44681251_2 
3-11_bs AVINGEQIR 1012.56650 1012.5649 -1.6 14.014 
 
V4 1 2 8 0.62 55.1 34.00 44681184_1 
3-11_bs AVINGEQIR 1012.56650 1012.5649 -1.6 14.014 
 
A3 2 2 5 0.38 47.9 34.00 44681184_2 
 
worth deleting.  The ranking rule preferences first the number of MS2 spectral counts 
among all samples that match a call above the specified threshold.  Ties in spectral counts 
are rank-resolved by the maximum score. The feature entries possessing discrepant calls 
are listed contiguously in the “annotate LCMS output” worksheet with the best (lowest) 
rank listed first, and so on.  At this stage the sample intensity information is preserved 
among each repeated entry.  The “call spectra/all spectra per feature” field is also based 
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on the spectral counts associated with calls, and can be used for quick filtering, using the 
“Rank_Filter_Output” macro or Excel filtering capability. 
3.3.7 Validation.   
 Depending on the protein system, footprinting chemistry, Mascot search 
parameters, and desired level of quantitative resolution, the validation step in data 
processing (Figure 3.2) can be nearly a “rubber stamp” step or can require a several-day 
endeavor.  This is an intimate step: no computer algorithm is employed to make 
decisions.  The first step is usually one of filtering.  The features important to the 
footprinting experiment should be scrutinized while superfluous features can be ignored 
by deletion.  The organization of the data in Excel allows the use of several Excel 
capabilities including filtering and formula entry to assist in this filtering.   
 For FPOP footprinting, where analytic coverage requires finding low abundant 
modifications, the filtering is often as follows.  (1) Features with a maximum relative 
intensity, among all samples, of less than 2% are marked for exclusion.  Very often these 
features did not trigger any MS2 experiments in any of the acquisitions.  (2) Features with 
|accurate mass errors| > 10 ppm and features with spurious modifications are corrected, 
where possible, using the “Unmodified peptide accurate mass comparison” Excel tool.  
This spreadsheet is not macro-enabled.  Its function is to allow the user to hypothesize 
correct modification calls when Mascot has made a mistake, or fill in missing sequence 
when a non proteolytic peptide is suggested with a large N- or C-terminal modification.  
(3) Modification calls associated with deamidation, water loss, ammonia loss, and other 
chemistries that show as much abundance in control samples as FPOP samples are 
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marked for exclusion.  (4) Non-tryptic peptides are marked for exclusion, though some of 
the time these are born from radical labeling chemistry.  (5) The .dta filename/feature ID 
list prepared for the “Match LCMS features with acc mass and Mascot calls” spreadsheet 
is used to determine which accurate mass-matched features lack MS2 spectra; these are 
marked for exclusion.  The final inclusion list is ready for validation decisions. 
 Without automated software and in the interest of expeditious analysis, a further 
filtering step based on relative intensity may be necessary for validating and completing 
the modification annotation of accurate mass-matched features.  We have used a custom 
Perl-based correlation program to facilitate this analysis29, and are working to make this 
software available and easier to use.  Manual accurate mass-matching validation and 
annotation completion requires using the .raw data browser and any tools for peptide 
hypothesis testing or de novo sequencing the user may already have. 
 The majority of features useful for footprinting should have a putatively assigned 
Mascot-derived identity.  The final decision in the validation step rests with which 
features to accept as correct without further validation.  This requires a familiarity with 
the expected sites and yields of modification.  For FPOP, a good starting place is the 
excellent review of •OH-mediated footprinting by Xu and Chance3 as well as the bottom-
up FPOP-analyses published by the Gross lab9, 14-16. 
 Features selected for validation can be processed in two ways.  Clearly one way is 
by manual inspection.  This may be necessary for LC-MS features with more than 5-10 
associated spectra and having more than one probable call, as determined from each call’s 
fraction of feature spectra—if such a feature provides information other 
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chromatographically resolved features do not (a new modified residue, perhaps).  
Alternatively, two Excel macro-enabled tools can expedite validation and correction 
before undertaking manual inspection.  The “UniqueID MS2 spectra extractor” 
spreadsheet takes as input the first 15 annotation columns as shown in Table 3.1 for all 
selected features needing validation, and uses the “condensed Mascot output” worksheet 
of the “Match LCMS features with acc mass and Mascot calls” spreadsheet to determine 
the best Mascot-matched MS2 spectra supporting each uncertain feature’s annotation.  
These spectra are found either in the folder containing all .dta files from the experiment 
or from the merged .mgf file(s) submitted to Mascot.  Keeping the latter on one’s hard 
drive is preferable from a file management standpoint.  The x-y data of each spectra is 
output to a worksheet together with the pertinent annotation hypothesis needing testing.  
The “MS2 call checker” spreadsheet is used to examine each of the spectra one-by-one 
by copying and pasting the desired spectrum and its hypothesis information into the first 
worksheet and executing the “compare_to_MS2_spectrum” macro.  An overlay of the 
theoretical and observed spectrum can provide definitive validation (Figure 3.4) of the 
call, or the user may inspect the “matches” and “missed” worksheets for numerical 
checking.  If the hypothesis is wrong, a new one can be made by altering the sequence, 
modification location(s), or modification mass in the first worksheet.  With each change 
or confirmation, update the final footprinting annotations accordingly. 
 Figure 3.4: An output match spectrum of the “MS2 call checker” spreadsheet.  The 
theoretical spectrum of barstar pe
at F74, is mapped onto the best Mascot
In this case manual validation clearly confirms the Mascot peptide call, as nearly all 
observed black peak ions are obscur
ions.  The modification location is also confirmed because the observed ion at 1369.4 m/z 
matches the expected unmodified b13 ion and the ion at 1532.4 matches 
modified b14 ion. 
 
3.3.8 Per-peptide data processing.
 Once the heavy lifting of validation is complete, the next steps can be completed 
in minutes.  The “Annotated Features Combiner” spreadsheet uses the final array of 
validated features and intensities; the format should be preserved from the longer output 
list from the “Match LCMS features with acc mass and Mascot calls” spreadsheet.  
Execution of the “Average_Like_Samples” macro initiates several dialogs.  The user 
specifies which samples are replicates for each entered treatment (protein state, labeling 
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condition, etc.).  For •OH-mediated footprinting samples, a time window can be set about 
the major unmodified elution time for each proteolytic peptide.  Typically oxidative 
modifications make peptides more hydrophilic such that they elute up to 10-15 min 
earlier than their unmodified analog in an 80 min gradient (Figure 3.3).  The fellow 
modified peptides eluting in this time window will be grouped with the unmodified to 
determine the “root” or total measured abundance (sum of intensities) of each proteolytic 
peptide.  From these values the fractions of modified and unmodified peptides are 
determined.  The last dialog asks the user to decide how to treat features still having more 
than call.  The two most-used treatments are to either (1) ignore all such features, or (2) 
include them but multiply their intensities by the fraction of spectral counts indicative of 
each discrepant call.  In this latter way important mixture peaks can be included without 
overestimating their contributions. 
 The Combiner spreadsheet’s “output” worksheet conveys these per-peptide 
footprinting results for each replicate and reports their averages and standard errors, in 
addition to each feature’s fractional contribution to its root.  The second output worksheet 
of the Combiner spreadsheet, “per sample absolute data”, carries through the list of all 
absolute intensities for each feature from the input, and reports each feature’s associated 
peptide’s total intensity.  This output worksheet is needed for the final Excel data 
processing spreadsheet.  The coloring of peptides by their root group in the output 
worksheets does not convey meaning but is meant to allow easier inspection. 
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3.3.9 Per-residue data processing.   
 Often for radical-based modification strategies, multiple features are observed that 
indicate modification at a single residue, due to five reasons.  (1) Multiple atomic sites of 
a residue may be vulnerable to modification, such as the indole ring of tryptophan to •OH 
attack3, 30, and these isomers separate in chromatography.  (2) The product chemistry may 
be varied at a single site.  For example, methionine is easily oxidized to a +16 Da 
sulfoxide, and will readily further oxidize to a +32 Da sulfone3. (3) More than one set of 
modified and unmodified proteolytic peptides spanning the residue are used in the 
analysis, due to a frequent missed cleavage.  Sometimes missed cleavages are desirable 
as they expand the region of analytic coverage into sequence regions having proteolytic 
substrate sites every 3-6 residues.  (4) The LC-MS peak software has split an LC-MS 
feature into two co-eluting features of the same mass centroid.  Sometimes the peak 
software is conservative in its de-charging, such that it does not group these LC-MS 
isobaric and co-eluting component EIC peaks together as one feature.  As long as these 
entries were not deleted in the validation step, their proper inclusion in the per-peptide 
and per-residue analysis is guaranteed.  (5) Oxidations at the ESI source give rise to post-
chromatography modifications of eluted unmodified species.  These features can be 
filtered in the validation step by inspection of their elution times and control levels, 
unless one is employing the method of •OH footprinting that utilizes the oxidative 
electrochemistry possible at the ESI source31-33. 
 The signals from all same-residue modifications should be incorporated in its 
modification yield calculation, according to equation 1. 
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Note that this equation will not sum missed cleavage peptides spanning residuei in the 
denominator if no modifications at residuei are detected for a peptide having the same 
missed cleavage sequence. The argument is as follows:  The protein modification yield at a 
residue should be recapitulated at the peptide level.  Unless there is a modification bias with 
proteolysis, the missed-cleavage peptide will also be modified at the residue in the same 
yield.  The lack of detection of the modified missed-cleavage peptide does not mean the 
missed-cleavage peptide isn’t modified; rather it is an analytic failure usually owing to a low 
frequency of missed cleavages. Therefore the unmodified missed-cleavage peptide should 
not be included in the yield denominator in this instance.  With trypsin proteolysis and •OH 
footprinting, an exception to this rule should be made for features showing deguanidination 
(-43 Da) at arginine34.  In this case the root total should be adjusted to include the root total 
of the shorter proteolytic peptide that shares the most number of residues with the 
deguanidination missed-cleavage peptide. 
 The “per-residue fraction modified analysis” spreadsheet performs the per-residue 
yield calculations on the “per sample absolute data” output from the Combiner spreadsheet 
with the execution of the “calculate_ratios” macro.  If uncertain modifications annotations 
were altered to include “or”, such as “M64 or M68” in the “MS2 ID'd modification” field, 
these uncertain calls should be resolved before final per-residue calculation by their 
omission.  Alternatively the “read_in_modifications” macro will direct the user to fix these 
entries before the “calculate_ratios” macro is executed; the “calculate_ratios” cannot 
interpret any modification entries that do not follow the 1-letter amino acid residue number 
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format with comma separations for multiply modified features.  The set of features used in 
the per-residue analysis may be smaller than used in the per-peptide analysis, because 
uncertain modification features still accurately convey labeling at the peptide level but 
should not be used at the residue level. 
 With the per-residue yields in hand, the analysis of SASA and structure(s) can begin.  
For footprinting strategies like FPOP, in which labeling yield depends on the inherent 
reactivity of a residue as well as its SASA, state vs. state comparisons at the per-residue 
level will be more discriminating than at the per-peptide level.  At the per-peptide level, 
small changes in yield at some sites may be masked by invariant yields at neighboring 
residues that are more sensitive to •OH, like methionine. 
3.4 Results and Discussion 
3.4.1 LC-MS feature coverage.   
 Of the 19,280 LC-MS EIC ion peaks detected among the cold, warm and control 
samples, 1,116 are the isotope and charge state contributors to 367 features associated 
with barstar or catalase.  The total peak area intensities of these 1,116 ion EICs is 69% of 
all EIC peaks.  The remaining 18,164 ions are predominantly singly charged or do not 
have a discernable charge state, and are very low in abundance.  Of the 367 features, 76 
were used in the final per-residue analysis of cold and warm barstar states.  Seventy-eight 
features were excluded because their relative intensities were less than 2% the average 
intensity for putative barstar features.  Eighty-seven features were omitted because they 
were not tryptic peptides of barstar.  Most of these features were also present in the 
control, indicating a chymotryptic or non-specific enzymatic origin, and 95% were less 
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than half the average intensity for each sample.  This may be more than expected; 
shortening the trypsin proteolysis may diminish the occurrence of these cleavages.  It is 
not clear how frequently non-specific cleavage products should be expected, as the 
discovery by error-tolerant searching of non-tryptic peptides is not typically disseminated 
in proteomics studies.  The remaining exclusions were for features indicated as mixtures 
of modified peptide isomers that could not be accurately split, features whose MS2 
spectra cannot definitively locate the modification, peptide features bearing known 
sample handling and ESI modifications (e.g. water loss, ammonia loss, deamidation), 
peptide features bearing unexpected modifications shared by control and FPOP samples 
alike (and thus are not FPOP signal), and catalase peptide features. 
3.4.2 Analytic sequence coverage.   
 The sequence coverage of barstar in this study was 100%.  All 89 residues were 
spanned among the detected unmodified tryptic and non-tryptic peptides of barstar. The 
analytic sequence coverage of barstar was 63%.  The first two lysine residues are 
invisible by virtue of trypsin proteolysis.  The tryptic peptide 
E23LALPEYYGENLDALWDCLTGWVEYPLVLEWR54 was not detected, but several 
low abundance unmodified semi-tryptic peptides spanning this region were detected.  
Unfortunately none were of sufficient abundance to warrant looking for their modified 
siblings; consequently barstar 23-54 is silent in this study.  This illustrates the need for 
more than one proteolysis method when the footprinting study goal is complete analytic 
coverage.  Nevertheless, the N- and C- terminal regions of barstar are well represented, 
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and we are confident in the structural conclusions drawn from the yield data for these 
regions. 
3.4.3 Barstar folding.   
 The FPOP data indicates Barstar is folded at 22°C and partially or completely 
unfolded at 0 °C.  Nineteen residues were detected as modified (Table 3.2); of these, I5, 
I10, L16, L20, T63, V70, L71, V73, F74, I84 are significantly more labeled and hence 
solvent accessible in the cold state.  E8 and E68 are significantly more protected in the 
warm state.  Significance is determined by the Student’s t-test at 95% confidence.  We 
cannot yet make any statistical conclusions for R11 and R75 (they’re both higher in the 
cold state) because their modification signals stem solely from -43 Da deguanidination 
missed-cleavage peptides.  It is not yet clear if the denominator treatment described in the 
Data Analysis section is appropriate for these modifications since these arginines are 
positioned in the middle of their missed-cleavage peptides.  
 Statistical significance does not necessarily convey a large change in SASA.  To 
approximate the physical change in SASA per residue, we have normalized the cold-
warm yield difference by the maximum yield measured for residues of the same amino 
acid class in Figure 3.5.  The maximum yields observed for each amino acid-kind of 
residue approximates the inherent reactivity of each residue type to •OH in the FPOP 
experiment, because these residues are expected to be the least sterically obscured in their 
respective classes.  Then for a relative change approaching 100% of this maximum, as 
seen for L16, L20, T63, V73, F74, and I84, signifies a large change in SASA, and thus 
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Table 3.2: FPOP yields per residue for 
barstar in two states. 
residue 0 °C 22 °C 
I5 0.45 +/- 0.01% 0.14 +/- 0.01% 
E8 0.005 +/- 0.002% 0.053 +/- 0.004% 
I10 0.177 +/- 0.003% 0.0354 +/- 0.0008% 
R11 0.056 +/- 0.007% 0.022 +/- 0.003% 
L16 0.27 +/- 0.01% 0.066 +/- 0.004% 
H17 0.42 +/- 0.04% 0.24 +/- 0.06% 
T19 0.0025 +/- 0.0005% 0.07 +/- 0.03% 
L20 0.204 +/- 0.004% 0.022 +/- 0.002% 
E57 0.64 +/- 0.02% 0.65 +/- 0.03% 
L62 0.16 +/- 0.03% 0.110 +/- 0.006% 
T63 0.11 +/- 0.02% 0.021 +/- 0.003% 
E68 0.010 +/- 0.002% 0.047 +/- 0.005% 
V70 0.013 +/- 0.001% 0.0033 +/- 0.0002% 
L71 0.013 +/- 0.001% 0.0033 +/- 0.0002% 
V73 0.10 +/- 0.02% 0.030 +/- 0.002% 
F74 2.9 +/- 0.2% 0.86 +/- 0.08% 
R75 0.066 +/- 0.007% 0.045 +/- 0.004% 
I84 1.8 +/- 0.8% 0.3 +/- 0.2% 
I86 0.6 +/- 0.3% 0.011 +/- 0.004% 
 
may convey complete exposure in the cold state.  A clear picture of structural differences 
between states is afforded by mapping the labeled residues onto the monomeric structure 
of WT barstar (we have used barstar C82A in this study) (Figure 3.6).  Residues 
determined by FPOP to be buried in the warm state relative to the cold state are also 
clearly buried in the native NMR structure (red residues).  E8 and E68 are very exposed 
in the native structure (green residues), and our data suggests they are less so in the cold 
state when.  Residues approximately half-exposed in the native structure are also deemed 
statistically equivalent in our analysis (blue residues).  Significantly, the majority of 
 residues assayed as protected in the native state ar
show little change or the opposite trend are hydrophilic.  This segregation in exposure is 
consistent with the essential role hydrophobic 
denaturation of proteins, in which the l
residues in the denatured state is compensated by their hydration at low temperature
Figure 3.5:  The difference plot of all modified residues except R11 and R75.  Each cold 
– warm yield difference is divided by the maximum yield for each kind of residue.  
Residues with values above the x
shown are propagated from the replicate
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residues play in the phenomenon of cold 
oss of van der Waals interactions between such 
 
-axis exhibit more labeling in the cold state.  Error bars 
-derived standard errors for each state.
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 Figure 3.6:  Four views of the native monomer barstar NMR structure 1BTA.pdb
17 residue sidechains shown in bond depiction.  Red residues are significantly more 
labeled in the cold state.  Green residues are significantly more labeled in the warm state.  
Blue residues are labeled in both states, but do not show a statistical difference.
 
3.5 Conclusion 
 In this study we have introduced a comprehensive protein
analysis method that can deliver residue
of label-sensitive residues in a protein or protein complex.  This methodology is best 
served by using high resolution MS hybrid instruments, nano
automated LC-MS peak detection and alignment software, and Mascot error
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-resolved labeling yields for the full complement 
-flow chromatography, 
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search capabilities.  Each of these things is a prime component of many proteomics 
centers (help with reference).  The methodology is applicable to targeted PTM analysis 
and any protein-footprinting strategy that imparts stable covalent modifications.  In 
particular, this analysis method well serves •OH-mediated footprinting studies. 
 The application of this method to the FPOP study of cold-denatured and room 
temperature-folded barstar protein shows the utility of •OH-labeling in identifying sites 
sensitive to changes in SASA between protein states.  In doing so, we have highlighted 
the means of implementing the data analysis tools, paying particular attention to aspects 
of data validation important to generating high-fidelity residue-resolved labeling yields. 
 Six of the seven Excel application tools presented here utilize macros written in 
visual basic for applications (VBA); the seventh is code-free.  We feel the relative 
transparency of the VBA and capabilities of Excel make these tools excellent resources 
for the skeptical protein-footprint scientist, as the data flow from one tool to the next is 
eminently not “black-box” but user-guided.  As of now, these tools will be available on 
request; we intend to make them freely available online in the coming months.  Finally, 
we acknowledge that the pioneers in •OH-mediated protein footprinting have also 
developed a software platform for the analysis of such data37; we have not yet compared 
analysis strategies. 
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4 Fast photochemical oxidation of proteins (FPOP) by the 
sulfate radical anion probes solvent accessibility 
 
4.1 Introduction  
Chemical footprinting1-3 of proteins is becoming an efficient alternative and 
augmentative method to X-ray crystallography and NMR spectroscopy for the elucidation 
of protein structure and interactions.  By mass spectrometric analysis of the protein-
footprint products in the presence and absence of ligand, the binding site(s) and induced 
changes in protein conformation can be determined, provided that the labeling reactions 
in these regions are attenuated in the holo state.  The most general and, thus, informative 
chemical reactions currently used for protein footprinting are hydrogen/deuterium 
exchange (HDX)4 and hydroxyl radical oxidation.5  The methods are complementary in 
revealing features of protein structure.   Predominantly side chain accessibility is sampled 
by properly controlled •OH reaction6, whereas HDX samples backbone amide hydrogen 
accessibility and secondary structure.7-8 
Hydroxyl radicals probe solvent accessibility because they have both comparable 
size to solvent water molecules and high reactivity with a significant fraction of amino-
acid side chains.  One of the advantages of •OH footprinting is that the stability 
(irreversibility) of modifications enables a “bottom-up” proteomics methodology of 
proteolysis and online LC-MS/MS for their detection and quantification.  Interest in other 
chemical probes that engender similarly stable modifications, including the highly 
reactive methylene carbene9-11, continues to increase, driven by the possibility that 
complementary structural information of protein complexes might be obtained with 
different chemical selectivity of accessible protein residues. 
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We demonstrated that FPOP occurs on the microsecond timescale for •OH 
labeling reactions,12  affording near millimolar levels of •OH from the homolytic 
cleavage of H2O2 upon irradiation by a 17 ns flash of 248 nM KrF excimer laser.  
Constituent Gln acts as a radical scavenger, ensuring the quenching of labeling on this 
timescale.  The strength of this approach to footprinting is the high yield of protein 
modification by •OH from a profoundly short exposure.  A microsecond labeling 
timescale avoids the sampling of  protein conformation that are altered by the 
modification, as ultimately will be the case for  timescales that are longer.13 
Herein we report a new footprinting agent for the FPOP method, an ionic sulfate 
radical anion, SO4-•. The primary reason for choosing SO4-• is that its reduction potential 
at 2430 mV is higher than that of •OH (1900 mV),14  making it a potentially useful 
oxidant for proteins.  For example, the formation of protein cross-links can be triggered 
by SO4-•15-16, and protein oxidation using SO4-• can occur in the metal-catalyzed 
oxidation reactions.17  It is a reasonable expectation that SO4-•, like •OH, oxidizes 
proteins very rapidly, which is an advantage of FPOP using •OH.  Reactions of SO4-• 
with amino acids and some dipeptides in aqueous solution are known albeit on a 
continuous timescale rather than pulsed as we demonstrate here.  This chemistry of SO4-• 
is determined by its very high electron affinity and its capability to oxidize aromatic and 
Met side chains to the corresponding radical cations, which subsequently undergo either 
fragmentation or hydration.18-19  The sulfate radical anion can also oxidize carboxyl 
anions including zwitterionic amino acids in aqueous solution to acyloxyl radicals 
(RCO2•), which rapidly decarboxylate to give carbon-centered radicals.14, 20  Radicals 
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formed by SO4-• hydrogen abstraction also occur for some amino acids such as Leu and 
Ser.20 
The precursor compound used for the generation of SO4-• is the relatively stable 
and water-soluble inorganic salt Na2S2O8.  The S2O82− aqueous ion has a UV band 
maximum at 215 nm; we measured the extinction coefficient at 248 nm in PBS as 24 M−1 
cm−1.  The photolysis of  S2O82− in water gives SO4-• radical anions with a quantum yield 
of 0.55 at 308 nm.21 
In the present study, we compared the amino-acid residue reactions of laser-
initiated sulfate radical anion with those of hydroxyl radicals after tuning the oxidation 
levels so that they nearly match. The tests were two proteins, apomyoglobin (aMb) and 
Ca2+-free calmodulin (CaM), and a mixture of peptides, bradykinin and angiontensin II, 
which were subjected to both peroxide and persulfate FPOP.  We focused the 
proteolysis/LC-MS/MS analysis (1) to identify the types of residue modifications and 
their frequency and ascertain whether any subset of residues SO4-• may better sample 
than •OH and (2) to determine whether persulfate FPOP exclusively modifies solvent 
accessible residues, and on a timescale fast enough to sample native conformation only. 
More than any other oxidative-modification protein footprinting method, FPOP is 
highly tunable both in yield (by altering starting material levels of quencher and labeling 
precursor), timescale, and targeted chemistry.  Besides hydroxyl radicals and sulfate 
radical anions, there are several potential peroxy-22 and diazirine23 species capable of UV 
photolysis to generate either other radicals or carbenes, which may be selected for their 
physical properties or residue specificity.  These opportunities make clear another 
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purpose of this study; that is, to illustrate a method for validating such starting materials 
for developing new methods of protein footprinting by FPOP.     
4.2 Experimental Procedures 
4.2.1 Reagents.   
 Bovine β-Lactoglobulin A (BLG), 30% hydrogen peroxide, sodium persulfate, 
angiotensin II, bradykinin, L-glutamine, L-methionine, catalase, urea, ethylene glycol-
bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), acetonitrile, formic acid, 
proteomics grade trypsin, and phosphate buffered saline (PBS) were purchased from the 
Sigma Aldrich Chemical Company (St. Louis, MO).  Bovine CaM was purchased from 
Oceanbiologics (Corvallis, OR).  The proteins were used without further purification.  
Purified water (18 MΩ) was obtained from an in-house Milli-Q Synthesis system 
(Millipore, Billerica, MA). 
4.2.1 Oxidative-modification labeling.   
 Each 50 µL sample was prepared in PBS (10 mM phosphate buffer, 138 mM 
NaCl, 2.7 mM KCl, pH 7.4 at 25 °C), with a final protein concentration of 10 µM.  The 
bradykinin and angiotensin II components of peptide mixture samples were also prepared 
at these concentrations.  Apo-CaM samples included 100 µM EGTA for the chelation of 
adventitious calcium.  Glutamine was added to a final concentration of 20 mM in normal 
FPOP samples.  Hydrogen peroxide or Na2S2O8 was added to a final concentration of 15 
mM or 3 mM, respectively, just before FPOP infusion except for BLG, where Na2S2O8 
was added to 5 mM.  The experimental apparatus and procedure for laser flash photolysis 
of samples was detailed previously.12  The laser power was adjusted to 44 mJ/pulse.  The 
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fraction of sample masked from irradiation was set to 20% by adjusting the infusion flow 
rate and laser pulse frequency; this ensured that no protein was double-shot.12-13 
Sample was collected in a microcentrifuge tube containing 20 µL of 70 mM Met, 
and immediately purified from excess H2O2 or Na2S2O8 by Millipore Ziptip (Billerica, 
MA)
 
0.6 µL bed solid-phase extraction.  C4 tips were used for BLG, aMb, and CaM 
samples; C18 tips were used for samples containing peptide mixtures.  Each 10 µL Ziptip 
accommodates up to 45 µL in aspirate with careful pipette action.  One slow 
aspiration/dispense cycle was sufficient to load the Ziptip with good recovery; this 
precaution minimized post-FPOP oxidation (data not shown).   
Except for BLG, four treatments per protein or peptide mixture were applied in 
triplicate.  “Native” samples were solutions of analyte, buffer, and Gln, and were not 
laser irradiated.  “Peroxide” sample solutions included H2O2 and were subjected to flash 
photolysis.  “Persulfate” sample solutions included Na2S2O8 and were subjected to flash 
photolysis.  “Persulfate control” sample solutions were prepared identically to 
“Persulfate” but were not laser irradiated.  Their persulfate exposure was limited to 5 min 
prior to desalting.  BLG samples were processed similarly but at two persulfate levels and 
in duplicate. 
4.2.2 Global mass spectrometry of FPOP-labeled β-lactoglobulin.    
 For BLG samples, ZiptipC4 eluent was diluted 5-fold in 50% acetonitrile and 
immediately infused onto a Waters Ultima Global quadrupole time-of-flight (Milford, 
MA), operating in V mode at 12,000 FWHM resolving power at 838.8 m/z 
((CF3COONa)6Na+ calibrant ion). 
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4.2.3 Proteolysis and LC-MS/MS 
Apomyoglobin samples were trypsin-digested for 18 h at 37 °C; CaM samples 
were trypsin-digested 6 h at 37 °C; each was digested at a 1:10 trypsin:protein weight 
ratio.  The peptides were desalted using ZiptipC18 (Millipore), and the 10 µL eluent was 
diluted 20-fold with purified water.  A small sample (2 µL) was loaded by autosampler 
(Eksigent nanoLC, Dublin, CA) onto a capillary column with a laser-pulled tip (Sutter 
Instruments, Novato, CA), bomb-packed with C18 reverse phase material (Magic, 
0.075mm × 200mm, 5µm, 300Å, Michrom, Auburn, Ca). The gradient was from 1% 
solvent B (97% acetonitrile, 3% water, 0.1% formic acid) to 60% solvent B over 60 min 
at an eluent flow of 260 nL/min.  The LC was coupled to the nanospray source of an 
LTQ-Orbitrap mass spectrometer (Thermo Fisher, Waltham, MA), for aMb and peptide 
mixture samples, or an LTQ-FT mass spectrometry (Thermo Fisher), for CaM.  Mass 
spectra of eluting peptides were obtained at high mass resolving power (100,000 for ions 
of m/z 400) with the FT mass spectrometer component, while MS/MS experiments on the 
six most abundant eluting ions per high resolution scan were performed in the LTQ at a 
normalized collision energy of 35% of maximum, using a 2 Da isolation width and wide-
band activation.  Ions submitted to MS/MS were placed in a dynamic exclusion list for 8 
s.  A blank run followed every sample acquisition. 
4.2.4 Data Analysis 
  The peak alignment algorithm of the Rosetta Elucidator data management system 
(Rosetta Biosoftware) was used to generate tables of extracted ion chromatogram 
features.  Manually validated Mascot error-tolerant search results were paired to their 
tabulated mass spectral features by a custom Excel VBA program, which also augmented 
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the search results with a 5 ppm threshold mass list of anticipated peroxide and persulfate 
FPOP products not found by Mascot.  Augmented hits were included only if a product-
ion spectrum verified the accurate mass match.  A third modification discovery method 
utilized a correlation algorithm to compare unidentified product-ion spectra to exemplary 
CID fragment spectra of unmodified tryptic peptides of aMb, CaM, and of bradykinin 
and angiontensin II.24 
4.3 Results and Discussion 
4.3.1 Optimal Sodium Persulfate FPOP Conditions.   
 The mass spectrum bounding the 15th charge state of β-lactoglobulin (BLG) 
obtained when 15 mM Na2S2O8 was mixed with PBS-buffered 10 µM BLG and 
incubated 5 min at room temperature (Figure 4.1a) shows an insignificant amount of 
protein oxidation.  The base peak corresponds to unmodified BLG; the very low levels of 
modified and/or ESI adducts of BLG are superimposable with the mass spectrum of a 
stock solution BLG (data not shown).  Thus, short-time exposure to low levels of 
Na2S2O8 does not oxidize BLG.  Apomyoglobin, CaM, bradykinin, and angiontensin II 
also do not show Na2S2O8 oxidation over short-time exposures, although ESI MS 
revealed that CaM in its starting state was already oxidized to show +16 and +32 Da 
adducts. 
 Irradiating the flowing solution containing the same level of Na2S2O8 with the 
KrF excimer laser, however, gives rise to a high yield of modified BLG (Figure 4.1b).  
Two aspects are readily apparent.  First, the dominant persulfate radical modification 
products correspond to successive +16 Da additions (or +1.07 m/z addition for the 15th 
charge state).  This is also the dominant product of •OH reactions in other protein 
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footprinting chemistry5 and is what we observed with 15 mM H2O2 FPOP (Figure 4.1d).  
Second, 15 mM Na2S2O8 FPOP gives a much higher yield of modified protein than the 
standard 15 mM H2O2 FPOP treatment.  Solely by reducing the concentration of Na2S2O8 
to 5 mM, the modification distribution seen in Figure 4.1c is moderated to nearly the 
same global protein outcome as with standard H2O2 FPOP.  A more rigorous analysis of 
this product distribution, presented in the Supporting Information section, shows it is well 
modeled by a Poisson distribution of 0, +16, +32, … Da states, indicating the labeling has 
sampled a single (native) conformation.  β-lactoglobulin is known to be conformationally 
sensitive to oxidation.25  It follows that 5 mM Na2S2O8 FPOP labeling, like 15 mM H2O2 
FPOP, labels faster than most secondary and tertiary protein motions26-27 and 
corroborates the theoretical prediction of sub-µs-to-µs labeling.  
4.3.2 Residue-Resolved Modification Measurement by LC-MS/MS.   
 Owing to the stable covalent label imparted by •OH and the high percentage of 
solvent-accessible residues that may be labeled, a “bottom-up” proteomics approach in 
data acquisition for modification identification and quantitation can be employed in 
protein footprinting, typically using trypsin proteolysis and online LC-MS/MS.5  We used 
this strategy because the global pattern of persulfate modification  
 
 Figure 4.1:  The ESI-QTOF mass spectra of the 
subjected to different labeling conditions.  Spectrum 
absent only laser irradiation; 
FPOP; (d) is of 15 mM H
 
indicates a similar promiscuity 
 Site-specific labeling was established by LC
all modifications at each site was determined (Tables 4.1, Supporting Information Tables 
4.1 and 4.2) as a “fraction
the data from persulfate and peroxide treatments are plotted in Figure 4.2.  
modified metric is calculated, per residue, by summing
detected peptides having a modi
denominator, signals for all peptides
sequences as the numerator set of peptides.  
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15th charge state of β-lactoglobulin 
(a) is of the 15 mM Na
(b) is of 15 mM Na2S2O8 FPOP; (c) is of 5 mM Na
2O2 FPOP. 
in residue reaction as with •OH labeling. 
-MS/MS analysis.  The aggregate of 
-modified” metric, and comparisons for amino-
, in the numerator
fication at that residue and by summing, 
, modified and unmodified, having the same 1
The fraction-modified metric is implicitly 
2S2O8 control, 
2S2O8 
acid types using 
The fraction-
,  signals for all 
in the 
° 
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normalized across samples because all variations in post-FPOP sample handling, 
proteolysis, de-salting, on-line chromatography, and mass spectrometry that affect a 
modified peptide’s signal will likely influence signals for its unmodified and modified 
siblings in the same proportion, with the exception of ionization efficiency.28   
We observed no detectable modifications of proteins in their mass spectra 
following control experiments for which no laser irradiation was used, consistent with 
global observations (e.g. Figure 4.1a).  Furthermore, we found that the fraction modified 
levels of persulfate control residues are statistically identical to the “native” control 
(absent peroxo- starting material) fraction modified levels, and with the exception of Met 
test the limit of detection.   These results follow from examination of Tables 4.1 and 
Supporting Information Tables 4.1 and 4.2, and they show one general trend necessary 
for validating persulfate FPOP as a viable labeling strategy. 
4.3.3 Selectivity of Na2S2O8 FPOP.   
 From these tables and Figure 4.2, it is clear that Na2S2O8 FPOP is a non-specific 
labeling method that samples many of the same residues with comparable reactivity to 
H2O2 FPOP.  Both methods reliably label over one half of the 20 common amino acids.  
Comparing reactivity on a residue-by-residue basis (Figure 4.2a) shows that peroxide 
FPOP more readily labels aliphatic residues as well as Phe, Thr, Gln, and Lys.  If 
equivalent levels of labeling are expected for 5 mM persulfate vs. 15 mM hydrogen 
peroxide, as witnessed at the protein global level, it seems unlikely that the large-
difference contributors underlying this trend (for example, aMb I21 in Table 4.1) are 
explained solely by the use of 3 mM Na2S2O8 starting material instead of 15 mM. 
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Table 4.1: Apomyoglobin Fraction Modified per Residuea 
residue 
SASA 
(Å2)b 
k
•OH              
(M-1 sec-1)c native peroxide persulfate 
persulfate 
control 
E6 56.1 2.3 x108 0 0.13 +/- 0.04% 0.069 +/- 0.007% 0.0003 +/- 0.0002% 
W7 15.3 1.3 x1010 1.41 +/- 0.09% 13.9 +/- 0.9% 15.3 +/- 0.6% 2.2 +/- 0.2% 
W14 6.8 1.3 x1010 0.84 +/- 0.06% 12.5 +/- 0.6% 4.6 +/- 0.5% 1.57 +/- 0.07% 
E18 65.5 2.3 x108 0 2.07 +/- 0.06% 2.4 +/- 0.2% 0.004 +/- 0.002% 
D20 65.8 7.5 x107 0 0.20 +/- 0.01% 0.247 +/- 0.009% 0 
I21 62.1 1.8 x109 0 0.45 +/- 0.03% 0.0573 +/- 0.0001% 0 
H24 7.7 4.8 x109 0.0047 +/- 0.0003% 0.70 +/- 0.05% 0.32 +/- 0.02% 0.0060 +/- 0.0004% 
Q26 22.5 5.4 x108 0 0.07 +/- 0.01% 0.07 +/- 0.01% 0.0001 +/- 0.0001% 
E27 49.0 2.3 x108 0 0.71 +/- 0.03% 0.24 +/- 0.01% 0.0001 +/- 0.0001% 
I30 7.9 1.8 x109 0 0.054 +/- 0.006% 0.002 +/- 0.002% 0 
T34 48.8 5.1 x108 0.0042 +/- 0.0009% 0.43 +/- 0.04% 0.08 +/- 0.03% 0.008 +/- 0.001% 
H36 54.5 4.8 x109 0.0023 +/- 0.0007% 2.4 +/- 0.2% 1.7 +/- 0.8% 0.009 +/- 0.004% 
P37 81.9 6.5 x108 0 0.38 +/- 0.04% 0.06 +/- 0.01% 0.0002 +/- 0.0002% 
E41 93.5 2.3 x108 0 0.105 +/- 0.005% 0.14 +/- 0.04% 0 
H64 41.8 4.8 x109 0.0022 +/- 0.0003% 0.81 +/- 0.01% 4.5 +/- 0.6% 0.042 +/- 0.009% 
V67 86.1 8.5 x108 0.00034 +/- 0.0001% 0.41 +/- 0.02% 0.071 +/- 0.009% 0.0003 +/- 0.0001% 
T70 79.3 5.1 x108 0.016 +/- 0.006% 0.09 +/- 0.02% 0.03 +/- 0.02% 0.009 +/- 0.003% 
H81 129.3 4.8 x109 0.029 +/- 0.003% 3.9 +/- 0.1% 7 +/- 1% 0.49 +/- 0.03% 
H82 5.1 4.8 x109 0.0052 +/- 0.0005% 0.61 +/- 0.04% 0.69 +/- 0.06% 0.011 +/- 0.001% 
E83 112.0 2.3 x108 0.018 +/- 0.002% 0.36 +/- 0.06% 0.73 +/- 0.02% 0.026 +/- 0.004% 
L86 1.9 1.7 x109 0 0.37 +/- 0.03% 0.0004 +/- 0.0003% 0 
L89 43.1 1.7 x109 0.010 +/- 0.002% 1.06 +/- 0.08% 0.08 +/- 0.02% 0.0077 +/- 0.0005% 
Q91 72.9 5.4 x108 0 0.29 +/- 0.02% 0.14 +/- 0.02% 0.04 +/- 0.03% 
H93 52.0 4.8 x109 0.0023 +/- 0.0004% 1.9 +/- 0.1% 1.63 +/- 0.07% 0.004 +/- 0.002% 
H113 80.6 4.8 x109 0 1.9 +/- 0.1% 2.0 +/- 0.4% 0.009 +/- 0.004% 
H116 63.9 4.8 x109 0 0.2 +/- 0.1% 1.7 +/- 0.5% 0 
H119 30.9 4.8 x109 0 0.95 +/- 0.07% 0.55 +/- 0.06% 0 
Q128 66.5 5.4 x108 0 0.34 +/- 0.03% 0.018 +/- 0.002% 0 
M131 0.9 8.5 x109 3.7 +/- 0.3% 25 +/- 1% 24 +/- 3% 5.9 +/- 0.4% 
K133 67.6 3.5 x108 0 0.09 +/- 0.01% 0.0001 +/- 0.0001% 0 
E136 76.3 2.3 x108 0 0.083 +/- 0.007% 0.137 +/- 0.006% 0 
L137 40.4 1.7 x109 0 0.27 +/- 0.03% 0.003 +/- 0.001% 0 
F138 19.8 6.9 x109 0 0.70 +/- 0.03% 0.141 +/- 0.007% 0.0009 +/- 0.0006% 
F151 26.7 6.9 x109 0 36 +/- 2% 7.9 +/- 0.4% 0 
a
 The numerator is the sum all signal of peptides modified at a residue.  The denominator is the sum of 
all signal of peptides, modified and unmodified, having the same sequences as the numerator set of 
peptides. 
b
 Solvent accessible surface area (SASA) was calculated as the sum of non-hydrogen side chain and α-
carbon areas using the online calculator at http://molbio.info.nih.gov/structbio/basic.html , using a 1.4 Å 
probe 29.  The myoglobin crystal structure 1WLA.pdb was used with heme atoms omitted 30.  
c
 http://allen.rad.nd.edu/browse compil.html.
 
 
 
 Figure 4.2:  With (a), the relative difference between persulfate and peroxide fraction 
modified, of CaM, aMb, bradykinin, and angiotensin II residues, are determined per 
residue; these values are averaged per amino
pairwise-comparison standard error.  In (b) the maximum fraction modified among all 
same-amino acid residues is plotted. 
pattern bars denote Na2S2
  
These differences must also arise from the differences in the inherent reactivities of 
and SO4-•, and from the difference in their size.  
sensitive to both labeling methods; aMb W7 and W14 are equivalently labeled by H
FPOP, butW7 is 3-fold more oxidized than W14 with Na
accessible surface area values are small but non
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-acid type.  The error bars denote the average 
Black bars denote H2O2 FPOP labeling; diagonal
O8 FPOP labeling. 
In particular, Trp is exceptionally 
2S2O8 FPOP.  The solvent
-zero, 15 and 7 Å2, respectively, for W7 
-
•OH 
2O2 
-
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and W14, so that the difference between labeling methods for this residue type may be a 
function exclusively of size differences in the reactant probes. 
The amino acid labeling levels are listed from left-to-right in both graphs of 
Figure 4.2 in order of decreasing observable peroxide reactivity per amino-acid group, as 
established by the maximum observed fraction modified per residue of each group 
(Figure 4.2b).  These maximum fraction values should pertain to the most fully solvent-
exposed sidechain residues of each amino acid group, and thus allow for a comparison of 
the inherent reactivity of  SO4-• vs. •OH.  The order of SO4-• reactivity is slightly 
different: M > Y = W > F = E = H > S > P > D = T > K = Q > L = V = I.  In either case, 
the most reactive residues are consistent with amino acid rate data and with the •OH 
labeling products from water radiolysis31, with the exception of Glu.  Persulfate FPOP is 
more reactive to His, and Tyr and equally reactive to Met, Trp, Glu, and Ser.  Despite the 
negative charge of SO4-• and its precursor, no increased affinity for basic residues is 
observed except for His.  This is probably due to attenuation of electrostatic interaction 
by the phosphate-buffered saline solution, but trypsin digestion may bias against 
detecting modified Lys and Arg. 
4.3.4 Chemistry of Na2S2O8 FPOP.   
 With the exception of the +34 Da His modification (Supporting Information) 
many modifications discernable for peroxide FPOP were also found among persulfate 
FPOP replicates (Table 4.2).  Furthermore, these modifications comprise the “usual 
suspects” in •OH labeling by peroxide-initiated and water radiolysis experiments.5  The 
commonality of the sets of modifications produced by each FPOP method suggests that 
the dominant chemical pathways of SO4-• labeling are analogous to the better understood 
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•OH mechanisms.32  A likely explanation for these similar outcomes is that both 
processes begin with an initial hydrogen abstraction reaction at aliphatic sites.  
Additionally, the transfer of radical to water (equation 1) may be a competing pathway, 
giving rise to the common •OH footprinting products. 
SO4-• + H2O    SO42- + H+ + •OH                      (1) 
There may be other novel products of SO4-• not detected in these experiments; that 85% 
of all +2 and higher charge state species of significant abundance were identified as aMb 
modified and unmodified peptides suggests that these putative products are from low-
yield pathways. 
4.3.5 Solvent Accessibility.   
 In comparing equilibrium states, as is typical for footprinting experiments5, 
changes in the fraction modified at a residue between states should solely reflect a change 
in solvent accessibility—all other biases are inherently normalized.  The sensitivity of 
persulfate FPOP labeling to solvent accessibility can be assayed by comparing the solvent 
accessible surface area (SASA) calculated from X-ray and NMR structures to the per-
residue fraction modified for any same-amino-acid set of residues of a protein.  The 
restriction to same residue types stems from the inherent •OH (and presumably with SO4-
•)  reactivity difference between free amino acids.5  An analysis of the aMb His 
modification levels is illustrative of the promise of this approach (Figure 4.3).  We find 
that its inherent reactivity is not too low to limit detection of the modifications and that a 
large range of SASA values are spanned by 11 myoglobin His residues.  The reactivity of 
His in Na2S2O8 FPOP correlates reasonably well with the calculated SASA (the Figure 
4.3b straight-line fit R2 is 0.83).  Although the R2 does not indicate perfect correlation, 
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one should bear in mind that part and perhaps most of the uncertainty is in the calculated 
SASA.  When H64, an outlier, is excluded, an even better correlation is obtained.  The 
motivation for omitting this residue (Figure 4.4) is that it is an axial ligand of the heme 
iron.  The H2O2 FPOP correlation of aMb His labeling with SASA is better still, even 
with H64 inclusion (plot not shown).  We propose that S2O82- or  SO4-• has an affinity for 
the heme binding pocket that H2O2 or •OH does not share, such that the local 
concentration of labeling agent is higher than that at the bulk.  That H64 and H93, the 
second heme-ligating residue, are not equally labeled suggests a preferred orientation, 
such as a chelate bridge, which in turn suggests an affinity model for persulfate. 
 
Table 4.2: Observed Residue Modifications 
of Persulfate and Peroxide FPOP
 
Amino 
Acid Net Modifications (Da) 
Asp -44
 
       Gln +16
 
       Glu -44
 
-30
 
-28
 
-18
 
    Gly
a
 
-44
 
       
His -23
 
-22
 
-10
 
+5
 
+16
 
+32
 
+34
b
 
 
Ile +14
 
+16
 
      Leu -2
 
+16
 
      Lys +14
 
+16
 
      Met +16
 
       Phe +16
 
+30
 
+46
 
     Pro +14
 
+16
 
      Ser -2
 
+16
 
      Thr -2
 
       Trp -14
 
+4
 
+16
 
+32
 
+48
 
 
  Tyr +16
 
+32
 
+34
b
 
     Val +14
 
+16
 
 
 
    
a
 Only C-terminus G153 of myoglobin exhibited 
carbon dioxide loss. 
b
 Only observed among persulfate FPOP replicates. 
 
 With the exception of Glu, all same-amino-acid residues of a protein show 
increasing labeling yield with increasing SASA, though the data sets for Trp, Phe, Leu, 
 Ile, and Thr are too small for proper correlation analysis.  Their sampling may be 
improved with a different proteolysis methodology, to give shorter or longer peptides in 
regions of too few or too many trypsin cleavage sites, thus enabling informative product
ion (MS/MS) spectra in these regions.  Nevertheless the
binary: never is a non-Met residue labeled that shouldn’t be.  
sensitive to oxidative labeling
in solvent accessibility without careful controls
even with mild oxidizing agents
persistent protein hydroperoxides that can arise as intermediates in the 
 
Figure 4.3: The modification yield
calculated solvent accessible surface area (SASA), with least
shown.  In plot (b) the myoglobin His64 was omitted; this improved the R
in (a) to 0.83.  The SASA values were calculated from the 1WLA.pdb crystal structure of 
myoglobin with its heme ignored by the calculator at 
http://molbio.info.nih.gov/structbio/basic.html, using a 1.4 Å probe. 
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 most compelling correlation is 
Although Met is extremely 
, it does not serve as the ideal residue for probing changes 
5
 because its inherent reactivity is high 
33
 and because it may serve as an oxidation sink for 
 
 
s of aMb His residues are plotted against their 
-squares straight
 
-
-line fits 
2
 fit from 0.63 
 Figure 4.4:  The 1.4 Å probe surface rendering of the m
structure, showing the heme binding pocket, His64, and Phe138.
 
formation of common oxidative
Furthermore, many proteins are isolated with endogenous Met oxidation; we found, for 
example, that CaM samples exhibited significant Met oxidation “out of the box” 
(Supporting Information Table 4.1, “native” column).
Apomyoglobin F138 labeling signal is 
the calculated SASA is but 25% less.  This calculation is based on the myoglobin crystal 
structure 1WLA30 with the heme removed.  This result quant
Hambly and Gross finding that 
burying F138.  This also underscores the potential biases of using static high resolution 
solid-state structures to determine dilute aqueous phase pr
the myoglobin E18 is dominated by significant CO
and persulfate FPOP.  Other acidic residues also exhibit this pathway, but their yields are 
significantly lower.  This may be a conseque
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yoglobin 1WLA.pdb crystal 
 
-modification products initiated by fast •OR chemistry.
 
50-fold lower than that of F151, although 
itatively reproduces the 
H-helix moves to close the pocket in the apo state, 
otein residue SASAs.  Finally, 
2 loss (- 44 Da) signal in both peroxide 
nce of local S2O82- and H2O2
34
  
 affinity but 
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probably not a consequence of error in SASA estimation as the magnitude of yield 
change is so large.  
4.3.6 Sodium persulfate vs. hydrogen peroxide FPOP: physical considerations and 
future prospects.   
 
 Although protein footprinting at physiologic levels of analyte, ionic activity, and 
pH are possible with FPOP, the requirement of peroxy starting material begs the 
definition of “physiologic”.  It is, therefore, advantageous that persulfate FPOP requires 
3-5 fold less starting material than peroxide FPOP to deliver the same levels of 
modification (Figure 4.1).  On the other hand, excess Na2S2O8 must be removed non-
enzymatically after labeling, and this may introduce another source of unbiased error.  
One application of the FPOP method that we would like to pursue is the study of 
membrane proteins in micelles, liposomes, lipoprotein particles, and synthetic protein-
wrapped phospholipid bilayer discs.35  The lipid bilayer permeability of S2O82- is in all 
likelihood dramatically smaller than that of H2O2, commonly known to be membrane-
permeable 36.  Marla and coworkers 37 showed that ONOO- readily permeates large 
unilamellar vesicles composed of L-α-phosphatidylcholine , stearyl amine, and 
cholesterol, but that SO42- is membrane-impermeable.  They argued the high 
peroxynitrate permeability may be due to its relatively high basicity (pKa =  6.8 38-39), 
whereas sulfate is the conjugate base of a strong acid.  Persulfate retains its anionic 
character in PBS-buffered solution and, thus, should be membrane-impermeable.  It is 
possible that by using H2O2 and Na2S2O82- in tandem FPOP experiments, a footprint may 
be acquired of extracellular-accessible and cytoplasmic-accessible residues in aqueous-
stable membrane particles imbedded with analyte protein.  Finally, the thermal stability 
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of S2O82- relative to H2O2 is advantageous for any temperature-varied FPOP experiment 
up to 50°C 40-41. 
4.4 Conclusions 
The H2O2 and Na2S2O8 FPOP results presented here demonstrate the viability of 
persulfate FPOP protein footprinting.  The ideal footprinting experiment is of state 
comparisons whereby one seeks differences in labeling yield at identical sites for two 
treatments (e.g., apo vs. holo, native vs. unfolded) to reflect residue protection (or 
exposure with signal increase) owing to direct inter- or intramolecular interaction or 
allosteric change from distal binding.  If a  detailed footprinting picture is required in 
which the “fraction modified” ascribes a solvent accessibility value, a thorough search 
and replicate quantitation for all FPOP modifications in addition to calibration with 
proteins of known structure will be required.  The kinds of modifications with persulfate 
and peroxide, with one exception, are identical, and the promiscuity of SO4-• is similar 
and tunable like •OH.  The choice for utilizing persulfate FPOP for non-residue-specific 
stable modification footprinting is best made considering its physical, rather than 
chemical properties.  Most importantly, this study demonstrates the utility of the general 
FPOP method.  That persulfate FPOP works serves as an invitation to try other UV-
sensitive precursor molecules, such as L-photoleucine23, or to use the sulfate radical 
anion to produce other radicals and radical anions (e.g., CO3-• from HCO3- or •NO2 from 
NO2-).  These approaches may give controllable radical species capable of very fast 
labeling, not only sampling native conformations is a non-specific or targeted way but 
also expanding the scope of FPOP. 
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4.5 Supporting Information 
4.5.1 Global mass spectrometry of FPOP-labeled β-lactoglobulin.    
The capacity of the 0.6 µL bed ZiptipC4 was approximately 3.3 µg, so that 180-
230 pmol samples of BLG were infused at a flow rate adjusted to ensure accuracy in the 
time-to-digital conversion of the QTOF multi-channel plate detector, requiring 80-180 
ion counts/scan base peak.  Scans spanning the entire chromatogram were summed to 
improve the signal to noise, typically 60-150 scans depending on the flow rate. 
4.5.2 β-lactoglobulin FPOP global product distribution analysis.   
 A 1216-1245 m/z spectrum window centered about the 15th charge state of BLG 
was fit with a model FPOP product distribution described previously13 for each BLG 
duplicate.  The window range encompassed all detected product peaks, and a 10 m/z 
region lower than the unmodified peak average m/z was used for baseline estimation.  A 
Mathcad 14 Minimize algorithm was used to fit a Poisson distribution to the resulting set 
of 0, +16, +32… state abundances. 
4.5.3 Optimal Sodium Persulfate FPOP Conditions.   
 Tuning the level of radical exposure controls the kind and extent of modifications.  
Early footprinting work used Fenton-generated •OH radicals to cleave DNA and protein 
backbones; absence of a cleavage product was indicative of protection due to 
biomolecular interaction.42  The ESI mass spectrum of BLG labeled by FPOP with 15 
mM Na2S2O8 and without Gln radical scavenger shows a background in each BLG 
charge state m/z region ≥ 20% the charge state’s base peak (data not shown).  We 
attribute this high baseline to the mass-spectral convolution of many protein fragments 
generated by radical-induced cleavage along the protein backbone.  Under these 
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conditions, too much radical labeling agent has persisted for too long an exposure.  The 
reactivity of protein side chains is, in general, not high at α-carbons because steric 
hindrance is protective under typical low-exposure conditions.43-44  Thus, the 
identification and quantitation of side chain-modified residues for scavenger-free 
Na2S2O8 FPOP-labeled protein would not measure the solvent accessibility at these sites 
in the protein’s native state.   
A more difficult problem is that this excessive labeling may also be the case with 
insufficient scavenger or too high a concentration of the radical precursor; that is, the 
quenching is not fast enough to stop labeling before side chain modifications cause 
protein conformational change leading to misleading labeling.  Therefore, we undertook 
an analysis on the underlying protein product distributions of the Figure 4.1 spectra to 
support the hypothesis that 5 mM Na2S2O8, 20 mM Gln (Figure 4.1c) is sufficient to label 
the native protein state without sampling partially unfolded products. 
In a previous study, we provided empirical evidence that FPOP with H2O2 labels 
proteins faster than any conformational response to •OH modifications.13  This result was 
based on the analysis of the mass spectra of the modified proteins, where a model was 
used to digitize signals for FPOP-labeled proteins into bins of primary modification of 0, 
+16, +32, … Da.  Simplification of the modification spectrum to a 0, +16, +32, … 
distribution allowed for a comparison to a Poisson distribution.  For BLG, CaM, and 
lysozyme, a good match occurred only when radical scavenger was present.  Testing for a 
Poisson distribution, which should apply for proteins having an invariant single 
conformation during labeling and for which there are many sites available to •OH 
modification,  is an appropriate means of establishing the “snapshot” nature of a 
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footprinting method .  We employed the same analysis here, using BLG as the test 
protein because it is highly sensitive to conformational changes due to oxidation.25   At 5 
mM Na2S2O8, the modification distribution is approximately Poisson (Supporting 
Information Figure 4.1), but when a larger number of sulfate anion radicals are produced 
with 15 mM Na2S2O8, FPOP labeling gives a distribution that clearly fails this test.  
Moreover, modeling the latter spectrum failed to meet a requirement that at least 20% of 
protein signal should contribute to the unmodified, 0th state.  This requirement stems from 
matching the laser pulse frequency, irradiation volume, and sample flow rate to ensure 
that all labeled protein, and an un-reacted volume that is 20% of the irradiation volume, 
vacates the flow cell before the next laser shot.  At 5 mM Na2S2O8, the 20% exclusion 
fraction can be properly accounted for by the modeling, and the 0, +16, +32, … 
distribution is consistent with a single BLG conformation during labeling.  Thus, the 
appropriate persulfate level for FPOP labeling is ≤ 5 mM Na2S2O8, with 20 mM 
constituent Gln and laser and optics parameters set as described in the Experimental 
Procedures section. 
4.5.4 Chemistry of Na2S2O8 FPOP.    
 Comparing the product-formation reactivities of SO4-• and •OH requires 
quantitation with good precision of every detectable modification.  Supporting 
Information Figure 4.2 shows the product-ion mass spectra for two unusual 
modifications.  Kynurenination (Supporting Information Figure 4.2a, +3.9949) of 
tryptophan is not a major oxidation product in water radiolysis labeling of Trp-NH231, but 
it is a common metal-catalyzed protein oxidation product.45-47  This modification pathway 
significantly contributes to the total Trp modification with both H2O2 and persulfate 
 FPOP methods.  A novel His and Tyr modification only seen with persulfate FPOP, 
however, is of +33.974 Da (
90% of the total modification reactions of His but is of trivi
nature of this modification has not yet been determined.
 
Supporting Information Figure 4.1:
the 15
th
 charge state QTOF 
diamonds with standard error bars plot the average of the normalized ion counts for 
duplicate FPOP treatments.  Dashed line
regression, best-fitting Poisson distribution.  (
for FPOP with 5 mM Na2
protein signal from the 0
th
FPOP volume.  In case (a
is modeled as only 7.4% of total protein signal.  The number of states per sample 
distribution fit to a Poisson was chosen to account for at least 98% of protein signal.
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al abundance for Tyr.  The 
 
  
  The 0, +16, +32, ... Da ion counts are modeled for 
m/z spectrum of β-lactoglobulin. Solid line-connected 
-connected circles show the non-
a) is for FPOP with 15 mM Na
S2O8.  The modeling was constrained to subtract
 state because this signal is attributed to the irradiation
), all 0th state signal is attributed to this non-reactio
 
-
linear 
2S2O8.  (b) is 
 20% of total 
-masked 
n fraction but 
 
  
   
Supporting Information 
peptides showing uncommon 
annotation is for peaks matching the theoretical 
GLSDGEW*QQVLNVWGK, with W7 modified by a net +4 Da (ky
Ions labeled in gray boxes carry this modification. These spectra were produced in both 
peroxide and persulfate FPOP replicates. (
is for LFTGH*PETLEK with H36 modified by a net +34 Da ma
gray boxes carry this modification.  This spectrum was only observed for persulfate 
FPOP replicates.  
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Figure 4.2:  The LTQ product-ion spectra of myoglobin 
•OH modifications. (a): [M + 2H]2+ of m/z 910.4569.  The 
y- and b- fragment ions of 
nurenine) mass shift.  
b): [M +2 H]2+ of m/z 653.3199. The annotation 
ss shift.  Ions labeled in 
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Supporting Information Table 4.1: Calcium-free Calmodulin Fraction Modified 
per Residuea 
residu
e 
SASA 
(Å2)a 
k
•OH              
(M-1 sec-1)b native peroxide persulfate 
persulfate 
control 
T5 55.63 5.1 x10
8
 
0.16 +/- 0.01% 1.25 +/- 0.05% 0.22 +/- 0.01% 0.15 +/- 0.02% 
I9 58.52 1.8 x10
9
 
0.026 +/- 0.005% 0.159 +/- 0.008% 0.022 +/- 0.007% 0.016 +/- 0.004% 
F12 7.58 6.9 x10
9
 
0.76 +/- 0.03% 2.9 +/- 0.2% 1.19 +/- 0.04% 0.67 +/- 0.01% 
K13 112.84 3.5 x10
8
 
0.20 +/- 0.01% 0.224 +/- 0.004% 0.17 +/- 0.01% 0.17 +/- 0.02% 
T28 47.02 5.1 x10
8
 
0.5 +/- 0.2% 2.6 +/- 0.4% 0.13 +/- 0.08% 0.06 +/- 0.04% 
E31 46.21 2.3 x10
8
 
2.6 +/- 0.4% 9.4 +/- 0.8% 7.8 +/- 0.4% 4 +/- 1% 
M36 2.44 8.5 x10
9
 
13 +/- 2% 35 +/- 2% 33 +/- 1% 15 +/- 4% 
M76 39.87 8.5 x10
9
 
24 +/- 1% 49 +/- 3% 62 +/- 2% 26 +/- 2% 
S81 46.75 3.2 x10
8
 
1.5 +/- 0.2% 4.3 +/- 0.3% 3.4 +/- 0.4% 2.3 +/- 0.5% 
Y99 101.55 1.3 x10
10
 
0.33 +/- 0.02% 2.0 +/- 0.2% 2.2 +/- 0.1% 0.22 +/- 0.02% 
M109 0 8.5 x10
9
 
17 +/- 2% 46 +/- 5% 45 +/- 3% 25 +/- 5% 
M124 15.55 8.5 x10
9
 
43 +/- 4% 79 +/- 9% 64 +/- 4% 46 +/- 6% 
M144 43.19 8.5 x10
9
 
37 +/- 2% 59 +/- 2% 58 +/- 3% 44 +/- 4% 
M145 10.97 8.5 x10
9
 
11 +/- 1% 49 +/- 7% 48 +/- 4% 19 +/- 2% 
aAll Table 4.1 footnotes apply except that 1CFC.pdb was used for the calmodulin SASA 
calculation (51). 
 
Supporting Information Table 4.2: Peptide Mixture Fraction Modified per 
Residue 
residue
 
k
•OH 
(M-1 
sec
-1)a
 
native
 
peroxide
 
persulfate
 
persulfate 
control
 
Y4_Angiotensin 
II 1.3 x10
10
 
0.027 +/- 0.006% 11 +/- 4% 17.8 +/- 0.9% 0.8 +/- 0.1% 
P7_Angiotensin 
II 6.5 x10
8
 
0 1.7 +/- 0.4% 0.020 +/- 0.008% 0 
F8_Angiotensin 
II 6.9 x10
9
 
0.0010 +/- 
0.0005% 6 +/- 1% 1.1 +/- 0.2% 
0.0011 +/- 
0.0002% 
P2_Bradykinin 6.5 x10
8
 
0.00015 +/- 
0.00001% 0.4 +/- 0.2% 0.07 +/- 0.01% 
0.00007 +/- 
0.00003% 
F5_Bradykinin 6.9 x10
9
 
0.0016 +/- 
0.0004% 7 +/- 2% 1.66 +/- 0.05% 0.05 +/- 0.04% 
S6_Bradykinin 3.2 x108 0.013 +/- 0.002% 1.9 +/- 0.7% 0.6 +/- 0.3% 0.3 +/- 0.1% 
P7_Bradykinin 6.5 x10
8
 
0.0008 +/- 
0.0003% 3 +/- 2% 1.2 +/- 0.3% 
0.00040 +/- 
0.00001% 
F8_Bradykinin 6.9 x10
9
 
0.0008 +/- 
0.0004% 3 +/- 1% 1.11 +/- 0.03% 
0.0007 +/- 
0.0004% 
a
 http://allen.rad.nd.edu/browse compil.html. 
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5 Mass Spectrometry-based Protein Footprinting 
Characterizes the Structures of Oligomeric Apolipoprotein E2, 
E3, and E4 
 
5.1 Introduction  
 Apolipoprotein E is a 34 kDa protein, whose function is to regulate lipid 
metabolism and control lipid redistribution in tissue and cells, especially in the brain 1.  
The three most common isoforms differ at two residues; apolipoprotein E2 (ApoE2) has 
cysteines at sites 112 and 158 whereas apolipoprotein E4 (ApoE4) has arginines at these 
residue sites.  The most common isoform, apolipoprotein E3 (ApoE3), has C112 and 
R158.  The ApoE4 isoform is strongly associated with Alzheimer’s disease 2-3, and is a 
risk factor for several other diseases 4.  These risk associations, which ultimately stem 
from the single mutation C112R,  differentiate ApoE4 from ApoE2 and ApoE3 in the 
preferred lipoprotein particle structure 5.  Structural determinations by X-ray 
crystallography and solution NMR of the lipid-free N-terminal domain showed it to be an 
elongated four-helix bundle6-7.  Since then, no high resolution structures have been 
reported for the wild type isoforms or their C-terminal domains in the lipid-free state 
owing to the propensity of apoE isoforms to oligomerize. 
 The three ApoE isoforms each self-associate in a lipid-free solution, forming 
predominantly tetramers at µM concentration 8-12.  The rate constants for the association-
dissociation process of monomer-dimer-tetramer have been determined by Garai and 
Frieden (8). Based on the most recent high resolution structure determination of the N-
terminal domain, Sivashanmugam and Wang 7  proposed a scheme whereby lipid binding 
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to the C-terminal-domain induces the N-terminal four-helix bundle to open, thus allowing 
further lipid interaction.  Potentially affecting this mechanism in a isoform-specific 
manner are the lipid-free domain interaction and kinetics of oligomerization.  Clearly 
high resolution structures of the full-length isoforms would inform these inferences, but 
no structures of the oligomers are known at the atomic level.  Thus, we undertook an 
implicit analysis of the full-length WT isoform structures at “residue resolution” by using 
mass spectrometry (MS)-based protein footprinting.  The overarching question we pose is 
whether the amino acid accessibility  of full-length ApoE2, ApoE3, and ApoE4 isoforms 
differ in their oligomeric states at µM concentrations.  We also seek to identify those 
regions responsible for oligomeric interactions by comparing the protein footprints of 
WT ApoE3 with those of a monomeric mutant of ApoE3. 
 MS-based protein footprinting provides peptide and residue-resolved structural 
information in the primary sequence dimension 13-14.  The general strategy provides 
insight about the difference between the structure of a protein or a protein complex in two 
or more states rather than resolve their structures in three dimensions.  The expectation is 
that labeling at solvent-accessible residues is attenuated at protein-ligand or protein-
protein interfaces in the complex compared to those residues in the apo state.  The 
approach is effective and efficient because, if the labeling is stable, identification of the 
modification sites can be done by using a proteomics-based “bottom-up” mass 
spectrometry methodology.  In this methodology, proteolytic peptides are 
chromatographically resolved and detected in a hybrid mass spectrometer capable of 
monitoring their accurate mass-to-charge ratios at high resolving power.  The 
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instrument’s other spectrometer acquires the characteristic product ion spectra of peptide 
ions subjected to collisional activation in an elution-dependent manner.  The high-
resolution LC-MS intensities provide a quantitative measure of each peptide, and their 
product ion spectra, acquired in this tandem MS mode (MS2), can indicate their identity 
and modification site(s). 
 An informative chemical footprinting method is hydroxyl radical-mediated 
modification of solvent accessible sidechains (for a comprehensive review detailing 
several methodologies for •OH generation, expected product chemistry, and MS analysis, 
see ref. 15).   Hydroxyl-radical labeling is advantageous because it effectively samples 
solvent accessibility, given that •OH has the same size as water, and it imparts stable 
(irreversible) modifications to solvent-accessible sidechains of over half of the common 
amino acids 16.  Here we used the method of fast photochemical oxidation of proteins 
(FPOP), as developed by Hambly and Gross with an  approach is similar to that of Aye 
and coworkers 17-18.  In the FPOP method, low millimolar levels of H2O2 are 
homolytically cleaved by a 17 ns flash of 248 nm light from a KrF excimer laser source.  
The resultant •OH reacts with the side chains of constituent proteins.  An important 
feature of FPOP is the reaction time scale can be controlled and in the presence of the 
scavenger glutamine, the lifetime of the radical is approximately 1 µs.  The use of a 
radical scavenger ensures that only equilibrium conformations are sampled by •OH; any 
modification-induced changes to conformation would evolve on a longer timescale 17, 19.  
To corroborate the FPOP results, we  also employed a method of acidic-side-chain 
footprinting, using glycine ethyl ester (GEE) and a zero-length cross-linker 20-22. 
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5.2 Experimental Procedures 
5.2.1 Reagents.   
 Acetonitrile, acetic acid, formic acid, 30% hydrogen peroxide, L-glutamine, L-
methionine, tris(2-carboxyethyl)phosphine hydrochloride (TCEP), catalase, guanidinium 
hydrochloride, glycine ethyl ester (GEE), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC), 2-amino-2-hydroxymethyl-propane-1,3-diol 
(Tris base), and phosphate buffered saline (PBS) were purchased from Sigma Aldrich 
Chemical Co. (St. Louis, MO).  Trypsin, sequencing grade, was purchased from Roche 
Diagnostics Corp. (Indianapolis, IN).  Purified water (18 MΩ) was obtained from a Milli-
Q Synthesis system (Millipore, Billerica, MA). 
5.2.2 Protein Expression, Mutagenesis, Purification, and Solubilization.   
 ApoE2, ApoE3, ApoE4, and ApoE3MM, each expressed in E. coli, were kindly 
provided by Drs. K. Garai and C. Frieden.  All proteins was dissolved in 6 M 
guanidinium chloride and dialyzed overnight into phosphate buffered saline (PBS) 
solution containing 100 µM TCEP disulfide reductant.  Protein concentrations were 
determined by measuring their 280 nm absorbance using ε280 = 44950 M-1 cm-1.  The 
resultant solutions were stored as aliquots at -80 °C after N2(l) freezing.  
5.2.3 FPOP labeling.  
 The FPOP labeling of ApoE3MM and ApoE3 in the monomer/oligomer 
experiment was performed on the same days under the same conditions for both proteins.  
Each started with a 3 h, 22 °C equilibration of 4 µM protein containing 20 mM Gln and 
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100 µM TCEP in PBS.  Three replicates were drawn from each of these solutions for 
FPOP labeling.  Just prior to FPOP, H2O2 was added to each replicate by 10-fold dilution 
from a concentrated solution, to give a final concentration of 40 mM.  The FPOP 
apparatus was essentially the same as originally described 17.  The KrF excimer laser 
power (GAM Laser Inc., Orlando, FL) was adjusted to 39 mJ/pulse and its pulse 
frequency set to 5 Hz.  The flow rate was adjusted to ensure a 25% exclusion volume to 
avoid repeat •OH exposure19.  Each replicate was collected in a microcentrifuge tube 
containing 10 µL of 200 fM catalase and Met to give a final concentration of 20 mM in 
the total sample volume.  The addition of Met was to mitigate post-FPOP oxidation of 
protein 23.  Catalase was allowed to oxidize H2O2 to O2(g) for 10 min at room 
temperature with pipette mixing; O2(g) was removed by three centrifugation steps during 
the incubation.  After 10 min, samples were frozen by immersion in N2(l) and stored at -
80 °C prior to proteolysis.  Control samples were handled in the same manner as those 
submitted to FPOP, but they were not laser irradiated; instead, they were incubated for 5 
min with H2O2, after which the solution was added to the catalase-methionine collection 
volume.  The FPOP labeling of WT-ApoE2, ApoE3, and ApoE4 was performed as 
described above with the following exceptions: the final H2O2 concentration was 20 mM, 
and the excimer laser power was measured to be 47 mJ/pulse.   
5.2.4 Carboxylic Acid labeling with GEE.   
 For the monomer/oligomer experiment, samples were drawn from the same 
ApoE3 and ApoE3MM equilibrated solution as was used for FPOP labeling, at 
approximately the same time.  GEE was added to a final concentration of 50 mM to a 
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portion of each equilibrated solution.  Samples were drawn from this solution, and EDC 
was added to each to give a final concentration of 5 mM.    One molar acetic acid was 
added to a final concentration of 0.5 M to quench the reaction after a certain incubation 
period starting after the addition of EDC.  Instead of running standard control samples for 
the GEE labeling, time-dependent data were obtained for  GEE/EDC exposures times of 
1, 3, 6, and 12 min for labeled ApoE3 and ApoE3MM samples, in duplicate, to provide a 
data trend.  Samples were frozen in N2(l) and stored at -80 °C prior to proteolysis. 
5.2.5 Proteolysis.  
 GEE-labeled samples were thawed and concentrated with Millipore ZiptipC4 prior 
to proteolysis; the eluent, 5 µL 50% acetonitrile acid-free, was diluted to 45 µL with 250 
mM Tris buffer, pH 7.3.  FPOP-labeled and control samples were thawed and used as 
such for proteolysis.  All samples were proteolyzed with 8:1 protein:trypsin (by weight) 
at 37 °C for 3 h.  ESI MS of several control replicates on a Bruker Maxis Q-TOF verified 
that the digestion was complete.  The samples were concentrated 3-fold by SpeedVac 
drying at 30 °C, then  immobilized on Millipore ZiptipC18, de-salted with elution into 10 
µL of 50% acetonitrile 1% formic acid solution.  A portion of this was diluted 25-fold 
with water and 0.1% formic acid for autosampler loading and subsequent analysis.  
5.2.6 LC-MS/MS acquisition.  
 The experiments were not analyzed by LC-MS/MS contiguously; a new column 
was packed for each, and the nanospray source conditions varied slightly for each 
analysis.  Five microliters of each replicate was loaded by autosampler onto a 20 cm 
column with a PicoFrit tip (New Objective, Inc, Woburn, MA), bomb-packed with C18 
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reverse phase material (Magic, 0.075 mm × 200 mm, 5 µm, 300 Å, Michrom, Auburn, 
CA).  Peptides were eluted by a 70 min, 260 nL/min gradient coupled to the nanospray 
source of an LTQ-Orbitrap mass spectrometer (Thermo Fisher, Waltham, MA).  Mass 
spectra were obtained at high mass resolving power (100,000 for ions of m/z 400) on the 
Orbitrap component, and the six most abundant ions eluting per scan were each subjected 
to CID MS2 experiment in the LTQ component, using a collision energy 35% of the 
maximum, a 2 Da isolation width, and wideband activation.  Precursor ions were added 
to a dynamic exclusion list for 8 s to ensure good sampling of the apex of their elution 
peaks.  Blanks were run between every sample acquisition. 
5.2.7 Data analysis.   
 The Rosetta Elucidator data management system (Rosetta Biosoftware) was used 
to generate tables of all LC-MS features eluting in time at high m/z resolution (± 5 ppm); 
all quantitation was based on ion abundances from extracted ion chromatograms.  
Usually more than one high resolution feature mapped to a single eluting peptide, owing 
to the splitting of its ion signal among multiple charge states and isotopomers.  All such 
features contributed to the measure of total peptide abundance.   Most modified and 
unmodified peptide features were annotated by error-tolerant Mascot database searching 
(Matrix Science, Boston, MA), with the common •OH outcomes added to its variable 
modification database 15.  An Excel visual basic-assisted strategy was employed to 
validate questionable Mascot-error tolerant calls.  Ultimately the CID product-ion spectra 
of over two thirds of all calls were checked manually.  Additional features having no 
Mascot annotations were included if their ions’ m/z matched those of putative tryptic 
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ApoE modified or unmodified peptides within 8 ppm, and they had product-ion spectra 
that were consistent (manual interpretation) with these calls.  This manual validation was 
assisted by using a custom correlation algorithm that compared these spectra to 
exemplary CID fragment spectra of unmodified tryptic peptides of the WT isoforms and 
ApoE3MM24. 
 The labeling yield per residue is determined according to equation 1. 
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 (1) 
Equation 1 avoids a potential underestimation bias by excluding the measured 
abundances for large peptides in the denominator, whose modified siblings did not give 
CID MS2 spectra definitively locating their modification sites.  Typically these large 
peptides are those which were not completely cleaved by trypsin. .  Comparing FPOP and 
control yields shows that, with one exception, there is no evidence that FPOP introduces 
a proteolytic bias, which could undermine eq 1.  We do observe a low abundance of the 
•OH-mediated loss of 43 u as a portion of the guanidino-group of Arg15; we have not 
included these low-abundant data because of their clear influence on trypsin proteolysis. 
5.3 Results 
5.3.1 Data Acquisition and Processing.   
 We determined the FPOP footprints of the WT isoforms existing as oligomers, as 
they do at low µM concentrations 8, 10-11, 25-26 (Supporting Information Table 5.1 presents 
the per-residue FPOP yields determined from all validated LC-MS features).  In this 
residue-resolved analysis, we tracked 266 unmodified and modified tryptic peptides of 
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the isoforms, from 1,457 extracted ion LC-MS chromatographic (EIC) ions comprising 
67.8% of all eluting ions.  We were able to find peptides from all regions of the protein 
after FPOP labeling and trypsin proteolysis except for the region 39-61.  Although 
peptide 39-61 is detectable as unmodified, it was not well sampled upon FPOP owing to 
its low abundance or response.  Nevertheless, approximately one in five residues was 
FPOP-modified at 0.1% or greater yield.  One of FPOP’s virtues is that, though the 
reaction window is short, protein labeling is high yield.  Consequently many solvent 
exposed residues of marginal reactivity can still be assayed as compared to the same kind 
of residues in synchrotron radiolysis •OH footprinting 27-29.  Same-day labeling, same-
column separation in LC/MS, and the Rosetta Elucidator peak alignment software 
ensured that the same modified and unmodified-peptide features were used in 
determining the residue yields for all WT samples.  We, therefore, attribute any 
significant differences in residue yields to differences in solvent-accessible surface areas 
(SASA) of the isoforms, as all other sources of bias are shared identically. 
 The average residue labeling yield per amino-acid type is similar but not identical 
to the known reaction rates of •OH with free amino acids 30, and to the MS analysis of 
•OH –amino amide reaction products 16.  We observe Cys > Met > Trp > His > Gln > Tyr 
> Phe > Asp > Pro > Glu > Leu > Val > Arg > Lys.  Differences between inherent and 
observed reactivity are due to the structural context of residues, as their inherent amino 
acid-reactivity with •OH is mitigated by solvent accessibility in a properly controlled 
footprinting experiment.  For example, Gln is less reactive with •OH than is Tyr or Phe as 
a free amino acid or amide.  Being more hydrophilic than these residues, however, Gln is 
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likely to be more solvent-exposed in a protein and so may suffer experience a higher 
level of modification than a more reactive amino acid that is protected in some way 
(Supporting Information Table 5.1, Q21 yield > Y162 yield). 
 The results are presented as a difference in labeling yield per residue as 
normalized to the average labeling yield for all residues of the same amino-acid type 
(Figures 5.1, 5.2, and 5.3).  A value above the x axis indicates more labeling in the 
comparison protein than at the same site in ApoE3.  Values below convey the opposite 
trend.  The extent of labeling is a function of the SASA of a site, and its inherent fully-
solvent-exposed reactivity with •OH.  We observe a linear correlation between the SASA 
of residues of the same amino acid type and their FPOP yield (data not shown).  Thus, by 
normalizing each residue’s yield by the maximum FPOP yield among all same-amino 
acid residues, the inherent reactivity dependence is eliminated, and we may compare the 
yields of dissimilar-amino acid residues.  Furthermore, the normalization of the yield 
difference between isoforms ensures that a departure from near zero labeling at a residue 
is not misinterpreted as complete exposure of the residue in one protein state, and 
complete concealment in its comparison state.   
5.3.2 WT-ApoE2 vs. ApoE3 vs. ApoE4.   
 The extent of modification per residue for WT-ApoE2, ApoE3, and ApoE4 are 
very similar, although ApoE4 exhibits more differences with ApoE3 than does ApoE2.  
In Figure1A, all detected residues shared by ApoE3 and ApoE4 are shown.  Only M108, 
Y162, P183, V185, and E266 are significantly different at a 95% confidence by a 
Student’s t-test.  In Figure 5.2A, all detected residues shared by ApoE3 and ApoE2 are 
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shown.  Tyrosine 162, E255, and E266 are significantly different.  If the uncertainties in 
yield measurements were zero, the differences in labeling, and therefore in solvent 
accessibility change, are small for the majority of the residues.  Comparing ApoE4 to 
ApoE3, 43 of 56 residues exhibit a change of less than 15% relative to the maximum 
SASA of each kind of amino acid in the proteins.  Comparing ApoE2 to ApoE3, 49 of 56 
residues also exhibit a maximum-amino acid-area-relative change of less than 15%. 
  
  
Figure 5.1:  Comparison of the tryptic
labeling yields for ApoE3 and ApoE4.  Panel 
between isoforms, relative to the maximum yield per residue for all residues of the same 
amino-acid type.  Background modification yields observed in the control experiments 
are subtracted from their corresponding
determined.  Error bars are propagated from the standard errors of the per
labeling yields for ApoE3 FPOP, ApoE3 control, ApoE4 FPOP, and ApoE4 control 
treatments.  Residues M108, Y162, P183, V185, 
significantly different between isoforms at 95% confidence by the Student’s t
B plots the FPOP labeling yield/tryptic peptide of ApoE3 in black and ApoE4 in red.  
The background modification fraction per peptide has
areas convey the standard error of each labeling measurement.  Where peptides exhibit 
very similar labeling levels, the red ApoE4 may bars obscure the ApoE3 bars.
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 Figure 5.2:  Comparison of the tryptic
labeling yields for ApoE2 and ApoE3.  Panel 
between isoforms, relative to the maximum yield per residue for all residues of the same 
amino-acid type.  Background modification yields obse
are subtracted from their corresponding FPOP yields before the relative value is 
determined.  Error bars are determined as described in Figure 5.1.  The asterisked 
residues Y162, E255, and E266, shown in red, are significant
isoforms at 95% confidence by the Student’s t
yield/tryptic peptide of ApoE3 in black and ApoE2 in red.  The background modification 
fraction per peptide has been subtracted.  The light
of each labeling measurement.  Where peptides exhibit very similar labeling levels, the 
red ApoE2 may bars obscure the ApoE3 bars.
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 We contend that a 15% change in SASA relative to the maximum SASA for the 
same kind of residues is small.  In absolute square ångstroms, a 15% change could be less 
than 5 or more than 30, depending on the type of residue—but relative to fully-exposed 
sidechain surface areas, this is a small area.  For example, W20 in the truncated protein 
ApoE3 1-183 has a SASA value of 199 Å2, determined by the GETAREA algorithm31 for 
the 1kc3.pdb NMR structure7.  The relative SASA change is due to at least two different 
protein oligomer conformations.  In the simplest scenario one conformation would 
exclusively describe 4 µM ApoE3, and the other would exclusively belong to the other 
ApoE isoform at 4 µM.  In this case a statistically-significant amino acid-relative labeling 
change is directly attributed to a change in the surface areas of each conformation.  If the 
change were less than 15% we would conclude the isoform is only slightly more exposed 
or protected than ApoE3.  This is the case for three of the five residues in ApoE4 
significantly different from their ApoE3 analogs: Y162 and P183 are slightly more 
exposed, with same-amino acid-relative changes of 7% and 5%, respectively, while E266 
is slightly protected, with a relative change of -10%.  Two of the three significantly 
different residues in ApoE2 compared to ApoE3, are not substantially so: relative to the 
average of all glutamic acid yields, E255 shows a -17% and E266 a -10% change in 
labeling. 
 The extent of modification per peptide between the isoforms is also similar 
(Figures 1B and 2B).  The analysis at the peptide level affords the inclusion of 88 more 
features than the analysis at the residue level. Each added feature’s precursor mass is 
within 5 ppm of a theoretical ApoE peptide mass, and each had an MS2 spectrum that 
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confirmed the identity of the root peptide sequence; however, each added feature’s 
modification could not be localized to a single residue by its MS2 spectrum.  The 
inclusion of these features provides for the most accurate measure of the peptide FPOP-
labeling yield.  Comparing ApoE4 to ApoE3 (Figure 5.1B), 22 of 29 peptides exhibited 
statistically identical labeling yields.  Peptides spanning 62-72, 120-134, and 261-274 
each exhibit slightly more labeling in ApoE4 than ApoE3, while 104-112 is significantly 
more labeled in ApoE3.  Comparing ApoE2 to ApoE3 (Figure 5.2B), only peptide 62-68 
is significantly different, with less labeling in ApoE2. 
 The wild-type isoforms are similar in their response to FPOP labeling and the 
residue-resolved differences are small compared to the average level of labeling 
measured per amino-acid type.  The one exception to this trend is M108.  Its modification 
level (5 ± 1%) is high for ApoE4,whereas M108 undergoes negligible modification for 
ApoE2 and ApoE3.  This effect cannot be confirmed with peptide-level analysis because 
signals corresponding to modified C112 are included in the consideration of ApoE3 104-
114 but cannot be for ApoE4 104-112 and ApoE4 104-114 tryptic peptides.  This 
difference suggests a structural difference in the region of ApoE4 with respect to the 
other isoforms.  It is also possible that C112, which is missing in E4, outcompetes M108 
in ApoE3 or that the MS detection of M108 modification may have been obscured by the 
multiple C112 modification fates32.  
 The modification extent for 158-167 of ApoE2 (Figure2B) is also high because its 
primary modification is of C158, an amino-acid that is not present in ApoE3 and ApoE4.  
The modification extent of Met also distinguishes ApoE 62-72 from the corresponding 
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peptides of ApoE4 and ApoE3; in this case, ApoE4 is appreciably less labeled than that 
in ApoE3.  A pair-wise residue comparison does not resolve this difference at 95% 
confidence (M64 p = 0.11), but the modification levels of M64, E66, and M68 together 
give rise to peptide signals that are significantly different.  This underscores the need to 
examine footprinting data at several levels of sequence context.  The variance in Met and 
Cys modification yields, although large, is not unusual, owing to the high sensitivity of 
sulfur-containing residues to endogenous reactive oxygen species and to oxidation during 
handling before and after the labeling experiment 15, 33-34.    
5.3.3 ApoE3 vs. ApoE3 Monomeric Mutant.   
 It is clear that in the C-terminal and linker domains the FPOP yields at the residue 
level of ApoE3MM are higher than those of WT-ApoE3 (Figure 5.3A).  This conclusion 
is based on analysis of 323 unmodified and modified tryptic peptides of ApoE3 and 
ApoE3MM, from 1,182 EIC features comprising 67.2% of all detected features 
(Supporting Information Table 5.2).  The criteria for inclusion are identical to those 
applied to the WT isoform experiment.  One in four residues is detected as modified.  The 
order of reactivity is nearly identical to that observed for •OH footprinting of the WT 
protein.  Figure 5.3A plots only the residues which are significantly different between 
ApoE3 and ApoE3MM, at 95% confidence.  A total of 26 residues spanning residues 167 
to 299 show significantly greater labeling for ApoE3MM, indicating these sites are more 
solvent-protected in the WT protein than the MM.  Clearly the C-terminal domain is 
involved in WT oligomerization, as was inferred from previous studies 10, 35.  The high 
density of protected sites in regions 183-205 and 232-251 may indicate localized regions 
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of oligomeric interaction in the WT.  Other sites in the C-terminal domain can’t fairly be 
compared.  Sites 257, 264, and 287 were detected as modified in both proteins.  These are 
three of the four mutation sites (F257A, W264R, L279Q, and V287E) that together 
engender monomericity36.  We do not compare their signals because each residue’s 
inherent •OH reactivity is different from its analog, no matter their possible difference in 
SASA. 
  
  
Figure 5.3:  Comparison of the tryptic
GEE labeling yields for ApoE3 and ApoE3MM.  Panel 
significant differences in FPOP yields between the proteins.  Each yield difference is 
normalized to the maximum yield per residue for all residues of the same amino
type, averaged from all FPOP experiments.  Background modification yields observed in 
the control experiments are subtracted from their corresponding FPOP yields before the 
relative value is determined.  Error bars are determined as described in Figure 5.1.  
Significance was determined at 95% confidence by the Student’s t
the residue-resolved significant differences in 3 min GEE yields between the proteins.  
Each yield difference is normalized to the average yield per residue for all acidic 
residues, averaged from all 3 min GEE experiments.  Error bars are the normalized 
standard errors for the 3 min measurement.  Significant difference was defined as at least 
2 GEE labeling time points exhibiting a difference at 95% confidence by the Student’s t
test, and having the same sign.  The bottom panel shows the residues along the ApoE3 
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primary sequence exhibiting more labeling in the monomeric mutant.  Black-underlined 
residues convey the significant FPOP labeling difference; red-underlined residues the 
significant GEE labeling difference. 
 
5.3.4 Glycyl Ethyl Ether (GEE) Footprinting.   
 To corroborate the findings in the FPOP monomer/oligomer experiment, we 
employed a second footprinting approach whereby carboxyl side chains were submitted 
to a GEE modification.  As with the FPOP data, quantitation was based on unmodified 
and modified LC-MS EIC features, with annotation accepted if the precursor ion is within 
5 ppm mass tolerance of theory and the product-ion spectra (MS2) is acceptable.  A 
control whereby the protein is not submitted to modification is unnecessary for this kind 
of labeling because exogenous background modifications at +85.0528 D are highly 
unlikely in the protein prior to modification and do not occur during peptide workup.  In 
the absence of GEE-induced unfolding, the time-dependence for the modification level 
should be monotonic; consequently, we used four GEE exposure times to more reliably 
differentiate the labeling yields of the acidic residues (Supporting Information Table 5.3).  
Two exemplary kinetic plots show that E212 is consistently more modified in ApoE3MM 
(Figure4a) whereas E109 is labeled nearly identically and at a lower level for both 
proteins (Figure4b).  This analysis informs a conservative criterion for assigning 
difference per acidic residue: by 3 min the pair-wise Student’s t-test should show a 
significant difference at 95% confidence, and this trend should also pertain at 6 and 12 
min.  By this criterion the significantly different residues are plotted in Figure 5.3B, 
showing their 3 min labeling yields. 
 Figure 5.4:  Exemplary plots of GEE labeling for 2 residues.  Open circles denote 
ApoE3MM GEE-modified yields at 4 time points; solid tria
yields.  Residue E212 data is shown in plot 
 
 The results from GEE labeling corroborate the findings 
results.  Figure 5.3D shows those residues that are more significantly labeled by FPOP 
(black) or GEE (blue) in the monomeric mutant.  Analysis of FPOP data at the peptide 
level conveys the same C
and 33-38 are slightly though significantly more labeled than the same regions of ApoE3.  
The magnitudes of change in FPOP labeling for ApoE3 vs. ApoE3MM at the residue 
level are, in general, more than three times greater than the changes seen comparing the 
three WT isoforms, and are more numerous.  By virtue of the normalization discussed 
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above, the magnitude of change measured in the monomer/oligomer experiment is 
indicative of a larger SASA change between monomer and oligomer, than is seen 
between WT isoforms explored in the 1st experiment. 
5.4 Discussion 
5.4.1 Structures of the ApoE isoforms.   
 We conclude that the overall structures (mixtures of structures) are nearly the 
same for the three ApoE isoforms by invoking a syllogism.  (1) FPOP snapshot –labels an 
ensemble of conformations and complexes at equilibrium17, 19.  (2) Of the 56 residues 
detected as modified among the isoforms, 95% were modified at statistically equivalent 
levels for ApoE2 and ApoE3, and 91% were so modified for ApoE3 and ApoE4.  (3) 
Therefore, the overall structures of the ApoE isoforms as measured by this technique are 
similar with one exception, to be discussed later.   
 Garai and Frieden8 have modeled the isoform monomer, dimer, and tetramer 
concentrations as a function of the total monomer concentration, based on self-
association rate constants for a monomer-dimer-tetramer model determined from FRET 
kinetics measurements.  At 4 µM total protein, their model shows that 84% of proteins 
are bound as tetramers, irrespective of the ApoE isoform.  A reasonable conclusion from 
the similarity in FPOP response among the ApoE isoforms, given the high prevalence of 
the tetrameric component in the oligomer state studied here, is that the ApoE2, ApoE3, 
and ApoE4 tetrameric structures are highly similar. 
 Despite the strong similarities in overall structure, the region of ApoE4 around 
M108 is different from that of ApoE2 and E3.  The extensive modification of M108 in 
 ApoE4 shows that it is somewhat solvent
modification in ApoE3 and E2 indicates that M108 is buried, consistent with the high 
resolution structures of the N
can occur by an intra or intermolecular interaction pulling on the 50
5.5).  Supporting this model are the M64 and M68 FPOP yields, which are slightly 
diminished in ApoE4 relative to those for ApoE3.  On the oth
methionine to •OH-mediated modification the overall change in SASA may not require a 
substantially different oligomeric structural model.
Figure 5.5:  ApoE4 24-162 X
sidechains depicted by element type and van der Waals radius.
 
5.4.2 Solvent Accessibility of N
 A comparison of the 
the carboxyl-terminal Trp residues are more solvent exposed than the 
residues for each isoform
most efficiently modified Trp, followed by W276, W210, and then the N
residues.  W39 cannot be detected as modified, although this may be du
abundance of tryptic peptide 39
using  apoE labeled with 
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 (Supporting Information Table 5.1).  For example,
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FPOP yields for same-amino-acid-type residues from the same protein.  These 
comparisons may allow more insightful conclusions about protein structure than yield 
comparisons of same residue in two different protein isoforms.  Essentially, residues of 
the same type may be ranked in order of their yield; those at the top of the list should 
have the highest SASA.   
5.4.3 Regions of oligomeric interaction.  
 This is the first study of only full-length ApoE that shows that the C-terminal 
domain is the primary region of self-association in the tetrameric form, which has long 
been the hypothesis5, 10-11.Westerlund and Weisgraber 10 showed in sedimentation 
experiments of C-terminal-truncated ApoE3 isoforms that region 267-299 is essential to  
association. This conclusion was reinforced by using several biophysical techniques for 
similar truncated ApoE isoforms 9, 25.  Furthermore, the 10 kDa C-terminal domain itself 
oligomerizes 11.  The choice of ApoE3MM used in our study was determined by the 
observation that mutations at F257, W264, V269, L179, and V287 resulted in a 
monomeric form in both the C-terminal domain alone 35 and the full-length apoE3 protein 
36
.  A substantial number of residues in the C-terminal and hinge domains are more 
solvent-accessible in the monomeric mutant than in the ApoE3 WT isoform, whereas 
modifications of their N-terminal domains are statistically identical.  Moreover, this 
result is demonstrated by two independent footprinting methods, FPOP and GEE labeling 
(Figure 5.3), with a high degree of consistency. The FPOP data indicate that, although 
these substitutions demonstrably prevent oligomerization, a larger region of self-
association interaction is at play, involving the hinge region (ApoE 192-215) as well.  
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That the formation of oligomers requires at least two patches for self-association is 
consistent with our results identifying multiple regions of oligomerization. 
5.4.4 Comparison of GEE and FPOP footprinting.   
 In general, there is good qualitative agreement between the results from FPOP 
and those from GEE footprinting.  An apparent discrepancy is seen for ApoE 181-205.  
Although several residues undergo some increased oxidative modification by FPOP in 
ApoE3MM, the levels of labeling by GEE are the same (Supporting Information Table 
5.3). This region contains only two modifiable residues, E186 and E205.  Aside from this 
low resolution sampling by GEE, there are several other aspects of GEE and FPOP 
footprinting germane to discrepancies in their outcomes.  Maybe the following discussion 
should come earlier. First, the secondary structure of a protein dictates that intermolecular 
or inter-domain interactions are not shared equally by neighboring residues, as the 
backbone torsion angles enforce different side-chain β−carbons orientations along a 
sequence.  Therefore, one should not expect neighboring residues to exhibit the same 
response when probing the “on” and “off” states of the interaction.  Second, the sampling 
of acidic residues, by their “priming” by EDC and subsequent reaction with GEE, 
requires interaction volumes that are larger than that of the water molecule, whereas •OH 
is a probe much the same size as water.  Additionally, the sites of reaction on acidic 
residues are different.  Whereas the e- pair of the oxygen conjugate base  attack 
carbodiimide carbon as a first step 40, •OH preferentially abstracts hydrogen from the Glu 
β and γ carbons 15, 41.  Thus the relevant solvent accessibilities are different for the same 
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residue.  Finally, the timescale of labeling is dramatically different; the much longer 
exposure to GEE labeling may sample conformations induced by initial labeling events.  
5.4.5 Comparison of the N-terminal domains of ApoE2, ApoE3, ApoE4, and 
ApoE3MM.   
 
 We find little difference between the labeling footprints of the N-terminal 
domains for the WT isoforms and between ApoE3 and its monomeric mutant isoform 
(Figures 1, 2, and 4).  Thus, the WT isoforms must adopt similar N-terminal structures as 
that of the monomeric mutant.  In a separate manuscript examining the ApoE3MM data, 
we propose that it adopts an N-terminal domain structure much like the most recent NMR 
ApoE3 1-183 structure 7.  With few exceptions, the rank order of yields of ApoE3 
residues detected as modified in the first and second experiment are the same, although 
the levels of modification are higher in the ApoE3 monomer/oligomer study owing to the 
doubling of H2O2 starting material.  Some of the detected oxidations in the latter case 
may be due to secondary protein-peroxy reactions that do not sample the equilibrium 
structure 42, but such signal cannot account for the overwhelming differences seen 
between ApoE3 and ApoE3MM. 
5.5 Conclusions   
At 4 µM, WT-ApoE2, ApoE3, and ApoE4 exist in solution as similar structures, 
primarily as tetramers, and that our data is consistent with the assignment of a four-helix 
bundle structure in the N-terminal domain of the 299 amino acid monomeric mutant of 
ApoE3.  Although the overall structures are similar, that of region M108 in E4 is 
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significantly different, though its overall change in SASA may be small.  By virtue of the 
per-residue trends drawn from two independent MS-based footprinting data sets of 
ApoE3 and ApoE3MM, we conclude that residues spanning 183-205 and 232-251 in the 
hinge and C-terminal domains are involved in inter and intramolecular interactions 
concomitant with tetrameric self-association in ApoE3.  Owing to their sequence 
invariance in this region, we suggest that the same oligomerization interaction occurs for 
ApoE2 and ApoE4.   
One advantage of MS-based protein footprinting is that it can sample physiologic 
mixtures.  Thus, future studies will characterize ApoE in the presence of Aβ proteins both 
with and without the context of lipoproteins.  This should be possible at high sequence 
resolution and may reveal interactions implied in the genetic association of ApoE4 with 
Alzheimer’s disease 43.
150 
 
5.6 Supporting Information 
Supporting Information Table 5.1: FPOP labeling yield per ApoE residue, WT 
experiment 
residue ApoE2 ApoE3 ApoE4 residue ApoE2 ApoE3 ApoE4 
V2 0.30 ± 0.05% 0.269 +/- 0.005% 0.29 +/- 0.03% P183 0.13 +/- 0.02% 0.091 +/- 0.003% 0.13 +/- 0.01% 
V6 0.4 +/- 0.1% 0.38 +/- 0.01% 0.41 +/- 0.05% L184 0.43 +/- 0.07% 0.42 +/- 0.01% 0.43 +/- 0.03% 
P10 0.8 +/- 0.1% 0.74 +/- 0.02% 0.81 +/- 0.07% V185 0.20 +/- 0.03% 0.142 +/- 0.003% 0.21 +/- 0.02% 
E13 0.31 +/- 0.02% 0.32 +/- 0.01% 0.32 +/- 0.02% R191 0.27 +/- 0.03% 0.283 +/- 0.009% 0.31 +/- 0.01% 
L14 0.24 +/- 0.04% 0.192 +/- 0.008% 0.18 +/- 0.01% V195 0.23 +/- 0.04% 0.208 +/- 0.005% 0.25 +/- 0.03% 
W20 3.9 +/- 0.5% 3.6 +/- 0.2% 3.9 +/- 0.3% L198 0.45 +/- 0.08% 0.40 +/- 0.02% 0.42 +/- 0.05% 
Q21 4.1 +/- 0.2% 3.8 +/- 0.3% 3.4 +/- 0.2% L203 0.28 +/- 0.04% 0.249 +/- 0.006% 0.28 +/- 0.03% 
W26 1.08 +/- 0.07% 1.0 +/- 0.1% 0.74 +/- 0.08% E205 0.26 +/- 0.02% 0.215 +/- 0.007% 0.198 +/- 0.007% 
W34 3.3 +/- 0.4% 2.9 +/- 0.2% 3.4 +/- 0.4% W210 3.4 +/- 0.3% 3.5 +/- 0.1% 4.2 +/- 0.5% 
M64 10 +/- 2% 9.4 +/- 0.9% 6 +/- 1% M218 1.0 +/- 0.8% 0.8 +/- 0.4% 1.0 +/- 0.2% 
E66 0.0 +/- 0.4% 0.6 +/- 0.2% 0.2 +/- 0.5% R226 0.12 +/- 0.02% 0.121 +/- 0.003% 0.144 +/- 0.009% 
M68 2.5 +/- 0.9% 3.6 +/- 0.6% 2 +/- 1% K233 0.042 +/- 0.007% 0.047 +/- 0.006% 0.066 +/- 0.006% 
Y74 2.8 +/- 0.1% 3.07 +/- 0.04% 3.08 +/- 0.08% L243 0.09 +/- 0.02% 0.079 +/- 0.006% 0.09 +/- 0.01% 
E77 1.47 +/- 0.07% 1.41 +/- 0.04% 1.34 +/- 0.04% E244 0.067 +/- 0.009% 0.067 +/- 0.005% 0.061 +/- 0.003% 
E79 0.18 +/- 0.02% 0.20 +/- 0.02% 0.20 +/- 0.02% Q248 0.14 +/- 0.02% 0.15 +/- 0.01% 0.15 +/- 0.02% 
L82 0.15 +/- 0.03% 0.13 +/- 0.01% 0.13 +/- 0.02% L252 0.5 +/- 0.1% 0.38 +/- 0.01% 0.37 +/- 0.01% 
P84 0.29 +/- 0.05% 0.279 +/- 0.009% 0.31 +/- 0.03% E255 0.37 +/- 0.01% 0.30 +/- 0.02% 0.250 +/- 0.002% 
V85 0.11 +/- 0.03% 0.108 +/- 0.008% 0.113 +/- 0.009% F257 0.5 +/- 0.6% 1.5 +/- 0.2% 0.9 +/- 0.6% 
E87 0.12 +/- 0.02% 0.12 +/- 0.01% 0.12 +/- 0.02% R260 0.034 +/- 0.006% 0.033 +/- 0.001% 0.036 +/- 0.003% 
E88 0.30 +/- 0.07% 0.31 +/- 0.02% 0.33 +/- 0.03% W264 11 +/- 1% 10.4 +/- 0.4% 10.6 +/- 0.6% 
M108 0.0 +/- 0.7% 0.0 +/- 0.5% 5 +/- 1% E266 0.38 +/- 0.01% 0.340 +/- 0.005% 0.299 +/- 0.006% 
C112 22 +/- 5% 26 +/- 1%  D271 0.91 +/- 0.06% 1.03 +/- 0.09% 0.77 +/- 0.05% 
M125 10 +/- 3% 12 +/- 1% 9 +/- 2% M272 6 +/- 3% 9 +/- 3% 5 +/- 2% 
L126 0.14 +/- 0.03% 0.16 +/- 0.01% 0.20 +/- 0.02% W276 6.7 +/- 0.9% 5.8 +/- 0.2% 5.9 +/- 0.3% 
L133 0.11 +/- 0.02% 0.102 +/- 0.005% 0.13 +/- 0.01% V287 0.15 +/- 0.03% 0.134 +/- 0.005% 0.13 +/- 0.02% 
H140 6 +/- 2% 6.2 +/- 0.5% 7 +/- 3% P293 2.0 +/- 0.6% 2.2 +/- 0.1% 1.9 +/- 0.4% 
Y162 n.d. 0.75 +/- 0.01% 0.90 +/- 0.02% P295 0.00 +/- 0.05% 0.08 +/- 0.04% 0.02 +/- 0.06% 
L181 0.21 +/- 0.04% 0.141 +/- 0.002% 0.19 +/- 0.02% H299 1.2 +/- 0.3% 1.08 +/- 0.06% 1.2 +/- 0.3% 
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Supporting Information Table 5.2: FPOP labeling yield per ApoE residue, 
oligomer/monomer experiment 
residue ApoE3 ApoE3MM residue ApoE3 ApoE3MM residue ApoE3 ApoE3MM 
K1 2.6 +/- 0.7% 3.6 +/- 0.1% R90 0.12 +/- 0.06% 0.256 +/- 0.008% R191 0.2 +/- 0.1% 0.60 +/- 0.04% 
E3 0.4 +/- 0.1% 0.47 +/- 0.02% K95 1.7 +/- 0.6% 2.9 +/- 0.2% V195 0.5 +/- 0.2% 1.09 +/- 0.04% 
V6 0.32 +/- 0.09% 0.36 +/- 0.01% M108 1 +/- 3% 5. +/- 1.% S197 0.07 +/- 0.02% 0.083 +/- 0.003% 
E9 0.18 +/- 0.07% 0.24 +/- 0.02% C112 53 +/- 12% 54 +/- 6% L198 0.5 +/- 0.1% 1.13 +/- 0.04% 
E19 0.07 +/- 0.01% 0.08 +/- 0.01% V116 0.24 +/- 0.09% 0.37 +/- 0.02% Q201 0.010 +/- 0.002% 0.016 +/- 0.001% 
W20 11 +/- 3% 16.0 +/- 0.4% Y118 0.24 +/- 0.09% 0.37 +/- 0.02% P202 0.18 +/- 0.05% 0.351 +/- 0.005% 
Q21 0.07 +/- 0.01% 0.08 +/- 0.01% V122 0.2 +/- 0.1% 0.12 +/- 0.01% L203 0.7 +/- 0.2% 1.67 +/- 0.05% 
S22 0.052 +/- 0.006% 0.070 +/- 0.006% M125 50 +/- 5% 47 +/- 5% E205 0.4 +/- 0.1% 0.84 +/- 0.02% 
W26 0.8 +/- 0.2% 1.1 +/- 0.2% L126 2 +/- 1% 2.0 +/- 0.1% W210 6 +/- 2% 16.4 +/- 0.4% 
L28 0.4 +/- 0.1% 0.53 +/- 0.05% L133 0.3 +/- 0.2% 0.184 +/- 0.007% M218 9 +/- 2% 22 +/- 3% 
R32 0.023 +/- 0.007% 0.042 +/- 0.004% H140 1.3 +/- 0.4% 2.0 +/- 0.2% V232 0.08 +/- 0.03% 4.7 +/- 0.6% 
W34 11 +/- 2% 14.2 +/- 0.2% V161 0.15 +/- 0.05% 0.20 +/- 0.03% K233 0.10 +/- 0.08% 0.389 +/- 0.004% 
Y36 1.3 +/- 0.2% 1.65 +/- 0.08% Y162 1.6 +/- 0.4% 1.92 +/- 0.05% K242 0.29 +/- 0.08% 0.55 +/- 0.01% 
M64 3.4 +/- 0.9% 3 +/- 1% A166 0.05 +/- 0.01% 0.076 +/- 0.006% L243 0.05 +/- 0.02% 1.06 +/- 0.06% 
M68 4 +/- 1% 2 +/- 1% R167 0.25 +/- 0.04% 0.40 +/- 0.01% E244 0.30 +/- 0.05% 0.49 +/- 0.02% 
Y74 4. +/- 1.% 3.8 +/- 0.7% S175 0.13 +/- 0.04% 0.27 +/- 0.02% Q248 0.18 +/- 0.03% 0.25 +/- 0.02% 
E77 0.3 +/- 0.2% 0.22 +/- 0.02% R180 0.20 +/- 0.05% 0.36 +/- 0.02% I250 0.03 +/- 0.01% 0.68 +/- 0.06% 
E79 0.2 +/- 0.1% 0.18 +/- 0.02% L181 0.31 +/- 0.08% 0.55 +/- 0.04% R251 0.012 +/- 0.003% 0.027 +/- 0.001% 
E80 1.2 +/- 0.8% 0.72 +/- 0.02% P183 0.36 +/- 0.08% 0.62 +/- 0.02% E255 0.28 +/- 0.07% 0.124 +/- 0.003% 
L82 0.6 +/- 0.5% 0.187 +/- 0.006% L184 0.4 +/- 0.1% 0.68 +/- 0.04% R260 0.29 +/- 0.06% 0.26 +/- 0.01% 
P84 0.7 +/- 0.3% 0.65 +/- 0.03% V185 0.33 +/- 0.08% 0.58 +/- 0.01% M272 40 +/- 6% 33 +/- 2% 
V85 0.9 +/- 0.6% 0.47 +/- 0.04% E186 0.20 +/- 0.05% 0.36 +/- 0.01% W276 11 +/- 3% 28.7 +/- 0.8% 
E87 0.8 +/- 0.3% 0.99 +/- 0.03% Q187 0.08 +/- 0.02% 0.154 +/- 0.008% V294 0.9 +/- 0.2% 0.24 +/- 0.03% 
E88 0.7 +/- 0.3% 0.82 +/- 0.03% R189 0.19 +/- 0.04% 0.34 +/- 0.02% H299 0.9 +/- 0.4% 2.30 +/- 0.05% 
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Supporting Information Table 5.3: GEE labeling yield per ApoE residue, 
oligomer/monomer experiment 
residue time (min) ApoE3 ApoE3MM residue 
time 
(min) ApoE3 ApoE3MM 
E7 1 5.19 +/- 0.06% 5.1 +/- 0.4% E66 1 0.214 +/- 0.008% 0.217 +/- 0.004% 
E7 3 6.3 +/- 0.3% 9.0 +/- 0.8% E66 3 0.29 +/- 0.02% 0.34 +/- 0.09% 
E7 6 8.5 +/- 0.8% 9.0 +/- 0.8% E66 6 0.44 +/- 0.08% 0.32 +/- 0.05% 
E7 12 10.6 +/- 0.3% 12.9 +/- 0.7% E66 12 0.6 +/- 0.1% 0.59 +/- 0.04% 
E9 1 4.6 +/- 0.6% 4.6 +/- 0.9% E77 1 0.7 +/- 0.3% 0.5 +/- 0.2% 
E9 3 5.91 +/- 0.08% 9.0 +/- 0.2% E77 3 0.52 +/- 0.02% 2 +/- 1% 
E9 6 9 +/- 1% 9.3 +/- 0.8% E77 6 1.1 +/- 0.1% 0.6 +/- 0.1% 
E9 12 10.9 +/- 0.3% 12.1 +/- 0.1% E77 12 1.4 +/- 0.1% 1.03 +/- 0.03% 
E11 1 0.17 +/- 0.04% 0.135 +/- 0.006% E80 1 2.2 +/- 0.6% 2.1 +/- 0.3% 
E11 3 0.16 +/- 0.01% 0.35 +/- 0.01% E80 3 2.5 +/- 0.1% 4.2 +/- 0.8% 
E11 6 0.37 +/- 0.02% 0.41 +/- 0.01% E80 6 4.9 +/- 0.8% 4.0 +/- 0.5% 
E11 12 0.9 +/- 0.6% 0.7 +/- 0.3% E80 12 7.3 +/- 0.3% 6.3 +/- 0.1% 
E13 1 1.67 +/- 0.07% 1.5 +/- 0.2% E88 1 0.08 +/- 0.06% 0.04 +/- 0.04% 
E13 3 1.98 +/- 0.04% 2.92 +/- 0.07% E88 3 0.021 +/- 0.003% 0.2 +/- 0.2% 
E13 6 3.2 +/- 0.5% 2.9 +/- 0.3% E88 6 0.084 +/- 0.008% 0.021 +/- 0.009% 
E13 12 3.63 +/- 0.06% 4.3 +/- 0.2% E88 12 0.075 +/- 0.008% 0.041 +/- 0.002% 
E19 1 2.9 +/- 0.1% 3.2 +/- 0.2% E96 1 0.26 +/- 0.04% 0.29 +/- 0.07% 
E19 3 4.18 +/- 0.08% 4.1 +/- 0.2% E96 3 0.405 +/- 0.009% 0.35 +/- 0.07% 
E19 6 5.7 +/- 0.4% 4.93 +/- 0.02% E96 6 0.55 +/- 0.09% 0.3043 +/- 0.0003% 
E19 12 10 +/- 2% 7.6 +/- 0.5% E96 12 0.9 +/- 0.3% 0.35 +/- 0.04% 
E27 1 0.3 +/- 0.1% 0.26 +/- 0.04% E109 1 0.11 +/- 0.01% 0.10 +/- 0.04% 
E27 3 0.30 +/- 0.02% 0.37 +/- 0.02% E109 3 0.21 +/- 0.03% 0.09 +/- 0.09% 
E27 6 0.51 +/- 0.02% 0.43 +/- 0.04% E109 6 0.13 +/- 0.08% 0.16 +/- 0.07% 
E27 12 0.62 +/- 0.02% 0.67 +/- 0.07% E109 12 0.37 +/- 0.09% 0.3 +/- 0.2% 
D35 1 0.07 +/- 0.02% 0.052 +/- 0.009% D110 1 0.11 +/- 0.01% 0.10 +/- 0.04% 
D35 3 0.069 +/- 0.003% 0.106 +/- 0.005% D110 3 0.21 +/- 0.03% 0.09 +/- 0.09% 
D35 6 0.16 +/- 0.04% 0.098 +/- 0.006% D110 6 0.13 +/- 0.08% 0.16 +/- 0.07% 
D35 12 0.16 +/- 0.02% 0.14 +/- 0.02% D110 12 0.37 +/- 0.09% 0.3 +/- 0.2% 
E66 1 0.214 +/- 0.008% 0.217 +/- 0.004% E186 1 0.75 +/- 0.02% 0.75 +/- 0.02% 
E66 3 0.29 +/- 0.02% 0.34 +/- 0.09% E186 3 0.94 +/- 0.02% 0.99 +/- 0.02% 
E66 6 0.44 +/- 0.08% 0.32 +/- 0.05% E186 6 1.3 +/- 0.1% 1.22 +/- 0.02% 
E66 12 0.6 +/- 0.1% 0.59 +/- 0.04% E186 12 1.9 +/- 0.2% 1.9 +/- 0.3% 
E77 1 0.7 +/- 0.3% 0.5 +/- 0.2% E205 1 0.4 +/- 0.1% 0.5 +/- 0.2% 
E77 3 0.52 +/- 0.02% 2 +/- 1% E205 3 0.46 +/- 0.03% 1.0 +/- 0.1% 
E77 6 1.1 +/- 0.1% 0.6 +/- 0.1% E205 6 0.8 +/- 0.1% 0.93 +/- 0.02% 
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E77 12 1.4 +/- 0.1% 1.03 +/- 0.03% E205 12 1.04 +/- 0.05% 1.13 +/- 0.07% 
E212 1 0.56 +/- 0.01% 1.7 +/- 0.3% E255 1 0.302 +/- 0.008% 1.3 +/- 0.3% 
E212 3 0.97 +/- 0.05% 2.1 +/- 0.2% E255 3 0.3538 +/- 0.0009% 1.41 +/- 0.07% 
E212 6 1.26 +/- 0.08% 2.5 +/- 0.3% E255 6 0.404 +/- 0.004% 1.8 +/- 0.1% 
E212 12 1.9 +/- 0.4% 3.2 +/- 0.2% E255 12 0.523 +/- 0.009% 2.4 +/- 0.3% 
E219 1 2.2 +/- 0.5% 14 +/- 4% E266 1 8 +/- 3% 3.1 +/- 0.4% 
E219 3 4.4 +/- 0.4% 24 +/- 3% E266 3 8.14 +/- 0.04% 5.5 +/- 0.8% 
E219 6 4.7 +/- 0.2% 20 +/- 2% E266 6 12 +/- 9% 6.3 +/- 0.2% 
E219 12 11 +/- 5% 26.2 +/- 0.8% E266 12 11 +/- 3% 8.23 +/- 0.08% 
E220 1 5 +/- 1% 16 +/- 6% E270 1 12 +/- 8% 1.4 +/- 0.2% 
E220 3 8.4 +/- 0.9% 26 +/- 4% E270 3 4 +/- 3% 2.4 +/- 0.2% 
E220 6 9.5 +/- 0.7% 21 +/- 2% E270 6 9 +/- 6% 2.8 +/- 0.2% 
E220 12 19 +/- 8% 25. +/- 1.% E270 12 1.9 +/- 0.9% 4.20 +/- 0.04% 
D227 1 2.2 +/- 0.4% 8 +/- 2% D271 1 0.05 +/- 0.05% 1.40 +/- 0.07% 
D227 3 4.5 +/- 0.5% 17 +/- 5% D271 3 0.02 +/- 0.02% 2.3 +/- 0.1% 
D227 6 6.0 +/- 0.3% 13 +/- 2% D271 6 0.03 +/- 0.03% 2.8 +/- 0.2% 
D227 12 12 +/- 5% 17.42 +/- 0.04% D271 12 0.2 +/- 0.2% 3.79 +/- 0.07% 
E231 1 1.4 +/- 0.3% 10 +/- 3% E281 1 0.97 +/- 0.06% 1.7 +/- 0.2% 
E231 3 3.1 +/- 0.5% 19 +/- 2% E281 3 1.28 +/- 0.02% 2.3 +/- 0.2% 
E231 6 5.1 +/- 0.3% 17 +/- 2% E281 6 1.70 +/- 0.04% 2.888 +/- 0.006% 
E231 12 9 +/- 4% 21 +/- 2% E281 12 2.3 +/- 0.2% 4.1 +/- 0.2% 
E234 1 32 +/- 5% 34 +/- 10% E287 1 0.3 +/- 0.3% 2.2 +/- 0.1% 
E234 3 45.3 +/- 0.6% 45 +/- 3% E287 3 0 2.95 +/- 0.03% 
E234 6 52 +/- 3% 39 +/- 3% E287 6 0.01 +/- 0.01% 3.9 +/- 0.1% 
E234 12 64 +/- 8% 45.4 +/- 0.4% E287 12 0 5.9 +/- 0.2% 
E238 1 3.8 +/- 0.4% 9.1 +/- 0.2% D297 1 1.4 +/- 0.2% 0.64 +/- 0.03% 
E238 3 5.2 +/- 0.3% 11 +/- 2% D297 3 2.14 +/- 0.06% 0.976 +/- 0.005% 
E238 6 6.4 +/- 0.4% 14.9 +/- 0.4% D297 6 3.49 +/- 0.03% 1.47 +/- 0.08% 
E238 12 8.93 +/- 0.05% 18.2 +/- 0.2% D297 12 5.17 +/- 0.04% 2.315 +/- 0.002% 
E244 1 0.086 +/- 0.001% 0.64 +/- 0.04% H299 1 0.011 +/- 0.008% 0.22 +/- 0.01% 
E244 3 0.108 +/- 0.009% 0.72 +/- 0.02% H299 3 0.023 +/- 0.005% 0.28 +/- 0.01% 
E244 6 0.129 +/- 0.004% 0.930 +/- 0.009% H299 6 0.042 +/- 0.008% 0.39 +/- 0.02% 
E244 12 0.164 +/- 0.005% 1.39 +/- 0.08% H299 12 0.2 +/- 0.1% 0.68 +/- 0.05% 
E245 1 0.41 +/- 0.04% 0.91 +/- 0.04%     
E245 3 0.49 +/- 0.02% 1.08 +/- 0.03%     
E245 6 0.58 +/- 0.01% 1.24 +/- 0.03%     
E245 12 0.69 +/- 0.06% 1.97 +/- 0.04%     
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6 Characterization of the Apolipoprotein E3 Monomer 
Structure by Mass Spectrometry-based Protein Footprinting. 
 
6.1 Introduction 
Apolipoprotein E (ApoE) has three common variants among humans, differing at 
two residues in the 299-residue protein.  Variant ApoE2 has cysteines at residues 112 and 
158; ApoE3 has a cysteine at 112 and an arginine at 158; and ApoE4 has arginines at 
both residues.  No high resolution structure of any variant has been determined, owing to 
the propensities of the full proteins to oligomerize.  ApoE is comprised of two domains 
connected by a protease-sensitive hinge region1; the N-terminal domain and C-terminal 
domain span residues 1-191 and 216-299, respectively.  The first X-ray crystal structure 
of ApoE23-164 revealed a four-helix-bundle structure of the N-terminal domain2; the most 
recent NMR structure of ApoE1-183 expands the high-resolution coverage of this domain3.  
Conversely, no high-resolution structure of the isolated C-terminal domain has been 
determined, although it is thought that this domain is the primary region for oligomeric 
interactions 1, 4-5.   
ApoE4 carries the highest risk of any genetic factor for Alzheimer’s disease 
(AD)6-8.  This high genetic risk ultimately is owed to the single amino-acid difference 
between ApoE4 and the most common ApoE variant, ApoE3.  There is evidence for 
several mechanisms of ApoE4-associated AD risk, although there is no consensus on a 
single theory9-12.  Significantly, ApoE4 has a higher preference of forming VLDL 
lipoproteins than do the other common ApoE variants, and this has been attributed to a 
conformation involving an N-terminal:C-terminal domain interaction enhanced in ApoE4 
possibly by a salt bridge between R61 and E25513-15.   Garai and Frieden 16 showed that 
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the oligomerization of lipid-free ApoE is not diffusion-controlled, and that the variants 
exhibit different rates of association and dissociation.  These differences may impact the 
lipoprotein dynamic equilibrium in the brain.  Such studies highlight the need for a 
fundamental understanding of the lipid-free ApoE structure, to help unravel the 
physiological consequence of mutation C158R.  
The central problem inhibiting the structural characterization of ApoE is 
oligomerization.  Zhang and colleagues 17 recently engineered two mutants of ApoE3, 
existing as monomers to 20 mg/mL and possessing lipid-binding and LDL receptor-
binding properties that are similar to those of ApoE3.  The two mutants share four 
substitutions in the C-terminal domain; one of the mutants has an additional substitution 
in this domain.  Its NMR 1H-15N HSQC spectrum in the lipid-free state shows many of 
the same spectral features as the spectrum of truncated ApoE3 1-183, suggesting that the 
four-helix bundle structure is present in the N-terminal domain of the full length 
monomeric mutant17.  This has been a common presumption in the modeling of ApoE 
domain interactions and lipid-binding reorganization3, 9.  We report here the testing of 
this hypothesis with a different method of structural characterization.   
Protein footprinting by covalent labeling of solvent-exposed sidechains, with 
detection and quantitation by mass spectrometry, is a method of analyzing structure by 
comparison18-19.  Usually two states of a protein or protein complex are modified under 
identical conditions.  By virtue of the irreversibility of the modification, the proteins can 
be proteolyzed in any appropriate manner, and the resulting peptides analyzed by 
chromatography and mass spectrometry to reveal modification sites.  In a proper 
footprinting experiment, the labeling modification yield at a site will depend on the 
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inherent reactivity of the residue to the labeling agent and on the site’s average solvent 
accessibility in the equilibrium state of interest.  Comparing the yields of labeling at 
identical residues between two states allows for an accurate assessment of the relative 
change in solvent accessible surface area (SASA) at the residue.  The state with 
attenuated labeling has lower SASA; such a result for the holo state in a ligand-binding 
experiment reveals the site of direct ligand interaction or of distal allosteric change upon 
binding.   
One class of protein footprinting utilizes hydroxyl-radical-mediated modification.  
This method has several advantages.  The •OH probes aqueous accessibility because its 
size is comparable to that of water molecules, and its high reactivity allows for reliable 
sampling of over half of the 20 common amino acids20-22.  Additionally, in oxygenated 
solutions, an abundant product of •OH-sidechain modification  that is common to most 
amino acids is the net incorporation of oxygen 23, a stable +16 Da modification easily 
detected by mass spectrometry.  While indiscriminate, •OH is not an “equal-opportunity” 
labeling agent: the reaction rate constant for the most reactive amino acid, Cys, is over 
1000 times greater than that for the least reactive, Gly 24.   
There are several ways of generating •OH for protein footprinting, including 
Fe(II)-reduction of H2O2 (Fenton chemistry)25-28, X-ray29-30 and γ-ray31-32 radiolysis of 
water, and UV homolysis of H2O2 33.  These methods and the various side-chain products 
they typically produce are detailed in a recent review24.  We use here the FPOP approach 
developed by Hambly and Gross34 and, independently, by Aye and colleagues35 for •OH–
mediated footprinting.  We use a KrF excimer laser to provide a 17 ns flash of 248 nm 
light to initiate the homolysis of H2O2 at low millimolar levels.  Twenty mM glutamine 
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serves as a chemical shutter, effectively scavenging all radicals within  approximately 1 
µs 34.  This ensures that only the equilibrium conformation(s) of the protein is sampled at 
high yield, avoiding potential oxidation-induced conformations that may evolve within 
ms of exposure 36. 
The hypothesis we test, that the N-terminus of the full length ApoE monomer has 
the structure of truncated ApoE31-183, requires a different kind of comparison than is 
normally employed in a footprinting experiment.  We segregate the extents of oxidative 
modification of residues among their same-amino-acid residue families, because the 
FPOP-yield should be proportional to the SASA among residues of the same kind.  Thus 
an accurate determination of relative exposure is possible.  The hypothesis of structural 
similarity in the N-terminal domain is tested by comparing FPOP-indicated buried and 
exposed residues to the calculated SASA of ApoE31-183. 
6.2 Experimental Procedures 
6.2.1 Reagents.   
Acetonitrile, formic acid, 30% hydrogen peroxide, L-glutamine, L-methionine, 
tris(2-carboxyethyl)phosphine hydrochloride (TCEP), catalase, guanidinium 
hydrochloride, and phosphate buffered saline (PBS) were purchased from the Sigma 
Aldrich Chemical Co. (St. Louis, MO).  Trypsin sequencing grade was purchased from 
Roche Diagnostics Corp. (Indianapolis, IN).  Purified water (18 MΩ) was obtained from 
a Milli-Q Synthesis system (Millipore, Billerica, MA).  ApoE3MM, expressed in E. coli, 
was kindly provided by Drs. K. Garai and C. Frieden.  Lyophilized ApoE3MM was 
solubilized in 6 M guanidinium chloride and dialyzed overnight into phosphate buffered 
saline (PBS) solution containing 100 µM TCEP disulfide reductant; the protein 
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concentration was determined by 280 nm absorbance.  The purity of the protein was 
confirmed by ESI MS on a Bruker Maxis Q-TOF (Billerica, MA) operating at 30000 
resolving power for ions of m/z 400, using a Millipore ZiptipC4 (Billerica, MA) de-salted 
aliquot of the stock solution.  The stock solution was split among aliquots, frozen by 
immersion in N2(I), and stored at -80°C prior to use.  
6.2.2 FPOP labeling.  
A solution of 4 µM ApoE3MM in PBS and 100 µM TCEP was prepared from 
thawed stock solutions and thermally equilibrated 2 h at room temperature (22 °C).  
Glutamine was solubilized to 150 mM in PBS and added to the protein solution to a final 
concentration of 20 mM.  From this solution, 35 µL replicates were drawn.  Just prior to 
FPOP, H2O2 was added to each replicate to a final concentration of 40 mM, by 10-fold 
dilution of a freshly prepared stock solution of H2O2.  The FPOP apparatus was used as 
previously described 34 but with 150 µm i.d. fused silica (Polymicro Technologies, 
Phoenix, AZ).  The KrF excimer laser power (GAM Laser Inc., Orlando, FL) was 
adjusted to 39 mJ/pulse, and its pulse frequency was set to 5 Hz.  The flow rate was 
adjusted to ensure a 25% exclusion volume to avoid repeat •OH exposure36.  Excess H2O2 
was removed immediately following FPOP labeling by collecting samples in 
microcentrifuge tubes containing 10 µL of 200 fM catalase.  This catalase solution also 
contained Met to give a final concentration of 20 mM following collection.  O2(g) was 
removed from the samples by centrifugation following pipette mixing three times during 
a 10 minute room temperature incubation; samples were subsequently frozen in N2(l) and 
stored at -80°C prior to proteolysis.  Control samples were drawn from the same 
equilibration solution and handled identically except that the laser was not used. 
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6.2.3 Proteolysis.  
FPOP-labeled and control samples were thawed and proteolyzed at an 8:1 
protein:trypsin weight ratio at 37 °C for 3 h.  Digestion completion was determined by 
ESI MS on a Bruker Maxis Q-TOF by using an extra control replicate.  The samples were 
concentrated 3-fold by SpeedVac drying at 30 °C, then Millipore ZiptipC18 de-salted, with 
eluted into 10 uL of 50% acetonitrile 1% formic acid solution.  A portion of this was 
diluted 25-fold with water and 0.1% formic acid for autosampler loading.  
6.2.4 LC-MS/MS acquisition.  
Each sample replicate was loaded by 5 µL autosampler (Eksigent nanoLC, 
Dublin, CA) injection onto a 20 cm x 75 µm silica capillary column with a PicoFrit tip 
(New Objective, Inc, Woburn, MA), bomb-packed with C18 reverse phase material 
(Magic, 0.075 mm × 200 mm, 5 µm, 300 Å, Michrom, Auburn, CA).  The gradient was 
from 1% solvent B (97% acetonitrile, 3% water, 0.1% formic acid) to 60% solvent B over 
70 min at an eluent flow of 260 nL/min.  The LC was coupled to the nanospray source of 
an LTQ-Orbitrap mass spectrometer (Thermo Fisher, Waltham, MA).  Mass spectra of 
eluting peptides were obtained at high mass resolving power (100,000 for ions of m/z 
400) by using the Orbitrap spectrometer component.  The six most abundant ions eluting 
per high- resolving-power scan were each subjected to CID MS2 experiment in the LTQ 
component, using a collision energy 35% of the maximum, a 2 Da isolation width, and 
wideband activation.  Precursor ions submitted to an MS2 experiment were rejected for 
repeat experiment within 6 s of their original MS2 scan; this dynamic exclusion setting 
enabled good sampling of the apex of most chromatogram peaks, which were typically 
12-18 s wide at half maximum.  Blanks were run between every sample acquisition. 
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6.2.5 Data analysis.   
A measure of the abundance of a peptide is the sum of the integrated areas of its 
extracted ion chromatogram (EIC) features from the Orbitrap MS data, determined at ± 5 
ppm about the theoretical m/z values of the isotopomer ions.  The Rosetta Elucidator data 
management system (Rosetta Biosoftware) was used to determine all EIC features 
aligned in time across all FPOP and control samples.  These EIC features were annotated 
by Mascot (Matrix Science, Boston, MA) error-tolerant searching with the variable 
modification list updated for known •OH sidechain modifications24.  The feature 
annotations were corrected for, or rejected by, errors in mass tolerance, unusual 
modifications, and discrepant annotations, using custom VBA software for efficient 
manual MS2 inspection.  The custom processing also augmented the Mascot results by 
identifying peaks not Mascot-annotated but within 8 ppm of a putative FPOP-modified or 
unmodified tryptic peptide of ApoE3MM.  These features were included if they had an 
associated product-ion spectra that were consistent with their accurate-mass match.  The 
interpretation of such spectra was assisted by a custom-developed correlation algorithm 
that compared these spectra to exemplary CID fragment spectra of unmodified tryptic 
peptides of ApoE3MM37.   
The yield per residue was determined as the sum of all peptide features modified 
at a residue divided by all peptide features having the same sequences as the peptide 
contributors modified at that residue.  This definition avoids potential yield 
underestimations that occurred, for example, when a tryptic peptide was detected as 
modified at a residue but a missed-cleavage peptide spanning this residue was only 
detected as unmodified.  Here is the argument:  The protein modification yield at a 
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residue should be recapitulated at the peptide level.  Unless there is a modification bias 
with trypsin proteolysis, the missed-cleavage peptide will also be modified at the residue 
in the same yield.  The lack of detection of the modified missed-cleavage peptide does 
not mean the missed-cleavage peptide isn’t modified; rather it is an analytic failure 
usually owing to a low frequency of trypsin missed cleavages. Therefore the unmodified 
missed-cleavage peptide should not be included in the yield denominator in this instance.  
Except for modifications at lysine and arginine, our data shows trypsin is not influenced 
by residue modifications.  
6.3 Results 
6.3.1 LC-MS/MS analysis.   
When subjected to LC-MS peak-alignment analysis, the proteolytic digests of the 
three samples submitted to FPOP and of the three control samples had 10,122 unique ion 
features of known charge state eluting during their 70 min LC-MS acquisitions.  An LC-
MS feature is a single ion isotopomer in a single charge state from a species eluting as a 
single peak in time.  Typically a signal from an abundant tryptic peptide species was split 
among two or more charge states, often +2 and +3.  The Orbitrap mass analyzer resolved 
the isotopomers, so that the measure of abundance of a tryptic peptide was determined by 
summing the extracted ion chromatogram (EIC) peak areas for a dozen or more co-
eluting features.  Owing to the precision of the Orbitrap, LC-MS features were included 
for integration as a single species if their 12C monoisotopic de-charged masses were 
within 5 ppm of the average of all such features co-eluting in time.  Thus, the 10,122 ion 
features were associated with 3,379 eluting species.  Of these, Mascot error-tolerant 
database searching and accurate mass-matching software identified 1,456 species, 
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comprising 62.5% of all ion abundances, as ions of ApoE3MM modified and unmodified 
peptides.  The remaining signal is predominantly associated with very low-abundance 
species of unknown or +1 charge state and tryptic peptides from catalase.   
Reporting the extent of the characterization of LC-MS/MS protein footprinting 
data is important for conveying the comprehensiveness of the analysis.  While we use a 
“bottom-up” MS-based proteomics methodology, we are not quantifying protein levels 
from a complex mixture with as few as two characteristic peptides, as is typically done in 
proteomics experiments38.  Instead, nearly two thirds of all signal stems from a single 
protein made complex by the labeling experiment; our task is to accurately determine the 
labeling yields localized to many specific sites. 
In addition to observing all standard •OH sidechain products 24, we found 
chemistries not commonly reported.  These include the net loss of 2H at Leu and Val (-
2.0157 D); loss of HSCH2 and gain of OH at Met (-29.9928 D); and the net losses of CO 
(-27.9949 D) and CO2 (-43.9898 D) involving both Asp and Glu residues.  In all such 
cases, the modifications tracked exclusively with FPOP-labeled samples.  Figure 6.1 
shows the evidence for Glu205 -44 D modification and is exemplary of FPOP-specific 
signal but for one aspect.  Typical •OH sidechain outcomes make the peptides more 
hydrophilic than are their unmodified roots; thus, they elute earlier in reverse-phase 
chromatography.  Figure 6.1A shows that the peptide ApoE3MM(192-206) - CO2 elutes 
later than unmodified ApoE3MM 192-206, consistent with the expectation that loss of an 
electronegative oxygen increases hydrophobicity.  
 Figure 6.1:  Quantitative and qualitative LC
and B show two extracted ion chromatograms (EICs).  The top is of m/z 
749.4046±0.0037, the 5 ppm window about the doubly protonated unmodified peptide.  
The bottom is of m/z 727.4097
peptide minus CO2.  Panel A is from FPOP
sample.  Panel C shows the MS
from the FPOP-labeled sample.  The labeled ions are consistent with the characteristic b
and y- CID fragment ions of the 
with the CO2 loss at E205.  Ions with an asterisk carry this 
carry a -18 D water loss. 
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-MS/MS data for ApoE3 192
±0.0036, the 5 ppm window about the doubly protonated 
-labeled sample; panel B is from control 
2
 scan of the CID fragmentation of the modified precursor 
ApoE3 192-206 sequence, AATVGSLAGQPLQER
-44 D loss; ions with a dagger 
-206.  Panels A 
- 
, 
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6.3.2 Per-residue labeling.   
Of ApoE3MM’s 299 residues, 69 were quantifiably detected as modified (Table 
6.1).  The uncertainties are determined by the propagation of the standard errors for the 
triplicate-averaged FPOP and control levels.  The modifications are of those reported for 
•OH-mediated labeling: +16 Da for most residues; +14 Da for aliphatic residues; +32 and 
+48 Da for cysteine, methionine, and tryptophan; +4 for tryptophan; +5, -10, and -23 Da 
for histidine; -2 Da for serine and threonine ; -30 Da for aspartic acid and glutamic acid; 
and -43 Da for arginine.  Seventeen other residues (V2, E7, T8, P10, E11, P12, E13, L14, 
E27, D35, L174, I177, L179, A192, E212, L262, and E281) were detected as modified 
but were of very low abundance and were either not well chromatographically resolved, 
or were of new OH products described above, or both.  These residue signals have not 
been included for the ApoE3MM self-analysis reported here.  
The same-amino acid residue averages for all detected-as-modified residues show 
a trend similar to the reported free amino acid reaction rate with •OH39 and to the MS 
analysis of •OH–amino amide reaction products21 (Table 6.2).  Sulfur-containing residues 
and aromatic residues are the most sensitive towards FPOP labeling, with hydrophobic 
residues next.  Free cysteine is the most •OH-reactive amino acid39, but trails methionine 
and tryptophan in Table 6.2.  This is probably due to the only cysteine residue, C112, 
being significantly buried.   
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Table 6.1: ApoE3MM FPOP labeling yield 
residue FPOP yielda exposureb  residue FPOP yielda exposureb 
K1 3.6 +/- 0.1% exposed  R180 0.37 +/- 0.02% NA 
V6 0.36 +/- 0.01%   L181 0.55 +/- 0.04%  
E19 0.08 +/- 0.01% buried  P183 0.63 +/- 0.02% exposed 
W20 16.0 +/- 0.4%   L184 0.68 +/- 0.04%  
Q21 0.08 +/- 0.01%   V185 0.58 +/- 0.01%  
S22 0.070 +/- 0.006% buried  E186 0.25 +/- 0.01%  
W26 1.1 +/- 0.2% buried  Q187 0.154 +/- 0.008%  
L28 0.53 +/- 0.05%   R189 0.154 +/- 0.008% NA 
R32 0.042 +/- 0.004% NA  V195 1.09 +/- 0.04% exposed 
W34 14.2 +/- 0.2%   S197 0.083 +/- 0.003%  
Y36 1.65 +/- 0.08%   L198 1.13 +/- 0.04%  
M64 1 +/- 1% buried  Q201 0.0160 +/- 0.0006% buried 
M68 4 +/- 1% buried  P202 0.351 +/- 0.005%  
Y74 3.8 +/- 0.7% exposed  L203 1.67 +/- 0.05% exposed 
E80 0.25 +/- 0.02%   E205 0.84 +/- 0.02% exposed 
L82 0.190 +/- 0.006% buried  W210 16.4 +/- 0.4%  
P84 0.72 +/- 0.04% exposed  M218 22 +/- 3%  
V85 0.48 +/- 0.04%   K233 0.389 +/- 0.004% buried 
E87 0.76 +/- 0.02% exposed  K242 0.55 +/- 0.01% buried 
E88 0.59 +/- 0.03%   L243 1.03 +/- 0.06%  
M108 5. +/- 1.% buried  E244 0.49 +/- 0.02%  
C112 7 +/- 2% NA  Q248 0.25 +/- 0.02% exposed 
V116 0.37 +/- 0.02%   I250 0.70 +/- 0.06% NA 
Y118 0.37 +/- 0.02% buried  R251 0.027 +/- 0.001% NA 
V122 0.12 +/- 0.01% buried  E255 0.124 +/- 0.003% buried 
M125 47 +/- 5% exposed  R260 0.124 +/- 0.003% NA 
L126 2.0 +/- 0.1% exposed  F265 1.88 +/- 0.04% NA 
T130 0.39 +/- 0.02%   P267 0.124 +/- 0.002% buried 
L133 0.45 +/- 0.02% buried  M272 33 +/- 2% exposed 
H140 2.0 +/- 0.2%   W276 28.7 +/- 0.8% exposed 
V161 0.20 +/- 0.03% buried  T289 0.85 +/- 0.03%  
Y162 1.92 +/- 0.05%   V294 0.24 +/- 0.03%  
A166 0.076 +/- 0.006% NA  P295 0.24 +/- 0.03%  
R167 0.150 +/- 0.006% NA  H299 2.31 +/- 0.05%  
S175 0.27 +/- 0.02% exposed     
a Each per-residue yield was determined by subtracting the average yield of the residue from triplicate 
control samples from the average yield of the residue from triplicate FPOP samples.  
b Residues marked as “buried” are less than 50% labeled compared to the average labeling of all 
modification-detected residues of the same type.  Residues marked as “exposed” are more than 50% 
labeled compared to the average labeling of all modification-detected residues of the same type.  
Arginine residues are marked as NA because the yield determinations for some Arg residues are biased, 
due to their FPOP-mediated loss of the Trypsin-substrate guanidinium group.  Other residues marked as 
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NA were the only of their kind detected as modified.  
 
Table 6.2: Average 
reactivity per amino acid 
amino 
acid average yield 
M 18.61% 
W 15.27% 
C 6.55% 
K 2.18% 
H 2.17% 
Y 1.93% 
F 1.88% 
L 0.92% 
I 0.70% 
T 0.62% 
V 0.43% 
E 0.42% 
P 0.41% 
R 0.15% 
S 0.14% 
Q 0.12% 
A 0.08% 
 
6.3.3 Basic residue yields.   
The average lysine labeling (Table 6.2) is higher than expected from its free-
amino acid reaction rate39.  This may be due to a bias imparted by using trypsin for 
proteolysis, as seven of eight peptides having a modified lysine are also trypsin-missed- 
cleavage peptides at that lysine (data not shown).  Their yield calculations are each 
relative to the measure of the analogous unmodified trypsin-missed-cleavage peptide, 
whose occurrence is less prevalent due to absence of modification at the interior cleavage 
site.  A more dramatic example of this bias is R180, whose only detected modified signal 
was the loss of its trypsin-substrate guanidinium group (-43 Da) in peptide 
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E179RLGPLVEQGR189; in this case the R180 yield was also re-calculated to include all 
fates of L181GPLVEQGR189 as an approximate measure of the total amount of peptide 
detected at R180.  It is likely that some other arginines have also undergone this 
modification, giving rise to peptides that are too large to validate by MS2.  Owing to these 
uncertainties in yield calculation and modification detection, we will not rely on the 
arginine data for self-comparison analysis presented here.  We note that in a more typical 
state vs. state experiment, the changes in labeling yield for the same arginine between 
states is still a valid, informative comparison. 
6.3.4 Normalized labeling yields and relative solvent accessibility.  
Of the 69 detected-as-modified residues in Table 6.1, sixteen are significantly 
less, and fourteen are significantly more labeled than the average labeling of the same 
kind of residue for each outlier.  There is an approximately linear response to fast 
oxidative-labeling and SASA, incumbent on careful LC-MS/MS analysis40-41.  Without a 
full structure for ApoE3MM, the structure cannot be tested by looking for a correlation of 
residue yield with calculated SASA.  Instead, we have digitized the residue yields to 
indicate whether each is buried, exposed, or neither.  Residues with a high level of 
labeling relative to others of the same-amino acid kind are solvent exposed, whereas 
residues with a low level of labeling are buried.  The exposure annotation in Table 6.1 
was determined by normalizing each residue’s yield with the appropriate average amino 
acid yield in Table 6.2, then employing a > 50% or <-50% threshold relative to the 
average yield to signify relative exposure.  The relative levels for all residues is conveyed 
in Figure 6.2.  If we instead compare each residue to the maximum per-residue 
modification yield in the appropriate set of same-amino acid residues, thresholds of 
 >80% and <26% of the maximum exactly reproduce the average yield
exposed and buried classi
Figure 6.2:  Residue-type
ApoE3MM primary sequence.  The average labeling for each kind of residue (Table 6.2) 
has been used to normalize the residue control
shifted by -1 to put residues exhibiting yields close to their same
average near zero.  Residues with less labeling than their like average are thus below the 
x axis; residues with more labeling than their like average are above the x axis.  B
and exposed cutoff thresholds are shown
respectively. 
 
Note that the y-axis of Figure 6.2 does not convey a measure of the absolute 
SASA at each site.  A residue sidechain SASA analysis of the 
using the GETAREA algorithm with a 
hydrogen sidechain values vary from 64.5 
176.58 Å2 for tryptophan.  Clearly a residue’s SASA is determined both by its structural 
context and by its amino acid identity.  For this reason the labeling yield was normalized 
to the average yield of same
exposure to be amino acid specific.   
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 as horizontal dashed lines at -0.5 and 0.5, 
ApoE31-183 
1.4 Å diameter probe42, shows that maximum non
Å2 for alanine to 184.1 Å2 for arginine and 
-amino acid residues, thus allowing the determination of 
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6.4 Discussion  
6.4.1 LC-MS/MS analysis of protein footprint data.   
This study compares each residue’s labeling, relative to all other detected-as-
modified residues, for a single protein state.  In contrast, in most cases of chemical 
footprinting, two states of a protein are studied (e.g., apo vs. holo, native vs. unfolded)29-
30, 41, 43-45
.  The burden of accurate detection and quantitation for the self-comparison 
experiment employed here is higher than that for the usual state vs. state experiment.  In 
the latter case, it is not important if some modification fates of a residue are overlooked, 
as long as the proteolysis and LC-MS/MS acquisition for each state are done under 
identical conditions (i.e., same-day labeling, proteolysis, and contiguous MS acquisition), 
and the same set of ion signals from each sample’s acquisition are used to calculate the 
yield of modification per residue.  Then the difference in the measured yield at a residue 
between the two states reflects the difference in its solvent accessibility, no matter if 
some residue modification fates are missed.  For example, tryptophan can be 
hydroxylated at several positions on its indole ring.  We typically see these structural 
isomers resolved by reverse phase chromatography (data not shown), but sometimes one 
or more of the Trp-hydroxylated isomers co-elutes with the same peptide hydroxylated at 
a different residue.  In the state vs. state experiment, this mixture EIC peak can be 
omitted because the same tryptophan residue is compared between states, using the same 
modified and unmodified peptide EIC peaks for each state—the mixture peak doesn’t add 
any information the other well-resolved Trp-modified peaks communicate.   
In this study’s self-comparison analysis, all Trp-modified EIC peaks are needed, 
to minimize the bias of underestimation when comparing different tryptophan residues of 
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the single ApoE3MM state.  Of course this applies to all kinds of residues.  For two co-
eluting peptide isomers, a fraction of the mixture peak’s EIC abundance is assigned to 
both peptide isomers, in proportion to the number of MS2 spectra, or spectral counts, 
associated with each peptide isomer.  A few mixture peaks have more than two isomer 
components; mostly these are of the common +15.9949 hydroxylation fate.  We have not 
included this source of signal for any residues in Table 6.1 because of the uncertainty in 
ascribing the appropriate EIC abundance fraction to each component.  In addition, V2, 
E7, T8, P10, and L14 were detected-as-modified, but all of their signal resides in such 
isomer-mixture peaks; consequently, they have not been included in the relative SASA 
analysis here.    
Modification fates can easily be missed in standard proteomics analysis as well.  
Error-tolerant searching via Mascot ensures that many more spectra looking like those of 
ApoE peptides are included: the error tolerant pass improved the ApoE3MM protein 
score to 56,907 from the initial broad database search score of 17,794.  Such database 
matching can introduce unacceptable errors in annotation, requiring manual MS and MS2 
inspection for their correction.  We have developed a generalized VBA software platform 
to organize and assist in the manual validation of hundreds features supporting the data 
reported here, and to determine which EIC peaks are comprised of isomer mixtures and 
provide their spectral counts. 
6.4.2 Comparison of the labeling yields to the ApoE31-183 3D NMR structure.   
 The FPOP footprint of ApoE3MM supports the hypothesis that the full structure 
is comprised in part by an N-terminal domain of similar fold to the ApoE31-183 solution 
phase NMR structure3.  The primary sequences in this region of ApoE3 and ApoE3MM 
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are identical; this invites an analysis of the NMR structure and FPOP data to test if the 
full length monomeric mutant resembles the truncated protein in the 1-183 region.  
Residue sidechain SASA values of ApoE31-183 were calculated by the GETAREA 
algorithm42, using a 1.4 Å diameter sphere to approximate the size of water.  The 
expectation of exact structural concordance between the truncated and full protein is 
unrealistic.  For this reason we have not chosen to use all labeled residues for a by-
residue-type correlation analysis with the appropriate ApoE31-183 SASAs.  Instead we 
reject the hypothesis of similarity if the “outlier” residues, determined by FPOP to be 
buried and exposed, are in fact not in the ApoE31-183 structure.  In Figure 6.3A the 
ApoE3MM buried residues S22, W26, L82, Y118, V122, L133, and V161 are each 
significantly less exposed in ApoE31-183 as well, having SASAs less than 25% of the 
maximum SASA for either Ser, Trp, Leu, Tyr, or Val residues.  Methionine SASA must 
be calculated differently as its product formation starts with •OH addition to its sulfur 
atom23-24; thus, the relevant SASA is of this atom only.  With this correction, residues 
M68 and M108 are also buried in ApoE31-183; given the low maximum methionine sulfur 
SASA in ApoE31-183, M64 should also be considered buried.  In Figure 6.3B, the 
ApoE3MM exposed residues K1, E87, M125, L126, S175, and P183 are also 
significantly more exposed in ApoE31-183, whereas Y74 and P84 are not.  Sixteen of 
nineteen residues of ApoE3MM exhibit FPOP labeling in concordance with the ApoE31-
183 structure; thus the structures may be quite similar with a slight change effecting the 
three discrepant residues. 
 The location of the FPOP-determined buried and exposed residues on the ApoE31-
183 show a strong spatial correlation: residues along the four-helix bundle tend to be 
 Figure 6.3:  The ApoE31
FPOP to be buried or exposed in ApoE3MM
hydrogen sidechain atom surface areas determined by the GETAREA algorithm of the 
ApoE31-183 NMR structure 2kc3.
values; the gray columns are the maximum SASA values per residue type, determined 
from the set of all such residues detected as modified.  Graph A is of buried residues; 
graph B is of exposed residues.  The asterisks mark re
with their exposure classifications.
 
buried, and residues at the loop turns comprising the “end caps” of the bundle tend to be 
exposed (Figure 6.4).  We propose that this is not coincidental, rather that the ApoE3MM 
adopts a similar helix-bundle structure in the 1
FPOP indicates E19, Y74, and P84 differ in ApoE3MM compared to the known structure 
of ApoE31-183.  In the ApoE3
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-183 protein SASA values for the set of residues determined by 
1-299. SASA values are the sums of the non
  The black columns are the individual residue SASA 
sidues exhibiting good agreement 
 
-183 region.  This suggests a reason why 
1-183 structure, these residues are resident in the same end 
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cap, from which the hinge and C-terminal domains are attached in ApoE3MM.  This end 
of the putative four-helix bundle may be more allosterically-sensitive then the rest of the 
protein to the C-terminal domain intra- and inter-domain interactions absent in the 
fragment protein.  There are no significant FPOP vs. SASA discrepancies between the 
structures that suggest a clear region of N- and C- terminal domain interaction, as the 
observed buried residues are turned inward or otherwise masked in the ApoE31-183 
structure.  We cannot conclude that there is no domain-domain interaction in the 
monomeric mutant. 
  
  
Figure 6.4:  A and B are 
residue sidechains shown in bond and heteroatom depiction.  Oxygen atoms are red, 
nitrogen atoms are blue, and sulfur atoms are yellow.  The green residues exhibited FPOP 
labeling 50% greater than th
residues.  The magenta residues exhibited FPOP labeling less than 50% of the average 
labeling among same-amino acid residues.
 
6.5 Conclusion  
The FPOP footprinting data of ApoE3MM provide residue
full monomeric structure’s N
based on a subset of the observed modified residues 
less labeled than the average labeling for residues of the same ki
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two views of the ApoE3 1-183 2kc3 NMR structure, with19 
e average observed labeling among same-amino acid 
 
-resolved 
-terminal-domain resembles ApoE31-183 structure.  This is 
that are significantly more labeled or 
nd.  The thresholds for 
 
evidence the 
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establishing relative exposure was chosen to maximize the inclusion of residues without 
unduly compromising the meaning of “buried” and “exposed”, relative to the size of each 
residue’s sidechain.  This tradeoff is one reason there is not enough conclusive evidence 
to indicate a possible N-teriminal:C-terminal domain interaction, as the subset of buried- 
and exposed-classified residues does not span enough of the C-terminus.  Another is that 
observed attenuated labeling at a site cannot distinguish intra-domain packing and inter-
domain interaction.  We propose it is likely the ApoE3MM N-terminal domain has a 
structure much like ApoE31-183, because the same residues buried in this domain in 
ApoE3MM, as determined by FPOP, are oriented away from solvent in the ApoE31-183 
NMR structure.  FPOP-observed residues buried in the ApoE3MM C-terminal domain 
may be so owing to the C-terminal domain’s inherent structure, or may be due to an inter-
domain interaction.   
The utility of FPOP for prediction of structure when one is not known should be 
done in a digitized approach as we have employed here, to ensure that only residues that 
are clearly delineated are used to test hypotheses.  On the other hand, with a high 
resolution structure of a highly homologous protein, a more rigorous analysis could be 
undertaken to test a hypothesis of close similarity.  Evidence for corroboration is seen 
when the labeling yield correlates in direct proportion to the putative SASA for residues 
of the same amino-acid type.  In either case, the analysis is based on comparing the FPOP 
yields of residues of the same-amino acid type.  This is a more complex analysis than is 
typically done in protein •OH footprinting experiments, which examine the changes in 
protein structure between two states.  Whereas tracking one modification fate of a residue 
can be sufficient to distinguish a SASA difference at that site between two protein states, 
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the experimenter must strive to quantitate all FPOP fates of the protein if a reliable 
judgment is to be made about the relative accessibility of each detected-as-modified 
residue.  Were •OH footprinting not so indiscriminate in its atomic-site targeting, this 
task would be easier.  The benefit to using •OH labeling, however, is that 1) they are so 
promiscuous, allowing many more sites of a protein to be probed; 2) with proper 
chemical control, can sample exclusively native conformations sensitive to 
modifications36; and 3) are very sensitive to SASA40-41. 
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7 β-amyloid 1-42 Binds to the Same Region in the N-
terminus Domains of Apolipoprotein E3 and Apolipoprotein 
E4, Determined by FPOP Footprinting and Mass 
Spectrometric Analysis 
 
7.1 Introduction 
 Alzheimer’s disease (AD) is a form of dementia, effecting more than 35 million 
people worldwide1.  The consensus of research is that AD is caused by the accumulation 
of misfolded proteins in the brain.  Certain β-amyloid (Aβ) peptides are particularly 
susceptible to such misfolding.  Aβ peptides are 36 to 43 amino acids long and originate 
from the sequential proteolysis of amyloid precursor protein, a transmembrane protein of 
unknown function, by β and γ secretases2.  Among these, Aβ1-40 (Aβ40) and Aβ1-42 
(Aβ42) are the most abundant components in the insoluble fibrils comprising a central 
characteristic feature of advanced AD, the senile plaques found in the extracellular space 
of gray matter3.  The “amyloid hypothesis” for AD development is that the dynamic 
equilibrium of soluble Aβ40 and Aβ42 is crucial—factors that increase Aβ peptide 
production or inhibit its clearance allow for their accumulation, which initiates AD and 
the formation of fibrillar deposits4.  This thinking stems in part from the observation that 
the soluble forms of Aβ peptide, especially Aβ42, are known to be neurotoxic5. 
 The highest genetic risk for AD is for homozygous carriers of the apolipoprotein 
E ε4 allele, who are twelve times more likely to develop late onset AD than people with 
two copies of the other common isoforms of apolipoprotein E (ApoE) 6-7.  ApoE is a 34 
kDa protein, whose function is to regulate lipid metabolism and control lipid 
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redistribution in tissue and cells, especially in the brain 8.  The three most common 
isoforms differ at two residues; apolipoprotein E2 (ApoE2) has cysteines at positions 112 
and 158; apolipoprotein E3 (ApoE3) has a cysteine at position 112 and an arginine at 
158, and apolipoprotein E4 (ApoE4) has arginines at these positions.  The protein has two 
distinct domains connected by a thrombin proteolysis-sensitive region9.   The N-terminal 
(Nt) 1-191 residue domain contains the LDL receptor-binding site, and substantial 
fragments of the Nt domain have been characterized by X-ray crystallography and 
solution NMR spectroscopy as having an elongated four-helix bundle structure10-11.  The 
C-terminal (Ct) 216-299 residue domain has not been characterized by high resolution 
methods because of its propensity to oligomerize12.  This property is shared by all of the 
common isoforms of ApoE, and no high resolution structures have been reported. 
 There are several hypotheses that explain the association of ApoE4 with AD13, 
but there is no clear consensus for a single cause.  In the early study that reported this 
association, it was discovered that ApoE binds to Aβ in cerebrospinal fluid6.  Since then 
the hypothesis that ApoE is directly involved in the deposition or clearance of Aβ is 
gaining widespread recognition14.  Vital to understanding this mechanism is the 
characterization of the ApoE-Aβ interaction.  Many studies have undertaken this goal, 
examining the interaction of lipoprotein and lipid-free forms of the common isoforms of 
ApoE and their fragment domains with soluble and insoluble preparations of Aβ40 and 
Aβ42 and Aβ analogs14.  Here we focus on delipidated ApoE interactions.  Several early 
studies showed that lipid-free ApoE binding with soluble Aβ influences fibrillogenesis15-
17
.   The association of lipid-free ApoE with soluble Aβ40 can be tight, with a KD of 10-
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20 nM, but this depends on the conformation of Aβ18-19.  Based on Nt and Ct domain 
fragment studies, there are at least two sites of interaction on ApoE segregated among 
these domains20-23.   None of these studies provide a high resolution characterization of 
the sites because of the oligomeric properties of both biomolecules. 
 Mass spectrometry (MS)-based chemical footprinting of proteins is a method for 
providing peptide and residue-resolved structural information, in the primary sequence 
dimension24-25.  A general strategy is to use this information to provide insight about the 
difference between structures of a protein or protein complex in two or more states, rather 
than resolve their structures in three dimensions.  Labeling that well samples solvent 
accessible residues will be attenuated at protein-ligand or protein-protein interfaces in the 
complex compared to the apo state.  If the labeling is stable, a proteomics-like “bottom-
up” mass spectrometry methodology can be employed, in which modified proteolytic 
peptides from both states are quantified by LC-MS and identified by their MS2 CID 
fragment spectra. 
 An important chemical footprinting method is hydroxyl radical-mediated 
modification of solvent accessible sidechains; a comprehensive review detailing several 
methodologies for •OH generation, expected product chemistry, and mass spectrometric 
analysis has recently been published26.   The advantages of •OH-based footprinting are 
that (1) residue solvent accessibility surface areas (SASAs) are well sampled, because the 
size of •OH is comparable to water; (2) the •OH-mediated modifications are stable and 
thus amenable to proteolytic peptide-based LC-MS/MS analysis; and (3) •OH samples 
residue sidechains non-specifically, detectably reacting with over half of the common 
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amino acids in properly controlled experiments27.  We use the method of fast 
photochemical oxidation of proteins (FPOP), developed by Hambly and Gross28, to 
provide the source of •OH.  This method employs a KrF excimer laser as a pulsed 248 
nm source; each 17 ns flash homolytically cleaves H2O2, added to the sample at a low 
millimolar level.  In the flow cell the resultant •OH reacts with protein sidechains on a 
microsecond timescale as added glutamine competitively scavenges radical.  This ensures 
that only equilibrium conformations are sampled by •OH; any modification-induced 
changes to conformation evolve on a slower timescale29. 
 By FPOP labeling and LC-MS/MS we are able to characterize the sites of 
interaction of Aβ42 with lipid-free ApoE3 and ApoE4.  We have examined this 
interaction at the 4 µM protein level, at which concentration these isoforms are primarily 
tetramers30, and at 100 nM for ApoE3 to probe its putative monomeric interaction with 
Aβ42.  We also report the FPOP-characterized interaction of Aβ40 with ApoE-orangutan 
because of the concordance of results with the human isoforms.     
7.2 Experimental Procedures 
7.2.1 Reagents.   
 Acetonitrile, formic acid, 30% hydrogen peroxide, L-glutamine, L-methionine, 
tris(2-carboxyethyl)phosphine hydrochloride (TCEP), sodium hydroxide, hydrochloric 
acid, catalase, sequencing grade trypsin, and phosphate buffered saline (PBS) were 
purchased from Sigma Aldrich Chemical Co. (St. Louis, MO).  Purified water (18 MΩ) 
was obtained from a Milli-Q Synthesis system (Millipore, Billerica, MA).  ApoE3, 
ApoE4, and Aβ42, each expressed in E. coli, were kindly provided by Drs. K. Garai and 
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C. Frieden.  Aβ40 was purchased from American Peptide Company (Sunnyvale, Ca).  
ApoE-orangutan was purchased from BioVision (Mountain View, CA).   
7.2.2 Stock solution preparations.   
 Purified ApoE3 and ApoE4, provided as solutions in ammonium bicarbonate, 
were dialyzed overnight into PBS. To prevent adventitious disulfide bond formation in 
ApoE3, TCEP was added to 200 µM; ApoE4 also received TCEP to maintain 
background composition equality with ApoE3 samples.  The purity of dialyzed proteins 
was confirmed by ESI MS on a Maxis QTOF spectrometer (Bruker Daltonics, Billerica, 
MA); disulfide-linked ApoE3 dimer was not observed (data not shown).  ApoE3 and E4 
solutions were split among aliquots, then frozen with N2(l) and stored at -80 °C.  ApoE-
orangutan was solubilized in PBS and apportioned and stored by the same protocol.  For 
all ApoE isoforms, stock concentrations were determined by their UV absorbance, with 
ε280 = 44,950 M-1 cm-1.  Lyophilized Aβ40 was solubilized at 1 mg/mL in 10 mM NaOH 
and apportioned and stored by the same protocol.  The stock Aβ42 solution was prepared 
from lyophilized material by solubilizing in 10 mM NaOH to 150 µM concentration; half 
the volume was apportioned to 16.7 µL aliquots for the nanomolar experiments.  The 
remainder volume and aliquots were N2(l)  frozen and stored at -80 °C prior to use.  
Stock glutamine, methionine, catalase, and hydrogen peroxide solutions were prepared in 
PBS on the same days as labeling.  Eppendorf Protein LoBind micro tubes (Eppendorf 
North America, Hauppauge, NY) were used for all protein stock and sample solutions, 
except for de-salting collection that used standard polypropylene microcentrifuge tubes.   
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7.2.3 Micromolar ApoE3 and ApoE4 experiments.   
 Equilibration stock solutions were prepared for ApoE3 and ApoE4 to the final 
concentrations of 4.0 µM protein, 22.2 mM glutamine, and for “Aβ42-present” 
equilibration solutions, 20 µM Aβ42.  For “Aβ42-free” samples, a volume of 10 mM 
NaOH was added equal to the Aβ42 addition in the counterpart equilibration solutions.  
A volume of 100 mM HCl equal to 10% of this addition volume was added to all 
equilibration solutions to maintain the PBS-buffered pH of 7.4.  The equilibration 
solutions were stored 2 hr at 22 °C with no stirring, prior to the first replicate draws for 
FPOP labeling.  Due to the time needed to complete FPOP labeling of each set of 
replicates, the ApoE4 equilibration solution was prepared 1 hr after the ApoE3 solution. 
7.2.4 Micromolar ApoE-orangutan experiment.   
 Three equilibration stock solutions were prepared.  For each, the final 
concentrations of ApoE-orangutan and glutamine was 2.22 µM and 22.2 mM, 
respectively.  The “1:4”, “1:1”, and “1:0” solutions’ Aβ40 concentrations were 8.89, 
2.22, and 0 µM, respectively.  10 mM NaOH was added to the 1:1 and 1:0 solutions to 
maintain equivalence with the 1:4 solution, and all solutions were spiked with a 1% 
volume of 100 mM HCl to return the pH to 7.4.  These solutions were stored 4.5 hr at 22 
°C with no stirring, prior to the first replicate draws for FPOP labeling. 
7.2.5 NanomolarApoE3 experiments.   
 The replicate 100 nM samples were each prepared to final concentrations of 111 
nM ApoE3, 22.2 mM glutamine, and for “Aβ42-present” samples, 5.6 µM Aβ42.  
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Equilibration stock solutions were not used because 25 min elapsed between each 
replicate’s labeling.  During this time the structural state of the system may change due to 
evolving protein-protein, protein-peptide, peptide-peptide, and biomolecule-plastic 
surface interactions. 
 Each replicate sample was processed as follows.  (1) At the time of 150 µM Aβ42 
stock solution preparation, 428 µL of 23.3 mM glutamine in PBS was added to 16.67 µL 
aliquots of either Aβ42 in 10 mM NaOH, or 10 mM NaOH for “Aβ42-free” samples.  
These aliquots were N2(l) frozen and stored at -80 °C.  (2) An aliquot was thawed 12 min 
and vortex-mixed.  (3) Five µL of 10 µM ApoE3 was added to the sample with vortex-
mixing.  (4) The sample was stored 2 hr 5 min at 22 °C, with no stirring.  (5) Hydrogen 
peroxide was added to the sample, and the entire volume was infused through the FPOP 
apparatus.  The standard FPOP protocol is described below.  The collection tube was the 
upper compartment of a 10000 MWCO Vivaspin 500 sample concentrator (GE 
Healthcare, Waukesha, WI), and contained 0.2 µg catalase in 36 µL 150 mM methionine.  
(6) The labeled sample was centrifuged at 13,500 x g for 5 min.  The retentate, typically 
10-20 µL, was transferred to a LoBind tube and left open for 25 min at 22 °C.  (7)  The 
labeled sample was N2(l) frozen and stored at -80 °C prior to proteolysis. 
7.2.6 FPOP labeling.  
 Just prior to FPOP, H2O2 was added to each replicate by 10-fold dilution from a 
concentrated solution, to give a final concentration of 20 mM.  Replicate draws from the 
equilibrium stock solutions were 40 µL for the ApoE3 and ApoE4 µM experiments and 
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90 µL for the ApoE-orangutan µM experiment.  The FPOP apparatus was essentially the 
same as originally described 28, using 150 µm ID fused silica.  The KrF excimer laser 
(GAM Laser Inc., Orlando, FL) was focused to give a 2.54 mm irradiation window on the 
silica.  The laser power, laser pulse frequency, and syringe pump flow rate were adjusted 
to the following values.  For ApoE3 and ApoE4 µM experiments, these were 47.6 
mJ/pulse, 5 Hz, and 17.95 µL/min.  For the ApoE-orangutan µM experiment, these were 
45.0 mJ/pulse, 5.5 Hz, and 18.52 µL/min.  For the ApoE3 nM experiment, these were 
47.0 mJ/pulse, 10 Hz, and 35.9 µL/min.  These flow rate and pulse frequency settings 
ensured at least a 20% exclusion volume to avoid repeat •OH exposure29.  For µM 
experiments, each replicate was collected in a microcentrifuge tube containing 0.2 µg of 
catalase in 10 µL of methionine solution, to give a final concentration of 10 mM Met in 
the total collected sample volume.  The addition of Met was to mitigate post-FPOP 
oxidation of protein 31.  For µM experiments, catalase was allowed to oxidize H2O2 to 
O2(g) for 10 min at room temperature with pipette mixing; O2(g) was removed by three 
centrifugation steps during the incubation.  After 10 min, samples were N2(l) frozen by 
and stored at -80 °C prior to proteolysis.  For all experiments, control samples were 
handled in the same manner as those submitted to FPOP, but they were not laser 
irradiated.  All experiments generated three replicates for each FPOP state and each 
control state, with the replicates’ origin preceding the FPOP step. 
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7.2.7 Proteolysis.   
 Micromolar experiment samples were proteolyzed with 8:1 protein:trypsin (by 
weight) at 37 °C for 7 hr.  Trypsin activity was quenched with 10% formic acid addition, 
and the samples were SpeedVac-concentrated 30-60 min to 30 µL.  Samples were de-
salted by ZiptipC18 (Millipore, Billerica, MA), with elution into 10 µL of 50% 
acetonitrile/1% formic acid solution.  A portion of each was diluted 33-fold with water 
and 0.1% formic acid for autosampler loading in its LC-MS/MS analysis.  Nanomolar 
experiment samples were proteolyzed with 0.1 µg trypsin at 37 °C for 9 hr before 
quenching with formic acid.  They were ZiptipC18 de-salted without prior SpeedVac-
concentration, eluted directly into autosampler vials containing 2 µL of the elution 
solution, and diluted with 50 µL of water. 
7.2.8 LC-MS/MS acquisition.   
 Each replicate was loaded by autosampler onto a 20 cm column with a PicoFrit tip 
(New Objective, Inc, Woburn, MA), bomb-packed with C18 reverse phase material 
(Magic, 0.075 mm × 200 mm, 5 µm, 300 Å, Michrom, Auburn, CA).  For µM samples 
the load volume was 5 µL; for nM samples it was 7 µL.  Peptides were eluted by an 80 
min, 260 nL/min gradient coupled to the nanospray source of an LTQ-Orbitrap mass 
spectrometer (Thermo Fisher, Waltham, MA).  Mass spectra were obtained at high mass 
resolving power (100,000 for ions of m/z 400) on the Orbitrap component, and the six 
most abundant ions eluting per scan were each subjected to CID MS2 experiment in the 
LTQ component, using a collision energy 35% of the maximum, a 2 Da isolation width, 
192 
 
and wideband activation.  Precursor ions were added to a dynamic exclusion list for 8 s to 
ensure good sampling of the apex of their elution peaks.  Blanks were run between every 
sample acquisition. 
7.2.9 Data Analysis.   
 Rosetta Elucidator (Microsoft, Bellevue, WA) peak detection and alignment 
software was used to generate an aligned LC-MS feature tables for each sample 
acquisition.  Briefly, a feature represents the naturally occurring isotopic ensemble of one 
molecule eluting in time.  A feature’s ion signal is split among its isotopes and sometimes 
among several charge states depending on its basicity and the ionization conditions at the 
MS source.  A feature’s quantitation is determined by summing the areas of all such co-
eluting LC-MS extracted ion chromatogram (EIC) peaks that share the same 
monoisotopic mass within a high resolution tolerance (5 ppm). 
 All sample replicates from the same experiment were subjected to a single 
alignment analysis so that their shared features nearly co-eluting in time would have the 
same unique ID and aligned elution time in the tables.  The alignment program also 
associated the all MS2 spectra with their LC-MS features using the same unique ID 
nomenclature.  Independent from the Elucidator analysis, the MS2 spectra were searched 
against a restricted database containing the ApoE isoforms, Aβ peptides, catalase, and 
other proteins using Mascot error-tolerant searching.  Common OH modification 
products26 were included in the variable modification list used by Mascot.  A custom 
Excel-based VBA program paired the Mascot calls with their LC-MS quantified features 
using the unique ID handles.  This program augmented these LC-MS Mascot annotations 
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with putative matches to a theoretical FPOP-modified tryptic peptide list of the ApoE 
isoforms.  These putative matches, and over half of the Mascot calls, were validated, 
corrected, or rejected by manual inspection of their associated MS2 spectra before their 
use in per-peptide and per-residue yield analysis.   
 Per-residue yields were calculated according to equation 1. 
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Here peptide is synonymous with feature and i is not the index of summation.  The 
denominator includes modified and unmodified peptides alike.  The denominator 
excludes signal from missed-cleavage peptides spanning residuei if such peptides are not 
also detected as modified there, because in this case the lack of modification detection is 
an analytic failure and does not stem from a true absence of labeling.  Per-peptide yields 
were determined more simply according to equation 2. 
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7.2.10 Utility of per-peptide and per-residue analyses.  
 The peptide-level survey is warranted because it is the most inclusive of LC-MS 
feature data, and is easily interpreted.  The per-peptide analysis uses modified peptide 
features whose peptide identity is certain but whose modification residue(s) cannot be 
determined by the associated MS2 spectrum or spectra.  Such indeterminateness is 
possible when an MS2 spectrum is sparse, the modification is in a peptide region 
insensitive to CID fragmentation, or multiple modifications are present on the peptide.  
The per-peptide analysis also uses LC-MS features that are clearly comprised of modified 
194 
 
peptide isomers without regard to which modified peptide is the most abundant species in 
the mixture peak.  For these reasons, the per-peptide analysis provides the most accurate 
measure of region-by-region footprinting yield.  On the other hand, the most •OH-
reactive residues, especially methionine and tryptophan 27, 32-33, dominate the signal 
contribution in peptides bearing them when they are solvent accessible in the protein.  A 
per-residue level analysis rescues the SASA insight neighboring less-reactive residues 
may inform, as it provides a primary sequence-resolved analysis of structure for all 
residues detected as modified.  The drawback of this analysis is that uncertain 
modification features and some mixture features cannot be used, though their peptide 
sequences are clearly identified. 
7.3 Results 
7.3.1 Micromolar ApoE3 and ApoE4 experiments.   
 A survey at the peptide level for both proteins indicates one shared region of 
protection, ApoE33-38, in the Aβ42-present state compared to the Aβ42-free state 
(Figure 7.1).  This peptide yield, shown as a red bar for the Aβ42-free ApoE3 and ApoE4 
states, is 50% more labeled than the Aβ42-present state for both isoforms.  The same 
modified and unmodified peptide LC-MS features were used in the comparison yield 
calculations, and the modifications were created by exact adherence to the labeling 
protocol repeated within a two hour timeframe.  These two facts mean the only 
explanations for the differences in FPOP-labeling between Aβ42-present and free states 
is due to (1) steric protection from •OH by direct interaction with Aβ42 in this region, (2) 
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steric protection from •OH by an allosteric response to ApoE-Aβ42 interaction, or (3) 
adverse radical scavenging by Aβ42.  The latter explanation is not likely, given the 
equivalence in labeling seen for much of the rest of the protein.  In particular, the C-
terminal domain does not show regions of interaction at the micromolar level.  The 
peptide 120-134 is significantly more labeled in the ApoE3 Aβ42-present state than the 
ApoE3 Aβ42-free state, but the opposite trend is seen for ApoE (Figure 7.1C). 
 At the per-residue resolved level, W34, Y36, and R167 are significantly more 
protected in the Aβ42-present state than the -free state for both ApoE3 and ApoE4 
(Figure 7.2).  P293 shows the same trend in ApoE3, while E80 and L252 are less 
protected in the Aβ42-present state than the -free state for ApoE4.   Once again, we 
attribute these differences to the interaction of Aβ42 with ApoE, though the effects at 
E80 and L252 in ApoE4 are small.  The differences plotted in Figure 7.2 are only those 
deemed significant by a Student’s t-test at 95% confidence, and they are each normalized 
to the maximum yield observed in the set of same-amino acid-type of residues (all 
differences are calculated from the per residue yields listed in Supporting Information 
Table 7.1).  This is done to lend a significance to the magnitude of the difference, 
because amino acids have inherently different reaction rates to •OH33.  The factors 
affecting the protein rate of labeling in FPOP, such as laser power and protein 
concentration, can vary between experiments; therefore, normalization is based on 
experiment yields and not external standards.  We interpret a normalized change of 1 to 
approximate full exposure of the residue in the comparison.  Thus, at least half of the 
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potential SASA of W34, Y36, and R167 is obscured in the Aβ42-present state for both 
proteins. 
 Forty-four residues spanning the full length of both proteins show no statistical 
change in labeling with the addition of Aβ42, consistent with the per-peptide analysis 
(Figure 7.2, red marks; Supporting Information Table 7.1).  For these regions we 
conclude there is not a strong interaction with Aβ42.  Two regions are under-sampled in 
our analysis.  Region 39-61 does not possess any intervening trypsin active sites.  The 
analytic detection of large peptides of this kind is problematic for online chromatography 
optimized for smaller proteolytic peptides, and the MS2 CID fragment spectra of 
modified large peptides often can’t resolve the modifications’ residue locations.  Region 
135-158 is weakly sampled because the FPOP signal can be split among dozens of small 
tryptic and semi-tryptic peptides by virtue of basic residues at positions 136, 142, 143, 
145, 146, 147, 150, 157, and 158. 
  
  
 Figure 7.1:  Comparison of the tryptic
wild type isoforms ApoE3 and ApoE4 in A
protein.  The length of each bar confers the sequence length of the peptide.  Peptides less 
than 7% of each state’s maximum ApoE peptide abundance are not shown for clarity, as 
they typically are overlapping missed
peptides.  Panel A plots the FPOP labeling yield for
state in black and -free state in red.  Standard errors for each yield measurement are 
shown in blue.  The background modification fract
All peptide pairs for the peptide states are shown; some black bars are obscured by red 
bars when the peptides have equivalent labeling yields.  Panel 
ApoE4 Aβ42-present and 
compares the apo/holo differential yield of ApoE3 (green) and ApoE4 (orange). 
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-peptide-resolved FPOP labeling yields for
β42-present and Aβ42-free states at 4 
-cleavage or short peptides spanning the displayed 
 ApoE3 peptides in the A
ion per peptide has been subtracted.  
B plots the per
-free states’ results, with the same color scheme.  Panel 
 
 the 
µM 
β42-present 
-peptide 
C 
 
 Figure 7.2:  Comparison of the residue
ApoE4 in Aβ42-present and A
significant differences in FPOP labeling yield between each state, per residue, normalized 
by the maximum yields observed among all residues of the same amino acid types.  
Significance is determined at 95% confidence by 
with red were detected as labeled in both states but their labeling difference was not 
significant.  Panel B similarly plots the ApoE4 per residue data.
  
 Both W34 and Y36 are resident in the same tryptic peptide of 
alternative explanation for the FPOP yield depression of these residues in the A
present state, is that the detection of the unmodified peptide 
the Aβ42-free samples by an ESI bias.  This unmodified peptide’s signa
contributor to the denominator in the yield calculations for both residues.  The EICs of 
unmodified F33WDYLR38
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-resolved FPOP labeling yields for ApoE3 and 
β42-free states at 4 µM protein.  Panel A plots the ApoE3 
the Student’s t-test.  Residues marked 
 
ApoE.  One 
F33WDYLR38
l is the major 
 
in sample acquisitions from each state show that the 
 
β42-
 
is attenuated in 
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unmodified peptide is apparently less abundant in the Aβ42-free state (Figure 7.3A, top 
panel), while the +15.9949 Da-modified peptide EICs exhibit the opposite trend (Figure 
7.3A, bottom panel).  The full MS spectra, averaged from the Orbitrap scans made during 
the elution of unmodified F33WDYLR38, shows that this depression is not owing to ion 
suppression, a major source of ESI bias34.  This follows because the spectra are highly 
similar between states, and no other ions are observed at high abundance (Figure 7.3B). 
7.3.2 Nanomolar ApoE3 experiment.  
 Only region16-25 shows a significant attenuation in labeling in the Aβ42-present 
state compared to the Aβ42-free in the 111 nM ApoE3 experiment (Figure 7.4).  No other 
regions show the opposite trend, though several, including 26-38, are silent in the FPOP 
analysis due to the complications of working with very dilute protein solutions.  At nM 
levels protein adsorption may have a significant effect on the system state: in a separate  
preliminary experiment we observed that β-lactoglobulin, an 18.3 kDa globular protein, 
is depleted 86% by the same sample handling steps described here (data not shown).   
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Figure 7.3:  LC-MS data underlying the yield calculations for W34 and Y36 in the 4 µM 
ApoE3 Aβ42-present and -free states.  In panel A, the upper two extracted ion 
chromatograms (EIC), at 450.2241+/- 0.0023 m/z, show LC-MS peaks eluting from 51.0 
to 51.3 min in the Aβ42-present  (black) and Aβ42-free (red) samples; by their accurate 
precursor ion m/z and MS2 fragmentation spectra, these features are identified as the 
unmodified doubly protonated peptide F33WDYLR38.  The lower two EIC, at 
458.2216+/- 0.0023 m/z, show several features shared by each sample; these are 
identified as isomers of hydroxylated F33WDYLR38; their residue-resolved sites of 
modification are indicated.  In all EIC the relative intensity is determined relative to the 
base peak intensity of the unmodified F33WDYLR38 Aβ42-present EIC; the modified 
peptide EICs are shown on a magnified scale.  In panel B, an average mass spectrum is 
shown for the 10 high resolution Orbitrap spectra acquired from 51.0 to 51.3 min.  The 
black trace is for the Aβ42-present sample; the red trace is for the Aβ42-free sample.  
Peaks at 450.224 and 899.439 correspond to doubly and singly protonated unmodified 
F33WDYLR38, respectively.  The zoomed inset of the spectrum about 450.224 shows the 
characteristic half-m/z 13C spacing for doubly-charged ions. 
 
 Figure 7.4 presents per-peptide data in a different way than Figure 7.1 and Figure 
7.2, due to an additional limitation imposed by chromatographic variance.  Each plotted 
value is the average of yield differences, not difference in average yields, between states, 
 normalized by the standard deviation and with control yield levels subtracted.  The LC
MS/MS acquisitions of the triplicate samples from the two treatments (FPOP and control) 
of the two states (Ab42-present and 
three replicate groups by virtue of their acquisition time.  The same column was used for 
each sample’s LC-MS/MS acquisition, though not consecutively, and significant shifts in 
elution times were observed between the sets of replicates.  Consequently LC
alignment and subsequent analysis was employed three times.  Normally, averaging 
yields for their comparison between states requires using the same EIC features for both 
states to avoid potential state bias.  We can’t ensure this requirement with three 
independent analyses, and thus plot the average of their independent results at the peptide 
level.  This limits the confidence with which we may make conclusions; nevertheless, the 
ApoE 16-25 peptide shows a very compelling increase in labeling in A
Figure 7.4:  Significance plot comparing the tryptic peptide FPOP labeling yields of 100 
nM ApoE3 in Aβ42-present and A
yield difference was calculated from three singlicate state vs. state compariso
quotient of this average with the standard deviation is plotted.  The length of each bar 
confers the sequence length of the peptide.
 
 
201 
–free, for a total of 12 samples) were segregated into 
β42
β42-free states.  The average state vs. state peptide 
 
 
-
-MS peak 
-free samples.  
 
ns; the 
 7.3.3 Micromolar ApoE
 Eight µM Aβ40 inhibits the FPOP labeling of 2 
the same sites as seen for A
(Figure 7.5).  In this preliminary experiment with a homolog of human ApoE, two levels 
of Aβ40 were tested together with an A
W34, Y74, L82, and W264 were most protected in the 1:4 ApoE:A
W264, the same residues showed intermediate protection in the 1:1 ApoE:A
Figure 7.5:  Residue-resolved FPOP labeling yields of the subset of residues 
a significant attenuation trend between three ApoE
orangutan in its Aβ40-free is shown as white specked columns, 2
columns, and 8 µM Aβ40 as black columns.
 
7.4 Discussion 
7.4.1 ApoE N-terminus 
 The data from the four experiments presented here suggest that there is an 
interaction between the ApoE variants and A
significantly lower levels of labeling in the A
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-orangutan experiment.   
µM ApoE-orangutan 
β42 in nM ApoE3 and µM ApoE3 and ApoE4 experiments 
β40 absent state.  Residues L14, W20, 
β40 state; except for 
  
-orangutan:Aβ40 states.  2
µM Aβ40 as gray 
 
domain-Aβ interaction.   
β (Figures 7.1, 7.2, 7.4, 7.5).  All show 
β-present state in the Nt domain.   
in several of 
W26, 
β40 state. 
that exhibit 
µM ApoE-
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Importantly, various residues in the 16-36 region are protected by Aβ in all experiments.  
Though the full lipid-free structure of ApoE is unknown, it is instructive to map the Aβ-
present state-protected sites in the Nt domains from the ApoE3, E4, and orangutan 
isoforms onto a single structure that models these domains; we have chosen the NMR 
solution phase structure of the ApoE3 1-18310 (Figure 7.6).  This choice is warranted for 
ApoE3 and ApoE4 because their X-ray crystal structures of their Nt domain fragments 
are highly similar11, 35.  Moreover, the full length proteins have a similar FPOP footprint 
in this region (Figure 7.1), which we’ve reported in a recent study (supplementary 
manuscript).  In the Nt domain, the 97% sequence homology between ApoE3 and ApoE-
orangutan suggests close structural homology as well. 
 Sites of protection are located along helix 1 and at its turn towards the N-
terminus, as well as at other sites residing in the loops connecting the four helices at the 
same end of their four-helix bundle (Figure 7.6).  Residues W26 and Y74 form a surface-
accessible patch on the Nt NMR structure; in the ApoE-orangutan structure these residues 
are clearly protected in the Aβ40-present state (Figure 7.6, green residues).  That this 
finding is for residues non-contiguous in sequence lends credence to the structural 
interpretation of these footprinting results.  Furthermore, the fact that three proteins in 
four experiments exhibit a similar response reinforces the conclusion that ApoE 16-36 is 
central to the Nt interaction with Aβ peptide. 
 Evidence for this interaction is not unprecedented.  Evans and colleagues23 
showed that the Nt fragment of ApoE3 inhibits the amyloid fibril formation, and Chan 
and colleagues22 observed the ApoE3 Nt-Aβ complex by dot blot analysis of gel filtration 
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fractions.  Golabek and colleagues21 determined the separate affinities of the ApoE3 Nt 
domain and Ct domain for Aβ40, with KDs of ~11 nM and 45 nM, respectively.  A recent 
MD study suggests that Aβ40 monomer will form a stable complex with the Nt domains  
of ApoE3 and ApoE4, with the interaction region comprising the adjacent 1st and 4th 
helices 36.  In this study, Luo and colleagues used the X-ray crystal structures of ApoE2, 
ApoE3 and ApoE4 Nt domain fragments, and the SDS-induced α-helical structure of 
Aβ40 determined by NMR spectroscopy37, as a starting point in the subsequent energy 
minimization, rigid-body docking, and MD simulations.  Germaine to our finding is their 
conclusion of the interaction region, which clearly involves a direct interaction with W34 
for both isoforms.  Y36 may also experience a change, though it is oriented more towards 
the 2nd helix of the four-helix bundle in the variant structures.  Due to the high number of  
 Figure 7.6:  Mapping of various per
onto the ApoE31-183 2kc3 NMR s
variant of ApoE3 absent A
protection for both ApoE isoforms in the 4 
Aβ42-free state.  The green residues exhibited significant protection in the 
orangutan, 8 µM Aβ40 state, compared to the A
yellow, shows significant protection for the 100 nM ApoE3:5 
to its Aβ42-free state.  Relative to the A
shows more labeling in the 4 
µM ApoE4:20 µM Aβ42 state.
 
basic sites spanning 135-158, there is no residue
interaction with the 4th helix.  A striking result from their study is that in the simulations 
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tructure10.  This NMR structure is of the 
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µM Aβ42 state, compared 
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the ApoE4 Nt domain reorganizes its conformation to accommodate Aβ40, whose 
orientation is flipped head-to-tail from the ApoE3 Nt domain-Aβ40 complex.  Such 
reorganization, an indirect consequence of the C112R mutation, may explain the 
difference in the Aβ42-induced response we observe at E80 and region 120-134 for 
ApoE3 compared to ApoE4.   
7.4.2 ApoE C-terminus domain-Aβ interaction.  
 While ApoE3 P293 is protected in the micromolar ApoE3 Aβ42-present state 
(Figure 7.2A), most of the modified fates of ApoE3 283-299 show no such trend (Figure 
7.1A).  Furthermore, the remaining regions of the Ct domain for both ApoE3 and ApoE4 
appear to be only slightly affected by the presence of Aβ42 in the 4µM experiments if at 
all (Supporting Information Table 7.1).  In particular, W264 and W276 show a concerted 
negative change in their modification levels in the Aβ42-present state relative to the –free 
state.  Taken together these may convey significance, but individually they are not 
statistically different.  Phu and colleagues20 have characterized the interaction of ApoE3 
201-299 (encompassing part of the thrombin-active hinge region as well as the Ct 
domain) and Aβ42 by monitoring the FRET between an Aβ42-attached fluorophore and 
ApoE Trp, and suggested that binding occurs in the vicinity of W264 and W276.  In their 
study of the Nt and Ct domains of ApoE3, Golabek and colleagues also observed Aβ40 
complexation, but with 4-10 fold weaker affinity than with the Nt domain21.  These 
studies were conducted in the same protein concentration regime (2-12 µM) as our 
micromolar experiments.  This allows comparison with our FPOP state change results for 
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the ApoE3 and ApoE4 µM experiments, and we find corroboration: (1) that a strong 
interaction region is localized to a region on the Nt domain; (2) a weaker interaction may 
be present in the Ct domain. 
7.4.3 Implications of the ApoE oligomeric state.   
 At µM levels, both ApoE3 and ApoE4 are mostly tetramers9, 12, 30, 38-39.  In an 
FPOP comparison study of a monomeric mutant of ApoE3 and WT ApoE3, we observed 
a significant change in the solvent accessibility of regions 181-221 and 242-290 
(supplementary manuscript).  Whatever interaction may be favored with Aβ in this 
region, we do not observe the kind of changes characteristic of the disruption of 
oligomeric structure witnessed in the monomeric mutant.  The fact that the 1-191 Nt 
domain is mostly not involved in oligomerization implies that the tetramer may take up 
four Aβ peptides independently, and it motivates our use of the monomeric Nt domain 
structure for mapping interaction sites (Figure 7.6).  This also predicts that the ApoE3 
monomer should show the same Aβ interactions in the Nt domain.  The 111 nM ApoE3 
experiment was conducted to footprint the WT monomer-Aβ42 interaction, because at 
this concentration ApoE3 is primarily monomeric30.  While peptide 33-38 is not well 
sampled in the experiment owing to post-labeling adsorption, the neighboring peptide 16-
25 shows significant protection.  If the underlying interaction with Aβ42 is proximal to 
both peptides, our prediction is validated.  
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7.4.4 Heterogeneity of participants.  
 The characterization of the insoluble aggregate or fibrillar content of Aβ42 and 
Aβ40 was not undertaken in the experiments, though a common starting point established 
for all replicates.  The introduction of Aβ42 from a thawed high pH stock solution to a 
final concentration of 0.09 mg/mL in PBS at 22 °C will initiate self associations that 
ultimately produce the spectrum of soluble oligomer and insoluble amyloid species40.  
Moreover, the 4 µM state of ApoE3 and ApoE4 cannot be describe exclusively as 
tetrameric, as higher order oligomers are present as well 9, 12, 30, 38-39.  Probing the 
complicated evolving state of the mixture of these biomolecules without employing an 
artificial simplification—such as using domain fragments, denaturants, or fluorophore 
labeling—risks missing important interactions whose characteristic change in signal is 
only presented by a subset of the molecules.  We have nevertheless undertaken such 
experiments, enabled by the sensitivity of FPOP and LC-MS/MS analysis to physiologic 
SASA.  The finding of significant results is more compelling in light of the inherent 
complexity of the system. 
7.5 Conclusion 
 ApoE 16-36, and W34 in particular, comprises a region in both ApoE3 and 
ApoE4 that is a site of direct Aβ42 interaction.  It may instead be a site of allosteric 
protection, induced by Aβ42 interaction elsewhere, but in the same domain only R167 
shows a similarly significant protection.  We propose that its protection is rather induced 
by the interaction of Aβ42 with ApoE16-36, based on a recent MD study of the Nt 
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fragment and Aβ4036.  This study has focused on the regions of interaction on ApoE3 and 
ApoE4 with Aβ peptide.   Owing to the use of excess levels Aβ42 as ligand, we cannot 
yet conclude which regions of Aβ42 peptide interact with ApoE3 or ApoE4.  Mass 
spectrometry-based FPOP footprinting is equally amenable to addressing this question, 
and is where we turn next in understanding this important interaction. 
7.6 Supporting Information 
Supporting Information Table 7.1: FPOP labeling yields1 for the 4 µM experiments 
residue ApoE3:Ab ApoE3 ApoE4:Ab ApoE4 
V6 0.20 +/- 0.01% 0.207 +/- 0.006% 0.210 +/- 0.007% 0.19 +/- 0.02% 
L14 0.097 +/- 0.005% 0.098 +/- 0.005% 0.095 +/- 0.005% 0.098 +/- 0.004% 
W20 3.8 +/- 0.4% 4 +/- 1% 2.8 +/- 0.9% 3 +/- 2% 
W26 0.4 +/- 0.2% 0.4 +/- 0.7% 0.2 +/- 0.6% 0.7 +/- 0.6% 
W34 15 +/- 1% 22 +/- 1% 17 +/- 1% 27 +/- 1% 
Y36 2.9 +/- 0.2% 3.81 +/- 0.08% 3.2 +/- 0.3% 4.9 +/- 0.4% 
M64 9 +/- 2% 9 +/- 2% 6 +/- 1% 6 +/- 3% 
M68 7 +/- 2% 7 +/- 2% 4 +/- 1% 4 +/- 2% 
Y74 3.28 +/- 0.03% 3.4 +/- 0.2% 2.8 +/- 0.2% 3.3 +/- 0.1% 
E77 0.094 +/- 0.007% 0.075 +/- 0.002% 0.09 +/- 0.01% 0.078 +/- 0.002% 
E80 0.09 +/- 0.01% 0.075 +/- 0.003% 0.093 +/- 0.002% 0.072 +/- 0.003% 
V85 0.085 +/- 0.008% 0.091 +/- 0.003% 0.083 +/- 0.004% 0.08 +/- 0.01% 
K95 1.93 +/- 0.03% 1.8 +/- 0.2% 2.9 +/- 0.2% 3.6 +/- 0.7% 
M108 3.4 +/- 0.9% 1 +/- 2% 2 +/- 1% 3 +/- 2% 
M125 10.5 +/- 0.9% 8 +/- 2% 4 +/- 1% 7 +/- 1% 
L126 0.043 +/- 0.007% 0.055 +/- 0.004% 0.050 +/- 0.003% 0.066 +/- 0.005% 
T130 0.0187 +/- 0.0005% 0.017 +/- 0.001% 0.015 +/- 0.001% 0.0177 +/- 0.0006% 
L133 0.037 +/- 0.001% 0.035 +/- 0.003% 0.031 +/- 0.002% 0.035 +/- 0.001% 
Y162 0.7 +/- 0.5% 0.5 +/- 0.5% 0.0 +/- 0.3% 0.4 +/- 0.3% 
R167 0.1149 +/- 0.0009% 0.156 +/- 0.005% 0.111 +/- 0.008% 0.20 +/- 0.01% 
L181 0.0114 +/- 0.0003% 0.0114 +/- 0.0008% 0.011 +/- 0.001% 0.0097 +/- 0.0005% 
L184 0.12 +/- 0.02% 0.16 +/- 0.03% 0.17 +/- 0.03% 0.132 +/- 0.007% 
E186 0.00 +/- 0.02% 0.04 +/- 0.03% 0.01 +/- 0.03% 0.00 +/- 0.02% 
Q187 0.038 +/- 0.003% 0.033 +/- 0.002% 0.046 +/- 0.004% 0.042 +/- 0.003% 
R189 0.074 +/- 0.004% 0.079 +/- 0.006% 0.073 +/- 0.004% 0.09 +/- 0.01% 
V195 0.050 +/- 0.007% 0.056 +/- 0.002% 0.055 +/- 0.005% 0.060 +/- 0.006% 
S197 0.11 +/- 0.01% 0.111 +/- 0.005% 0.118 +/- 0.005% 0.127 +/- 0.003% 
L198 0.12 +/- 0.02% 0.134 +/- 0.008% 0.135 +/- 0.005% 0.14 +/- 0.01% 
Q201 0.023 +/- 0.001% 0.029 +/- 0.003% 0.033 +/- 0.003% 0.031 +/- 0.005% 
P202 0.049 +/- 0.008% 0.057 +/- 0.008% 0.063 +/- 0.007% 0.06 +/- 0.01% 
L203 0.06 +/- 0.01% 0.063 +/- 0.004% 0.060 +/- 0.004% 0.059 +/- 0.002% 
Q204 0.021 +/- 0.003% 0.022 +/- 0.006% 0.025 +/- 0.004% 0.026 +/- 0.005% 
W210 0.7 +/- 0.3% 1 +/- 1% 0 +/- 1% 0 +/- 2% 
M218 0 +/- 2% 2 +/- 1% 0.0 +/- 0.3% 1 +/- 1% 
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E219 0.0 +/- 0.9% 0.6 +/- 0.3% 0.0 +/- 0.7% 0.5 +/- 0.6% 
M221 2 +/- 2% 1 +/- 1% 0.6 +/- 0.6% 0 +/- 1% 
R226 0.044 +/- 0.006% 0.049 +/- 0.002% 0.052 +/- 0.003% 0.05 +/- 0.01% 
Q248 0.052 +/- 0.002% 0.052 +/- 0.002% 0.048 +/- 0.002% 0.046 +/- 0.004% 
L252 0.048 +/- 0.004% 0.043 +/- 0.004% 0.048 +/- 0.002% 0.031 +/- 0.005% 
E255 0.054 +/- 0.003% 0.051 +/- 0.002% 0.060 +/- 0.003% 0.055 +/- 0.002% 
F257 0.24 +/- 0.07% 0.3 +/- 0.1% 0.16 +/- 0.04% 0.22 +/- 0.06% 
R260 0.107 +/- 0.002% 0.118 +/- 0.006% 0.102 +/- 0.003% 0.116 +/- 0.009% 
W264 12.5 +/- 0.6% 14.1 +/- 0.9% 9.0 +/- 0.4% 10.0 +/- 0.6% 
L268 0.9 +/- 0.1% 0.9 +/- 0.2% 0.5 +/- 0.1% 0.5 +/- 0.1% 
M272 14 +/- 2% 14 +/- 2% 10 +/- 1% 11 +/- 3% 
W276 4.8 +/- 0.2% 5.3 +/- 0.6% 3.4 +/- 0.7% 4.2 +/- 0.8% 
P293 0.200 +/- 0.002% 0.238 +/- 0.009% 0.23 +/- 0.02% 0.25 +/- 0.02% 
N298 0.12 +/- 0.01% 0.11 +/- 0.03% 0.17 +/- 0.03% 0.04 +/- 0.04% 
H299 0.26 +/- 0.04% 0.22 +/- 0.02% 0.22 +/- 0.02% 0.19 +/- 0.02% 
1Each residue’s yield was determined by subtracting the average yield among control replicates from the average yield among 
FPOP replicates. 
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